Document and Entity Information
Document and Entity Information - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2020 | Mar. 01, 2021 | Jun. 30, 2020 | |
Document And Entity Information [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2020 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Year Focus | 2020 | ||
Document Transition Report | false | ||
Entity File Number | 0-28364 | ||
Entity Registrant Name | NORWOOD FINANCIAL CORP | ||
Entity Incorporation, State or Country Code | PA | ||
Entity Tax Identification Number | 23-2828306 | ||
Entity Address, Address Line One | 717 Main Street | ||
Entity Address, City or Town | Honesdale | ||
Entity Address, State or Province | PA | ||
Entity Address, Postal Zip Code | 18431 | ||
City Area Code | 570 | ||
Local Phone Number | 253-1455 | ||
Title of 12(b) Security | Common Stock, $.10 par value | ||
Trading Symbol | NWFL | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Common Stock, Shares Outstanding | 8,226,068 | ||
Entity Public Float | $ 147.9 | ||
Documents Incorporated by Reference [Text Block] | Portions of the definitive Proxy Statement for the 2021 Annual Meeting of Stockholders. (Part III) | ||
Entity Central Index Key | 0001013272 | ||
Amendment Flag | false | ||
Document Fiscal Period Focus | FY |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
ASSETS | ||
Cash and due from banks | $ 19,445 | $ 15,038 |
Interest-bearing deposits with banks | 92,248 | 377 |
Cash and cash equivalents | 111,693 | 15,415 |
Securities available for sale | 226,586 | 210,205 |
Loans receivable (net of allowance for loan losses 2020: $13,150; 2019: $8,509) | 1,397,582 | 916,072 |
Regulatory stock, at cost | 3,981 | 4,844 |
Premises and equipment, net | 17,814 | 14,228 |
Bank owned life insurance | 39,608 | 38,763 |
Accrued interest receivable | 6,232 | 3,719 |
Foreclosed real estate owned | 965 | 1,556 |
Goodwill | 29,290 | 11,331 |
Other intangibles | 530 | 235 |
Other assets | 17,583 | 14,242 |
Total Assets | 1,851,864 | 1,230,610 |
LIABILITIES | ||
Deposits: Noninterest-bearing demand | 359,559 | 207,299 |
Deposits: Interest-bearing demand | 149,692 | 99,366 |
Deposits: Money market deposit accounts | 259,974 | 128,441 |
Deposits: Savings | 232,329 | 161,705 |
Deposits: Time | 533,831 | 360,718 |
Total Deposits | 1,535,385 | 957,529 |
Short-term borrowings | 63,303 | 62,256 |
Other borrowings | 42,459 | 56,438 |
Accrued interest payable | 1,601 | 2,432 |
Other liabilities | 14,331 | 14,527 |
Total Liabilities | 1,657,079 | 1,093,182 |
STOCKHOLDERS' EQUITY | ||
Preferred stock, no par value, authorized 5,000,000 shares, | ||
Common stock, $.10 par value, authorized: 20,000,000 shares issued: 2020: 8,236,331 shares; 2019: 6,340,563 shares | 824 | 634 |
Surplus | 95,388 | 49,471 |
Retained earnings | 93,796 | 86,536 |
Treasury stock at cost: 2020: 10,263 shares; 2019: 12,007 shares | (342) | (400) |
Accumulated other comprehensive income | 5,119 | 1,187 |
Total Stockholders' Equity | 194,785 | 137,428 |
Total Liabilities and Stockholders' Equity | $ 1,851,864 | $ 1,230,610 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Consolidated Balance Sheets [Abstract] | ||
Allowance for loan losses | $ 13,150 | $ 8,509 |
Preferred Stock, No Par Value | ||
Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 |
Common Stock, Par Value Per Share | $ 0.10 | $ 0.10 |
Common Stock, Shares Authorized | 20,000,000 | 20,000,000 |
Common Stock, Shares, Issued | 8,236,331 | 6,340,563 |
Treasury Stock, Shares | 10,263 | 12,007 |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
INTEREST INCOME | ||
Loans receivable, including fees | $ 54,046 | $ 41,889 |
Securities: Taxable | 2,915 | 3,277 |
Securities: Tax exempt | 1,422 | 2,037 |
Interest-bearing deposits with banks | 72 | 81 |
Total Interest Income | 58,455 | 47,284 |
INTEREST EXPENSE | ||
Deposits | 6,610 | 7,139 |
Short-term borrowings | 325 | 468 |
Other borrowings | 1,044 | 1,071 |
Total interest expense | 7,979 | 8,678 |
Net Interest Income | 50,476 | 38,606 |
PROVISION FOR LOAN LOSSES | 5,450 | 1,250 |
Net Interest Income After Provision for Loan Losses | 45,026 | 37,356 |
OTHER INCOME | ||
Other Income | 6,209 | 5,448 |
Net realized gains on sales of securities | 71 | 254 |
Net gain on sale of loans | 527 | 169 |
Earnings and proceeds on life insurance policies | 845 | 830 |
Other | 540 | 465 |
Total Other Income | 7,780 | 6,778 |
OTHER EXPENSES | ||
Salaries and employee benefits | 17,121 | 14,655 |
Occupancy | 3,128 | 2,936 |
Furniture and equipment | 1,020 | 783 |
Data processing and related operations | 2,457 | 1,869 |
Federal Deposit Insurance Corporation insurance assessment | 399 | 153 |
Advertising | 385 | 267 |
Professional fees | 1,062 | 1,113 |
Postage and telephone | 983 | 834 |
Taxes, other than income | 997 | 751 |
Foreclosed real estate | 53 | 45 |
Amortization of intangible assets | 114 | 101 |
Merger related | 2,049 | |
Other | 4,672 | 3,804 |
Total Other Expenses | 34,440 | 27,311 |
Income before Income Taxes | 18,366 | 16,823 |
INCOME TAX EXPENSE | 3,286 | 2,608 |
Net income | $ 15,080 | $ 14,215 |
EARNINGS PER SHARE | ||
BASIC | $ 2.09 | $ 2.27 |
DILUTED | $ 2.09 | $ 2.25 |
Service Charges And Fees [Member] | ||
OTHER INCOME | ||
Other Income | $ 5,115 | $ 4,450 |
Income From Fiduciary Activities [Member] | ||
OTHER INCOME | ||
Other Income | $ 682 | $ 610 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Consolidated Statements of Comprehensive Income [Abstract] | ||
NET INCOME | $ 15,080 | $ 14,215 |
Other comprehensive income: | ||
Unrealized gain on pension liability | 241 | 375 |
Tax Effect | (51) | (79) |
Investment securities available for sale: | ||
Unrealized holding gains | 4,809 | 7,736 |
Tax Effect | (1,011) | (1,624) |
Reclassification of gains from sale of securities | (71) | (254) |
Tax Effect | 15 | 53 |
Other comprehensive income | 3,932 | 6,207 |
COMPREHENSIVE INCOME | $ 19,012 | $ 20,422 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands | Common Stock [Member] | Surplus [Member] | Retained Earnings [Member] | Treasury Stock [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Total |
Beginning balance at Dec. 31, 2018 | $ 630 | $ 48,322 | $ 78,434 | $ (81) | $ (5,020) | $ 122,285 |
Beginning balance, shares at Dec. 31, 2018 | 6,295,113 | 2,470 | ||||
Net Income | 14,215 | 14,215 | ||||
Other comprehensive income | 6,207 | 6,207 | ||||
Cash dividends declared | (6,113) | (6,113) | ||||
Acquisition of treasury stock | $ (428) | (428) | ||||
Acquisition of treasury stock, shares | 12,797 | |||||
Stock options exercised | $ 3 | 635 | $ 638 | |||
Stock options exercised, shares | 32,350 | 32,350 | ||||
Sale of treasury stock for ESOP | 18 | $ 109 | $ 127 | |||
Sale of treasury stock for ESOP, shares | (3,260) | |||||
Compensation expense related to stock options | 208 | 208 | ||||
Restricted stock awards | $ 1 | 288 | 289 | |||
Restricted stock awards, shares | 13,100 | |||||
Ending balance, shares at Dec. 31, 2019 | 6,340,563 | 12,007 | ||||
Ending balance at Dec. 31, 2019 | $ 634 | 49,471 | 86,536 | $ (400) | 1,187 | 137,428 |
Net Income | 15,080 | 15,080 | ||||
Other comprehensive income | 3,932 | 3,932 | ||||
Cash dividends declared | (7,820) | (7,820) | ||||
Acquisition of treasury stock | $ (108) | (108) | ||||
Acquisition of treasury stock, shares | 3,243 | |||||
Acquisition of UpState New York Bancorp, Inc. | $ 186 | 45,151 | 45,337 | |||
Acquisition of UpState New York Bancorp, Inc., shares | 1,865,738 | |||||
Stock options exercised | $ 2 | 266 | $ 268 | |||
Stock options exercised, shares | 15,530 | 15,530 | ||||
Sale of treasury stock for ESOP | (36) | $ 166 | $ 130 | |||
Sale of treasury stock for ESOP, shares | (4,987) | |||||
Compensation expense related to stock options | 204 | 204 | ||||
Restricted stock awards | $ 2 | 332 | 334 | |||
Restricted stock awards, shares | 14,500 | |||||
Ending balance, shares at Dec. 31, 2020 | 8,236,331 | 10,263 | ||||
Ending balance at Dec. 31, 2020 | $ 824 | $ 95,388 | $ 93,796 | $ (342) | $ 5,119 | $ 194,785 |
Consolidated Statements of St_2
Consolidated Statements of Stockholders’ Equity (Parenthetical) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Consolidated Statements of Stockholders’ Equity [Abstract] | ||
Cash dividends declared | $ 1.01 | $ 0.97 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net Income | $ 15,080,000 | $ 14,215,000 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Provision for loan losses | 5,450,000 | 1,250,000 |
Depreciation | 1,322,000 | 1,005,000 |
Amortization of intangible assets | 114,000 | 101,000 |
Deferred income taxes | 850,000 | 988,000 |
Net amortization of securities premiums and discounts | 1,246,000 | 1,448,000 |
Net realized gains on sales of securities | (71,000) | (254,000) |
Earnings and proceeds on life insurance policies | (845,000) | (830,000) |
Loss (gain) on sales of fixed assets and foreclosed real estate owned | 128,000 | (97,000) |
Net gain on sale of loans | (527,000) | (169,000) |
Mortgage loans originated for sale | (12,312,000) | (4,715,000) |
Proceeds from sale of loans originated for sale | 12,839,000 | 4,838,000 |
Compensation expense related to stock options | 204,000 | 208,000 |
Compensation expense related to restricted stock | 332,000 | 289,000 |
(Increase) decrease in accrued interest receivable | (1,087,000) | 57,000 |
(Decrease) increase in accrued interest payable | (1,006,000) | 626,000 |
Other, net | (7,920,000) | (522,000) |
Net Cash Provided by Operating Activities | 13,797,000 | 18,438,000 |
Securities available for sale: | ||
Proceeds from sales | 24,497,000 | 27,247,000 |
Proceeds from maturities and principal reductions on mortgage-backed securities | 58,876,000 | 33,656,000 |
Purchases | (82,351,000) | (21,543,000) |
Purchase of regulatory stock | (4,001,000) | (6,595,000) |
Redemption of regulatory stock | 7,326,000 | 5,677,000 |
Net increase in loans | (80,770,000) | (77,401,000) |
Purchase of premises and equipment | (749,000) | (1,623,000) |
Proceeds from sales of foreclosed real estate owned | 612,000 | 556,000 |
Proceeds from sales of bank premises and fixed assets | 10,000 | 246,000 |
Acquisition, net of cash and cash equivalents acquired | 15,193,000 | |
Net Cash Used for Investing Activities | (61,357,000) | (39,780,000) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Net increase in deposits | 163,743,000 | 10,749,000 |
Net increase in short-term borrowings | 1,047,000 | 9,210,000 |
Repayments of other borrowings | (23,979,000) | (26,846,000) |
Proceeds from other borrowings | 10,000,000 | 31,000,000 |
Stock options exercised | 268,000 | 638,000 |
Sale of treasury stock for ESOP | 130,000 | 127,000 |
Acquisition of treasury stock | (108,000) | (428,000) |
Cash dividends paid | (7,263,000) | (6,041,000) |
Net Cash Provided by Financing Activities | 143,838,000 | 18,409,000 |
Net Increase (Decrease) in Cash and Cash Equivalents | 96,278,000 | (2,933,000) |
CASH AND CASH EQUIVALENTS - BEGINNING | 15,415,000 | 18,348,000 |
CASH AND CASH EQUIVALENTS - ENDING | 111,693,000 | 15,415,000 |
Supplemental Disclosures of Cash Flow Information | ||
Interest paid | 8,810,000 | 8,052,000 |
Income taxes paid, net of refunds | 2,793,000 | 2,407,000 |
Supplemental Disclosures of Cash Flow Information | ||
Transfers of loans to foreclosed real estate owned and repossession of other assets | 592,000 | 1,865,000 |
Dividends payable | 2,139,000 | $ 1,582,000 |
Merger with UpState New York Bancorp, Inc. | ||
Noncash assets acquired: Securities available-for-sale | 13,948,000 | |
Noncash assets acquired: Regulatory stock | 2,487,000 | |
Noncash assets acquired: Loans | 413,535,000 | |
Noncash assets acquired: Premises and equipment, net | 5,529,000 | |
Noncash assets acquired: Accrued interest receivable | 1,426,000 | |
Noncash assets acquired: Deferred tax assets | 1,495,000 | |
Noncash assets acquired: Other assets | 376,000 | |
Total Noncash assets acquired | 438,796,000 | |
Liabilities assumed: | ||
Time deposits | 204,440,000 | |
Deposits other than time deposits | 206,919,000 | |
Accrued interest payable | 175,000 | |
Other liabilities | 6,496,000 | |
Total Liabilities assumed | 418,030,000 | |
Net Noncash Assets Acquired | 20,766,000 | |
Cash Acquired | $ 24,037,000 |
Nature of Operations
Nature of Operations | 12 Months Ended |
Dec. 31, 2020 | |
Nature of Operations [Abstract] | |
Nature of Operations | NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 - NATURE OF OPERATIONS Norwood Financial Corp (Company) is a one bank holding company. Wayne Bank (Bank) is a wholly-owned subsidiary of the Company. The Bank is a state-chartered bank headquartered in Honesdale, Pennsylvania. The Company derives substantially all of its income from bank-related services which include interest earnings on commercial mortgages, residential real estate mortgages, commercial and consumer loans, as well as interest earnings on investment securities and fees from deposit services to its customers. The Company is subject to regulation and supervision by the Federal Reserve Board while the Bank is subject to regulation and supervision by the Federal Deposit Insurance Corporation and the Pennsylvania Department of Banking and Securities. Revenue Recognition Under ASC Topic 606, management determined that the primary sources of revenue emanating from interest and dividend income on loans and investments along with noninterest revenue resulting from investment securities gains, loans servicing, gains on loans sold and earnings on bank-owned life insurance are not within the scope of this Topic. The following presents noninterest income, segregated by revenue streams in-scope and out-of-scope of Topic 606, for the year ended December 31: (dollars in thousands) 2020 2019 Noninterest Income In-scope of Topic 606: Service charges on deposit accounts $ 377 $ 336 ATM Fees 457 384 Overdraft Fees 985 1,380 Safe deposit box rental 102 94 Loan related service fees 1,288 614 Debit card 1,656 1,424 Fiduciary activities 682 610 Commissions on mutual funds & annuities 122 141 Other income 540 465 Noninterest Income (in-scope of Topic 606) 6,209 5,448 Out-of-scope of Topic 606: Net realized gains on sales of securities 71 254 Loan servicing fees 128 77 Gain on sales of loans 527 169 Earnings on and proceeds from bank-owned life insurance 845 830 Noninterest Income (out-of-scope of Topic 606) 1,571 1,330 Total Noninterest Income $ 7,780 $ 6,778 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2020 | |
Summary of Significant Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, the Bank, and the Bank’s wholly-owned subsidiaries, WCB Realty Corp., Norwood Investment Corp. and WTRO Properties. All significant intercompany accounts and transactions have been eliminated in consolidation. The year ended December 31, 2020 includes the acquisition of UpState New York Bancorp, Inc. effective July 7, 2020. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of deferred tax assets, the determination of other-than-temporary impairment on securities, the determination of goodwill impairment and the fair value of financial instruments. Significant Group Concentrations of Credit Risk Most of the Company’s activities are with customers located within its markets in Northeastern Pennsylvania and the New York Counties of Delaware, Sullivan, Ontario, Otsego and Yates. Note 3 discusses the types of securities that the Company invests in. Note 4 discusses the types of lending that the Company engages in. The Company does not have any significant concentrations to any one industry or customer. Concentrations of Credit Risk The Bank operates primarily in Wayne, Pike, Lackawanna, Luzerne and Monroe Counties, Pennsylvania and Delaware, Sullivan, Ontario, Otsego and Yates Counties, New York. Accordingly, the Bank has extended credit primarily to commercial entities and individuals in these areas whose ability to honor their contracts is influenced by the region’s economy. These customers are also the primary depositors of the Bank. The Bank is limited in extending credit by legal lending limits to any single borrower or group of related borrowers. Securities Securities classified as available for sale are those securities that the Company intends to hold for an indefinite period of time but not necessarily to maturity. Any decision to sell a security classified as available for sale would be based on various factors, including significant movement in interest rates, changes in maturity mix of the Company’s assets and liabilities, liquidity needs, regulatory capital considerations and other similar factors. Securities available for sale are carried at fair value. Unrealized gains and losses are reported in other comprehensive income, net of the related deferred tax effect. Realized gains or losses, determined on the basis of the cost of the specific securities sold, are included in earnings. Premiums and discounts are recognized in interest income using a method which approximates the interest method over the term of the security. Bonds, notes and debentures for which the Company has the positive intent and ability to hold to maturity are reported at cost, adjusted for premiums and discounts that are recognized in interest income using the interest method over the term of the security. Management determines the appropriate classification of debt securities at the time of purchase and re-evaluates such designation as of each Consolidated Balance Sheet date. Declines in the fair value of available for sale securities below their cost that are deemed to be other than temporary are reflected in earnings as realized losses. In estimating other-than-temporary impairment losses, management considers (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent of the Company to not sell the securities and it is more likely than not that it will not have to sell the securities before recovery of their cost basis. Regulatory Stock The Company, as a member of the Federal Home Loan Bank (FHLB) system is required to maintain an investment in capital stock of its district FHLB according to a predetermined formula. This regulatory stock has no quoted market value and is carried at cost. Management evaluates the regulatory stock for impairment. Management’s determination of whether these investments are impaired is based on their assessment of the ultimate recoverability of their cost rather than by recognizing temporary declines in value. The determination of whether a decline affects the ultimate recoverability of their cost is influenced by criteria such as (1) the significance of the decline in net assets of the FHLB as compared to the capital stock amount for the FHLB and the length of time this situation has persisted, (2) commitments by the FHLB to make payments required by law or regulation and the level of such payments in relation to the operating performance of the FHLB, and (3) the impact of legislative and regulatory changes on institutions and, accordingly, on the customer base of the FHLB. Management considers the FHLB’s regulatory capital ratios, liquidity, and the fact that new shares of FHLB stock continue to change hands at the $ 100 par value. Management believes no impairment charge is necessary related to FHLB stock as of December 31, 2020. Loans Receivable Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are stated at their outstanding unpaid principal balances, net of an allowance for loan losses and any deferred fees. Interest income is accrued on the unpaid principal balance. Loan origination fees are deferred and recognized as an adjustment of the yield (interest income) of the related loans. The Company is generally amortizing these amounts over the contractual life of the loan. The accrual of interest is generally discontinued when the contractual payment of principal or interest has become 90 days past due or management has serious doubts about further collectability of principal or interest, even though the loan is currently performing. A loan may remain on accrual status if it is in the process of collection and is either guaranteed or well secured. When a loan is placed on nonaccrual status, unpaid interest credited to income in the current year is reversed and unpaid interest accrued in prior years is charged against the allowance for loan losses. Interest received on nonaccrual loans generally is either applied against principal or reported as interest income, according to management’s judgment as to the collectability of principal. Generally, loans are restored to accrual status when the obligation is brought current, has performed in accordance with the contractual terms for a reasonable period of time and the ultimate collectability of the total contractual principal and interest is no longer in doubt. Troubled Debt Restructurings A loan is considered to be a troubled debt restructuring (TDR) loan when the Company grants a concession to the borrower because of the borrower’s financial condition that it would not otherwise consider. Such concessions include the reduction of interest rates, forgiveness of principal or interest, or other modifications of interest rates that are less than the current market rate for new obligations with similar risk. Loans Acquired Loans acquired including loans that have evidence of deterioration of credit quality since origination and for which it is probable, at acquisition, that the Company will be unable to collect all contractually required payments receivable, are initially recorded at fair value (as determined by the present value of expected future cash flows) with no valuation allowance. Loans are evaluated individually to determine if there is evidence of deterioration of credit quality since origination. The difference between the undiscounted cash flows expected at acquisition and the investment in the loan, or the “accretable yield,” is recognized as interest income on a level-yield method over the life of the loan. Contractually required payments for interest and principal that exceed the undiscounted cash flows expected at acquisition, or the “non-accretable difference,” are not recognized as a yield adjustment or as a loss accrual or a valuation allowance. Increases in expected cash flows subsequent to the initial investment are recognized prospectively through adjustment of the yield on the loan over its remaining estimated life. Decreases in expected cash flows are recognized immediately as impairment. Any valuation allowances on these impaired loans reflect only losses incurred after the acquisition. For purchased loans acquired that are not deemed impaired at acquisition, credit discounts representing the principal losses expected over the life of the loan are a component of the initial fair value. Loans may be aggregated and accounted for as a pool of loans if the loans being aggregated have common risk characteristics. Subsequent to the purchase date, the methods utilized to estimate the required allowance for credit losses for these loans is similar to originated loans; however, the Company records a provision for loan losses only when the required allowance exceeds any remaining credit discounts. The remaining differences between the purchase price and the unpaid principal balance at the date of acquisition are recorded in interest income over the life of the loans. Mortgage Servicing Rights Servicing assets are recognized as separate assets when rights are acquired through purchase or through the sale of financial assets. Capitalized servicing rights are reported in other assets and are amortized into noninterest income in proportion to, and over the period of, the estimated future net servicing income of the underlying financial assets. Servicing assets are evaluated for impairment based upon a third party appraisal. Fair value is determined using prices for similar assets with similar characteristics, when available, or based upon discounted cash flows using market-based assumptions. Impairment is recognized through a valuation allowance to the extent that fair value is less than the capitalized amount. The Company’s loan servicing assets at December 31, 2020 and 2019, respectively, were no t impaired. Total servicing assets included in other assets as of December 31, 2020 and 2019, were $ 337,000 and $ 187,000 , respectively. Allowance for Loan Losses The allowance for loan losses is established through provisions for loan losses charged against income. Loans deemed to be uncollectible are charged against the allowance for loan losses, and subsequent recoveries, if any, are credited to the allowance. The allowance for loan losses is maintained at a level considered adequate to provide for losses that can be reasonably anticipated. Management’s periodic evaluation of the adequacy of the allowance is based on the Company’s past loan loss experience, known and inherent risks in the portfolio, adverse situations that may affect the borrower’s ability to repay, the estimated value of any underlying collateral, composition of the loan portfolio, current economic conditions and other relevant factors. This evaluation is inherently subjective as it requires material estimates that may be susceptible to significant revision as more information becomes available. The allowance consists of specific and general components. The specific component relates to loans that are classified as substandard. For such loans that are also classified as impaired, an allowance is established when the discounted cash flows (or collateral value or observable market price) of the impaired loan is lower than the carrying value of that loan. The general component covers non-classified loans and is based on historical loss experience adjusted for qualitative factors. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. Management determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis for commercial and construction loans by either the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, the Company does not separately identify individual consumer and residential real estate loans for impairment disclosures, unless such loans were acquired with impairment or are the subject of a restructuring agreement. Premises and Equipment Land is carried at cost. Premises and equipment are stated at cost less accumulated depreciation. Depreciation expense is calculated principally on the straight-line method over the respective assets estimated useful lives as follows: Years Buildings and improvements 10 - 40 Furniture and equipment 3 - 10 Leases The Company applies a right-of-use (ROU) model that requires a lessee to record, for all leases with a lease term of more than 12 months, an asset representing its right to use the underlying asset and a liability to make lease payments. For leases with a term of 12 months or less, a practical expedient is available whereby a lessee may elect, by class of underlying asset, not to recognize an ROU asset or lease liability. At inception, lessees must classify all leases as either finance or operating based on five criteria. Balance sheet recognition of finance and operating leases is similar, but the pattern of expense recognition in the income statement, as well as the effect on the statement of cash flows, differs depending on the lease classification. See Note 8 for related disclosures. Transfers of Financial Assets Transfers of financial assets, including loan and loan participation sales, are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when (1) the assets have been isolated from the Company, (2) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets and (3) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity or the ability to unilaterally cause the holder to return specific assets. Foreclosed Real Estate Real estate properties acquired through, or in lieu of, loan foreclosure are to be sold and are initially recorded at fair value less cost to sell at the date of foreclosure establishing a new cost basis. After foreclosure, valuations are periodically performed by management and the real estate is carried at the lower of its carrying amount or fair value less cost to sell. Revenue and expenses from operations and changes in the valuation allowance are included in other expenses. Bank Owned Life Insurance The Company invests in bank owned life insurance (BOLI) as a source of funding for employee benefit expenses. BOLI involves the purchasing of life insurance by the Bank on a select group of employees. The Company is the owner and beneficiary of the policies. This life insurance investment is carried at the cash surrender value of the underlying policies. Income from the increase in cash surrender value of the policies or from death benefits realized is included in other income on the Consolidated Statements of Income. Goodwill In connection with three acquisitions the Company recorded goodwill in the amount of $29.3 million, representing the excess of amounts paid over the fair value of net assets of the institutions acquired. Goodwill is tested and deemed impaired when the carrying value of goodwill exceeds its implied fair value. The value of the goodwill can change in the future. We expect the value of the goodwill to decrease if there is a significant decrease in the franchise value of the Bank. If an impairment loss is determined in the future, we will reflect the loss as an expense for the period in which the impairment is determined, leading to a reduction of our net income for that period by the amount of the impairment loss. No impairment was recognized for the years ended December 31, 2020 and 2019. Other Intangible Assets At December 31, 2020, the Company had other intangible assets of $ 530,000 , which is net of accumulated amortization of $ 1,224,000 . These intangible assets will continue to be amortized using the sum-of-the-years digits method of amortization over ten years . At December 31, 2019, the Company had other intangible assets of $ 235,000 which was net of accumulated amortization of $ 1,110,000 . Amortization expense related to other intangible assets was $ 114,000 and $ 101,000 for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, the estimated future amortization expense for the core deposit intangible is as follows (in thousands): 2021 $ 123 2022 101 2023 85 2024 69 2025 54 Thereafter 98 $ 530 Income Taxes Deferred income tax assets and liabilities are determined based on the differences between financial statement carrying amounts and the tax basis of existing assets and liabilities. These differences are measured at the enacted tax rates that will be in effect when these differences reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion of the deferred tax assets will not be realized. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. The Company and its subsidiary file a consolidated federal income tax return. The Company recognizes interest and penalties on income taxes as a component of income tax expense. The Company analyzes each tax position taken in its tax returns and determines the likelihood that the position will be realized. Only tax positions that are “more-likely-than-not” to be realized can be recognized in an entity’s financial statements. For tax positions that do not meet this recognition threshold, an entity will record an unrecognized tax benefit for the difference between the position taken on the tax return and the amount recognized in the financial statements. The Company does no t have any unrecognized tax benefits at December 31, 2020 or 2019, or during the years then ended. No unrecognized tax benefits are expected to arise within the next twelve months. Advertising Costs Advertising costs are expensed as incurred. Earnings per Share Basic earnings per share represents income available to common stockholders divided by the weighted average number of common shares outstanding during the period less any unvested restricted shares. Diluted earnings per share reflects additional common shares that would have been outstanding if dilutive potential common shares had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential common shares that may be issued by the Company relate solely to outstanding stock options and are determined using the treasury stock method. Treasury shares are not deemed outstanding for earnings per share calculations. Employee Benefit Plans The Company has a defined contributory profit-sharing plan which includes provisions of a 401(k) plan. The Company’s contributions are expensed as the cost is incurred. The Company has several supplemental executive retirement plans. To fund the benefits under these plans, the Company is the owner of single premium life insurance policies on the participants. The Company provides pension benefits to eligible employees. The Company’s funding policy is to contribute at least the minimum required contributions annually. Interest Rate Derivatives The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments. Stock Option Plans The Company recognizes the value of share-based payment transactions as compensation costs in the financial statements over the period that an employee provides service in exchange for the award. The fair value of the share-based payments for stock options is estimated using the Black-Scholes option-pricing model. The Company used the modified-prospective transition method to record compensation expense. Under the modified-prospective method, companies are required to record compensation cost for new and modified awards over the related vesting period of such awards and record compensation cost prospectively for the unvested portion, at the date of adoption, of previously issued and outstanding awards over the remaining vesting period of such awards. No change to prior periods presented is permitted under the modified-prospective method. Restricted Stock The Company recognizes compensation cost related to restricted stock based on the market price of the stock at the grant date over the vesting period. The product of the number of shares granted and the grant date market price of the Company’s common stock determines the fair value of restricted stock under the Company’s 2014 Equity Incentive Plan. The Company recognizes compensation expense for the fair value of the restricted stock on a straight-line basis over the requisite service period for the entire award. Cash Flow Information For the purposes of reporting cash flows, cash and cash equivalents include cash on hand, amounts due from banks, interest-bearing deposits with banks and federal funds sold. Off-Balance Sheet Financial Instruments In the ordinary course of business, the Company has entered into off-balance sheet financial instruments consisting of commitments to extend credit, letters of credit and commitments to sell loans. Such financial instruments are recorded on the balance sheets when they become receivable or payable. Trust Assets Assets held by the Company in a fiduciary capacity for customers are not included in the financial statements since such items are not assets of the Company. Trust income is reported on the accrual method. Treasury Stock Common shares repurchased are recorded as treasury stock at cost. Comprehensive Income Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Certain changes in assets and liabilities, such as unrealized gains and losses on available for sale securities and defined benefit pension obligations, are reported as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income as presented in the Consolidated Statement of Comprehensive Income. Segment Reporting The Company acts as an independent community financial services provider and offers traditional banking related financial services to individual, business and government customers. Through its Community Office and automated teller machine network, the Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and mortgage loans; and the providing of safe deposit services. The Company also performs personal, corporate, pension and fiduciary services through its Trust Department. Management does not separately allocate expenses, including the cost of funding loan demand, between the commercial, retail, mortgage banking and trust operations of the Company. As such, discrete information is not available and segment reporting would not be meaningful. Reclassification of Comparative Amounts Certain comparative amounts for the prior year have been reclassified to conform to current-year classifications. Such reclassifications had no material effect on net income or stockholders’ equity. New Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This Update is effective for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment . To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The Update is effective for smaller reporting companies and all other entities for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years . This Update is not expected to have a significant impact on the Company’s financial statements. In August 2018, the FASB issued ASU 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contract s. This Update is intended to improve financial reporting for insurance companies that issue long-duration contracts, such as life insurance, disability income, long-term care, and annuities, by requiring updated assumptions for liability measurement, standardizing the liability discount rate, simplifying and improving the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts by requiring those benefits to be measured at fair value instead of using two different measurement models, simplifying the amortization of deferred acquisition costs, and increasing transparency by improving the effectiveness of disclosures. This Update is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits (Topic 715-20). This Update amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The Update eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The Update also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. This Update is effective for public business entities for fiscal years ending after December 15, 2020, and must be applied on a retrospective basis. For all other entities, this Update is effective for fiscal years ending after December 15, 2021. This Update is not expected to have a significant impact on the Company’s financial statements. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments ‒ Credit Losses , which, in addition to addressing other matters, ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20. The effective date and transition requirements for ASU 2018-19 are the same as those in ASU 2016-13. This Update is not expected to have a significant impact on the Company’s financial statements. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives, and Hedging (Topic 815); and Financial Instruments (Topic 825), which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. ASU 2019-04 makes clarifying amendments to certain financial instrument standards. For entities that have not yet adopted ASU 2016-13, the effective dates for the amendments related to ASU 2016-13 are the same as the effective dates in ASU 2016-13. For entities that have adopted ASU 2016-13, the amendments related to ASU 2016-13 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. For entities that have not yet adopted ASU 2017-12 as of April 25, 2019, the effective dates for the amendments to Topic 815 are the same as the effective dates in ASU 2017-12. For entities that have adopted ASU 2017-12 as of April 25, 2019, |
Securities
Securities | 12 Months Ended |
Dec. 31, 2020 | |
Securities [Abstract] | |
Securities | NOTE 3 - SECURITIES The amortized cost, gross unrealized gains and losses, and fair value of securities were as follows: December 31, 2020 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains Losses Value (In Thousands) AVAILABLE FOR SALE: U.S. Government agencies $ 3,998 $ — $ ( 29 ) $ 3,969 States and political subdivisions 70,672 2,419 — 73,091 Corporate obligations 3,019 13 — 3,032 Mortgage-backed securities- government sponsored entities 143,712 2,809 ( 27 ) 146,494 Total debt securities $ 221,401 $ 5,241 $ ( 56 ) $ 226,586 December 31, 2019 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains Losses Value (In Thousands) AVAILABLE FOR SALE: States and political subdivisions $ 70,015 $ 1,293 $ ( 3 ) $ 71,305 Corporate obligations 4,097 3 — 4,100 Mortgage-backed securities- government sponsored entities 135,646 238 ( 1,084 ) 134,800 Total debt securities $ 209,758 $ 1,534 $ ( 1,087 ) $ 210,205 The following tables show the Company’s investments’ gross unrealized losses and fair value aggregated by security type and length of time that individual securities have been in a continuous unrealized loss position (in thousands): December 31, 2020 Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. Government agencies $ 3,969 ( 29 ) — — 3,969 ( 29 ) Mortgage-backed securities-government sponsored entities $ 4,980 $ ( 27 ) $ — $ — $ 4,980 $ ( 27 ) $ 8,949 $ ( 56 ) $ — $ — $ 8,949 $ ( 56 ) December 31, 2019 Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses States and political subdivisions $ 1,296 $ ( 2 ) $ 481 $ ( 1 ) $ 1,777 $ ( 3 ) Mortgage-backed securities-government sponsored entities 32,415 ( 241 ) 61,096 ( 843 ) 93,511 ( 1,084 ) $ 33,711 $ ( 243 ) $ 61,577 $ ( 844 ) $ 95,288 $ ( 1,087 ) The Company has six debt securities in the less than twelve month category and no debt securities in the twelve months or more category as of December 31, 2020. In management’s opinion, the unrealized losses on securities reflect changes in interest rates subsequent to the acquisition of specific securities. No other-than-temporary-impairment charges were recorded in 2020. Management believes that all other unrealized losses represent temporary impairment of the securities, and it is more likely than not that it will not have to sell the securities before recovery of their cost basis. The amortized cost and fair value of debt securities as of December 31, 2020 by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to prepay obligations with or without call or prepayment penalties. Amortized Fair Cost Value (In Thousands) Due in one year or less $ 5,498 $ 5,532 Due after one year through five years 5,373 5,510 Due after five years through ten years 23,276 23,676 Due after ten years 43,542 45,374 77,689 80,092 Mortgage-backed securities - government sponsored entities 143,712 146,494 $ 221,401 $ 226,586 Gross realized gains and gross realized losses on sales of securities available for sale were $ 71,000 and $ 0 , respectively, in 2020, compared to $ 254,000 and $ 0 , respectively, in 2019. The proceeds from the sales of securities totaled $ 24,497,000 and $ 27,247,000 for the years ended December 31, 2020 and 2019, respectively. Securities with a carrying value of $ 199,361,000 and $ 157,233,000 at December 31, 2020 and 2019, respectively, were pledged to secure public deposits, securities sold under agreements to repurchase and for other purposes as required or permitted by law. |
Loans Receivable and Allowance
Loans Receivable and Allowance for Loan Losses | 12 Months Ended |
Dec. 31, 2020 | |
Loans Receivable and Allowance for Loan Losses [Abstract] | |
Loans Receivable and Allowance for Loan Losses | NOTE 4 - LOANS RECEIVABLE AND ALLOWANCE FOR LOAN LOSSES Set forth below is selected data relating to the composition of the loan portfolio (in thousands): December 31, 2020 December 31, 2019 Real Estate: Residential $ 263,127 18.6 % $ 229,781 24.9 % Commercial 579,104 41.0 391,327 42.3 Agricultural 66,334 4.7 — — Construction 21,005 1.5 17,732 1.9 Commercial loans 283,741 20.1 134,150 14.5 Other agricultural loans 40,929 2.9 — — Consumer loans to individuals 158,049 11.2 151,686 16.4 Total loans 1,412,289 100.0 % 924,676 100.0 % Deferred fees, net ( 1,557 ) ( 95 ) Total loans receivable 1,410,732 924,581 Allowance for loan losses ( 13,150 ) ( 8,509 ) Net loans receivable $ 1,397,582 $ 916,072 During 2020 the Company participated in the Paycheck Protection Program (“PPP”), administered directly by the United States Small Business Administration (“SBA”). The PPP provides loans to small businesses who were affected by economic conditions as a result of COVID-19 to provide cash-flow assistance to employers who maintain their payroll (including healthcare and certain related expenses), mortgage interest, rent, leases, utilities and interest on existing debt during the COVID-19 emergency. As of December 31, 2020, the Company had outstanding principal balances of $ 95,043,000 in PPP loans. The PPP loans are fully guaranteed by the SBA and may be eligible for forgiveness by the SBA to the extent that the proceeds are used to cover eligible payroll costs, interest costs, rent, and utility costs over a period of up to 24 weeks after the loan is made as long as certain conditions are met regarding employee retention and compensation levels. PPP loans deemed eligible for forgiveness by the SBA will be repaid by the SBA to the Company. PPP loans are included in the Commercial loan category. In accordance with the SBA terms and conditions on these PPP loans, the Company received approximately $ 2.5 million in fees associated with the processing of these loans. Upon funding of the loan, these fees were deferred and will be amortized over the life of the loan as an adjustment to yield in accordance with FASB ASC 310-20-25-2. As a result of the acquisition of UpState, the Company added $ 15,410,000 of loans that were accounted for in accordance with ASC 310-30. Based on a review of the loans acquired by the Company’s senior lending management, which included an analysis of credit deterioration of the loans since origination, the Company recorded a specific credit fair value adjustment of $ 6,937,000 . For loans that were acquired with specific evidence of deterioration in credit quality, loan losses will be accounted for through a reduction of the specific reserve and will not impact the allowance for loan losses until actual losses exceed the allotted reserves. For loans acquired without a deterioration of credit quality, losses incurred will result in adjustments to the allowance for loan losses through the allowance for loan loss adequacy calculation. Changes in the accretable yield for purchased credit-impaired loans were as follows for the twelve months ended December 31: (In thousands) 2020 2019 Balance at beginning of period $ — $ 29 Additions 1,724 — Accretion ( 353 ) ( 29 ) Reclassification and other ( 6 ) — Balance at end of period $ 1,365 $ — The following table presents additional information regarding loans acquired and accounted for in accordance with ASC 310-30 (in thousands): December 31, 2020 December 31, 2019 Outstanding Balance $ 15,570 $ 793 Carrying Amount $ 9,281 $ 696 Loans acquired with credit deterioration of $ 15,410,000 and accounted for in accordance with ASC 310-30 were individually evaluated to estimate credit losses and a net recovery amount for each loan. The net cash flows for each loan were then discounted to present value using a risk-adjusted market rate. The table below presents the components of the purchase accounting adjustments: (In Thousands) July 7, 2020 Contractually required principal and interest $ 15,410 Non-accretable discount ( 5,213 ) Expected cash flows 10,197 Accretable discount ( 1,724 ) Estimated fair value $ 8,473 There were no material increases or decreases in the expected cash flows of these loans since the acquisition date. There has been no allowance for loan losses recorded for acquired loans with specific evidence of deterioration in credit quality. As of December 31, 2020, for loans that were acquired prior to 2020 with or without specific evidence of deterioration in credit quality, adjustments to the allowance for loan losses have been accounted for through the allowance for loan loss adequacy calculation. The Company maintains a loan review system, which allows for a periodic review of our loan portfolio and the early identification of potential impaired loans. The system takes into consideration, among other things, delinquency status, size of loans, type and market value of collateral and financial condition of the borrowers. Specific loan loss allowances are established for identified losses based on a review of such information. A loan evaluated for impairment is considered to be impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. All loans identified as impaired are evaluated independently. The Company does not aggregate such loans for evaluation purposes. Impairment is measured on a loan-by-loan basis for commercial and construction loans by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral-dependent. Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, the Company does not separately identify individual consumer and residential mortgage loans for impairment disclosures, unless such loans are part of a larger relationship that is impaired, or are classified as a troubled debt restructuring. The following tables show the amount of loans in each category that were individually and collectively evaluated for impairment at the dates indicated: Real Estate Loans Commercial Other Consumer Residential Commercial Agricultural Construction Loans Agricultural Loans Total (In thousands) December 31, 2020 Individually evaluated for impairment $ — $ 2,582 $ — $ — $ 80 $ — $ — $ 2,662 Loans acquired with deteriorated credit quality 591 3,995 2,043 194 246 2,212 — 9,281 Collectively evaluated for impairment 262,536 572,527 64,291 20,811 283,415 38,717 158,049 1,400,346 Total Loans $ 263,127 $ 579,104 $ 66,334 $ 21,005 $ 283,741 $ 40,929 $ 158,049 $ 1,412,289 Real Estate Loans Commercial Other Consumer Residential Commercial Agricultural Construction Loans Agricultural Loans Total (In thousands) December 31, 2019 Individually evaluated for impairment $ — $ 2,144 $ — $ — $ — $ — $ — $ 2,144 Loans acquired with deteriorated credit quality 476 220 — — — — — 696 Collectively evaluated for impairment 229,305 388,963 — 17,732 134,150 — 151,686 921,836 Total Loans $ 229,781 $ 391,327 $ — $ 17,732 $ 134,150 $ — $ 151,686 $ 924,676 The following table includes the recorded investment and unpaid principal balances for impaired loans with the associated allowance amount, if applicable. Unpaid Principal Recorded Principal Associated Investment Balance Allowance December 31, 2020 (In thousands) With no related allowance recorded: Real Estate Loans Commercial $ 2,582 $ 3,234 $ — Commercial loans 80 80 — Subtotal 2,662 3,314 — Total: Real Estate Loans Commercial $ 2,582 $ 3,234 $ — Commercial loans 80 80 — Total Impaired Loans $ 2,662 $ 3,314 $ — Unpaid Recorded Principal Associated Investment Balance Allowance December 31, 2019 (In thousands) With no related allowance recorded: Real Estate Loans Commercial $ 143 $ 394 $ — Subtotal 143 394 — With an allowance recorded: Real Estate Loans Commercial 2,001 2,001 417 Subtotal 2,001 2,001 417 Total: Real Estate Loans Commercial 2,144 2,395 417 Total Impaired Loans $ 2,144 $ 2,395 $ 417 The following information for impaired loans is presented for the years ended December 31, 2020 and 2019: Average Recorded Interest Income Investment Recognized 2020 2019 2020 2019 (In thousands) Total: Real Estate Loans Commercial $ 2,105 $ 1,036 $ 14 $ 233 Commercial loans 16 — — — Total Loans $ 2,121 $ 1,036 $ 14 $ 233 Troubled debt restructured loans are those loans whose terms have been renegotiated to provide a reduction or deferral of principal or interest as a result of financial difficulties experienced by the borrower, who could not obtain comparable terms from alternate financing sources. As of December 31, 2020, troubled debt restructured loans totaled $ 75,000 and did not require a specific reserve. During 2020, there were no new loan relationships identified as troubled debt restructurings. During 2020, there was a charge-off in the amount of $ 20,000 on loans classified as troubled debt restructurings. As of December 31, 2019, troubled debt restructured loans totaled $ 99,000 and did not require a specific reserve. During 2019, there were no new loan relationships identified as troubled debt restructurings, while one loan identified as troubled debt restructuring with a balance of $ 977,000 as of December 31, 2018 was transferred to foreclosed real estate during 2019. On April 7, 2020, federal banking regulators issued a revised interagency statement that included guidance on their approach for the accounting of loan modifications in light of the economic impact of the COVID-19 pandemic. The guidance interprets current accounting standards and indicates that a lender can conclude that a borrower is not experiencing financial difficulty if short-term modifications are made in response to COVID-19, such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant related to the loans in which the borrower is less than 30 days past due on its contractual payments at the time a modification program is implemented. The agencies confirmed in working with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. Foreclosed assets acquired in settlement of loans are carried at fair value less estimated costs to sell and are included in foreclosed real estate owned on the Consolidated Balance Sheets. As of December 31, 2020 and 2019, foreclosed real estate owned totaled $ 965,000 and $ 1,556,000 , respectively. As of December 31, 2020, included within foreclosed real estate owned is one commercial property that was received via a deed in lieu. As of December 31, 2020, the Company has initiated formal foreclosure proceedings on four consumer residential mortgage loans with an outstanding balance of $ 454,000 . Management uses an eight point internal risk rating system to monitor the credit quality of the overall loan portfolio. The first four categories are considered not criticized, and are aggregated as “Pass” rated. The criticized rating categories utilized by management generally follow bank regulatory definitions. The Special Mention category includes assets that are currently protected but are potentially weak, resulting in an undue and unwarranted credit risk, but not to the point of justifying a Substandard classification. Loans in the Substandard category have well-defined weaknesses that jeopardize the liquidation of the debt, and have a distinct possibility that some loss will be sustained if the weaknesses are not corrected. Loans greater than 90 days past due are considered Substandard unless full payment is expected. Any portion of a loan that has been charged off is placed in the Loss category. To help ensure that risk ratings are accurate and reflect the present and future capacity of borrowers to repay a loan as agreed, the Company has a structured loan rating process with several layers of internal and external oversight. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as nonperformance, repossession, or death occurs to raise awareness of a possible credit event. The Company’s Loan Review Department is responsible for the timely and accurate risk rating of the loans on an ongoing basis. Every credit which must be approved by Loan Committee or the Board of Directors is assigned a risk rating at time of consideration. Loan Review also annually reviews relationships of $ 1,500,000 and over to assign or re-affirm risk ratings. Loans in the Substandard categories that are collectively evaluated for impairment are given separate consideration in the determination of the allowance. The following table presents the classes of the loan portfolio summarized by the aggregate Pass and the criticized categories of Special Mention, Substandard, Doubtful and Loss within the internal risk rating system as of December 31, 2020 and December 31, 2019 (in thousands): Special Pass Mention Substandard Doubtful Loss Total December 31, 2020 Commercial real estate loans $ 566,418 $ 6,346 $ 6,340 $ — $ — $ 579,104 Real estate - agricultural 58,322 5,111 2,901 — — 66,334 Commercial loans 282,915 437 389 — — 283,741 Other agricultural loans 35,772 2,786 2,371 — — 40,929 Total $ 943,427 $ 14,680 $ 12,001 $ — $ — $ 970,108 Special Pass Mention Substandard Doubtful Loss Total December 31, 2019 Commercial real estate loans $ 376,109 $ 12,268 $ 2,950 $ - $ - $ 391,327 Commercial 133,695 248 207 - - 134,150 Total $ 509,804 $ 12,516 $ 3,157 $ - $ - $ 525,477 For residential real estate loans, construction loans and consumer loans, the Company evaluates credit quality based on the performance of the individual credits. Nonperforming loans include loans that have been placed on nonaccrual status and loans remaining in accrual status on which the contractual payment of principal and interest has become 90 days past due. The following table presents the recorded investment in the loan classes based on payment activity as of December 31, 2020 and December 31, 2019 (in thousands): Performing Nonperforming Total December 31, 2020 Residential real estate loans $ 262,556 $ 571 $ 263,127 Construction 21,005 — 21,005 Consumer loans to individuals 157,864 185 158,049 Total $ 441,425 $ 756 $ 442,181 Performing Nonperforming Total December 31, 2019 Residential real estate loans $ 229,214 $ 567 $ 229,781 Construction 17,732 — 17,732 Consumer loans to individuals 151,607 79 151,686 Total $ 398,553 $ 646 $ 399,199 Management further monitors the performance and credit quality of the loan portfolio by analyzing the age of the portfolio as determined by the length of time a recorded payment is past due. The following table presents the classes of the loan portfolio summarized by the aging categories of performing loans and nonaccrual loans as of December 31, 2020 and December 31, 2019 (in thousands): Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Purchased Credit Impaired Loans Total Loans December 31, 2020 Real Estate loans Residential $ 261,406 $ 355 $ 204 $ — $ 571 $ 1,130 $ 591 $ 263,127 Commercial 573,376 59 — — 1,674 1,733 3,995 579,104 Agricultural 63,615 — — — 676 676 2,043 66,334 Construction 20,811 — — — — — 194 21,005 Commercial loans 282,374 1,009 90 — 22 1,121 246 283,741 Other agricultural loans 38,454 — — — 263 263 2,212 40,929 Consumer loans 157,538 233 93 — 185 511 - 158,049 Total $ 1,397,574 $ 1,656 $ 387 $ — $ 3,391 $ 5,434 $ 9,281 $ 1,412,289 Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Purchased Credit Impaired Loans Total Loans December 31, 2019 Real Estate loans Residential $ 227,766 $ 727 $ 245 $ — $ 567 $ 1,539 $ 476 $ 229,781 Commercial 387,897 176 2,935 — 99 3,210 220 391,327 Construction 17,695 — 37 — — 37 — 17,732 Commercial loans 134,018 82 — — 50 132 — 134,150 Consumer loans 151,309 233 65 — 79 377 — 151,686 Total $ 918,685 $ 1,218 $ 3,282 $ — $ 795 $ 5,295 $ 696 $ 924,676 The following table presents the allowance for loan losses by the classes of the loan portfolio: (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total Beginning balance, December 31, 2019 $ 1,552 $ 4,687 $ 95 $ 949 $ 1,226 $ 8,509 Charge Offs ( 41 ) ( 452 ) — ( 18 ) ( 431 ) ( 942 ) Recoveries 6 39 — 44 44 133 Provision for loan losses 443 3,730 55 385 837 5,450 Ending balance, December 31, 2020 $ 1,960 $ 8,004 $ 150 $ 1,360 $ 1,676 $ 13,150 Ending balance individually evaluated for impairment $ — $ — $ — $ — $ — $ — Ending balance collectively evaluated for impairment $ 1,960 $ 8,004 $ 150 $ 1,360 $ 1,676 $ 13,150 (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total Beginning balance, December 31, 2018 $ 1,328 $ 5,455 $ 93 $ 712 $ 864 $ 8,452 Charge Offs ( 102 ) ( 627 ) — ( 284 ) ( 420 ) ( 1,433 ) Recoveries 24 125 — 48 43 240 Provision for loan losses 302 ( 266 ) 2 473 739 1,250 Ending balance, December 31, 2019 $ 1,552 $ 4,687 $ 95 $ 949 $ 1,226 $ 8,509 Ending balance individually evaluated for impairment $ — $ 417 $ — $ — $ — $ 417 Ending balance collectively evaluated for impairment $ 1,552 $ 4,270 $ 95 $ 949 $ 1,226 $ 8,092 During the period ended December 31, 2020, the allowance for loan losses increased from $ 8,509,000 to $ 13,150,000 . This $ 4,641,000 increase in the required allowance was due primarily to a $ 2.3 million increase in the qualitative factor related to economic conditions and a $ 2.2 million increase due to new qualitative factors directly related to the COVID-19 pandemic. During the period ended December 31, 2019, the allowance for loan losses increased from $ 8,452,000 to $ 8,509,000 . This $ 57,000 increase in the required allowance was due primarily to a $ 417,000 specific reserve for impaired loans and a $ 447,000 increase in the qualitative factor related to economic conditions. This increase was partially offset by a reduction in the historical loss factor from 0.26 % at December 31, 2018 to 0.15 % on December 31, 2019. Interest income that would have been recorded on loans accounted for on a non-accrual basis under the original terms of the loans was $ 727,000 and $ 101,000 for 2020 and 2019, respectively. As of December 31, 2020 and 2019, the Company considered its concentration of credit risk to be acceptable. As of December 31, 2020, the highest concentrations are in commercial rentals and the residential rentals category, with loans outstanding of $ 125.3 million, or 86.4 % of bank capital, to commercial rentals, and $ 117.8 million, or 81.2 % of bank capital to residential rentals. There were no charge-offs on loans within these concentrations for the years ended December 31, 2020 and 2019, respectively. During 2020, the Company sold residential mortgage loans totaling $ 12,312,000 . During 2019, the Company sold residential mortgage loans totaling $ 4,715,000 . Gross realized gains and gross realized losses on sales of residential mortgage loans were $ 527,000 and $ 0 , respectively, in 2020 and $ 169,000 and $ 0 , respectively, in 2019. The proceeds from the sales of residential mortgage loans totaled $ 12,839,000 and $ 4,838,000 for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the outstanding value of loans serviced for others totaled $ 72.5 million and $ 28.5 million, respectively. |
Premises and Equipment
Premises and Equipment | 12 Months Ended |
Dec. 31, 2020 | |
Premises and Equipment [Abstract] | |
Premises and Equipment | NOTE 5 - PREMISES AND EQUIPMENT Components of premises and equipment at December 31 are as follows: 2020 2019 (In Thousands) Land and improvements $ 3,878 $ 2,806 Buildings and improvements 21,545 17,914 Furniture and equipment 9,717 8,164 35,140 28,884 Accumulated depreciation ( 17,326 ) ( 14,656 ) $ 17,814 $ 14,228 Depreciation expense totaled $ 1,322,000 and $ 1,005,000 for the years ended December 31, 2020 and 2019, respectively. |
Deposits
Deposits | 12 Months Ended |
Dec. 31, 2020 | |
Deposits [Abstract] | |
Deposits | NOTE 6 - DEPOSITS Aggregate time deposits in denominations of $250,000 or greater were $ 205,376,000 and $ 137,108,000 at December 31, 2020 and 2019, respectively. At December 31, 2020, the scheduled maturities of time deposits are as follows (in thousands): 2021 $ 353,950 2022 106,898 2023 40,440 2024 24,131 2025 8,412 $ 533,831 |
Borrowings
Borrowings | 12 Months Ended |
Dec. 31, 2020 | |
Borrowings [Abstract] | |
Borrowings | NOTE 7 – BORROWINGS Short-term borrowings at December 31 consist of the following: 2020 2019 (In Thousands) Securities sold under agreements to repurchase $ 63,303 $ 30,505 Federal Home Loan Bank short-term borrowings — 31,751 $ 63,303 $ 62,256 The outstanding balances and related information of short-term borrowings are summarized as follows: Years Ended December 31, 2020 2019 (Dollars In Thousands) Average balance during the year $ 57,014 $ 48,945 Average interest rate during the year 0.55 % 0.96 % Maximum month-end balance during the year $ 69,294 $ 62,256 Weighted average interest rate at the end of the year 0.43 % 1.30 % Securities sold under agreements to repurchase generally mature within one day to one year from the transaction date. Securities with an amortized cost and fair value of $ 63,462,000 and $ 64,429,000 at December 31, 2020 and $ 36,313,000 and $ 36,195,000 at December 31, 2019, respectively, were pledged as collateral for these agreements. The securities underlying the agreements were under the Company’s control. The collateral pledged for repurchase agreements that are classified as secured borrowings is summarized as follows (in thousands): As of December 31, 2020 Remaining Contractual Maturity of the Agreements Overnight and continuous Up to 30 days 30-90 days Greater than 90 days Total Repurchase Agreements: Mortgage-backed securities - government sponsored entities $ 64,429 $ — $ — $ — $ 64,429 Total liability recognized for repurchase agreements 63,303 As of December 31, 2019 Remaining Contractual Maturity of the Agreements Overnight and continuous Up to 30 days 30-90 days Greater than 90 days Total Repurchase Agreements: Mortgage-backed securities - government sponsored entities $ 36,195 $ — $ — $ — $ 36,195 Total liability recognized for repurchase agreements 30,505 The Company has a line of credit commitment available from the FHLB of Pittsburgh for borrowings of up to $ 150,000,000 , which renews annually in June. At December 31, 2020, there were no borrowings outstanding on this line. There were $ 31,751,000 of borrowings outstanding on this line of credit at December 31, 2019. The Company has a line of credit commitment available from Atlantic Community Bankers Bank for $ 7,000,000 , which expires on June 30, 2021. There were no borrowings under this line of credit at December 31, 2020 and 2019. The Company has a line of credit commitment available from PNC Bank for $ 16,000,000 at December 31, 2020. There were no borrowings under this line of credit at December 31, 2020 and December 31, 2019. The Company also has a line of credit commitment from Zions Bank for $ 17,000,000 . There were no borrowings under this line of credit at December 31, 2020 and December 31, 201. Other borrowings consisted of the following at December 31, 2020 and 2019: 2020 2019 (In Thousands) Fixed rate term borrowing due May 2020 at 1.85 % $ — $ 5,000 Amortizing fixed rate borrowing due June 2020 at 1.49 % — 1,034 Amortizing fixed rate borrowing due July 2020 at 2.77 % — 2,974 Amortizing fixed rate borrowing due December 2020 at 1.71 % — 2,538 Amortizing fixed rate borrowing due December 2020 at 3.06 % — 1,034 Amortizing fixed rate borrowing due March 2022 at 1.75 % 1,126 2,009 Amortizing fixed rate borrowing due August 2022 at 1.94 % 3,376 5,351 Amortizing fixed rate borrowing due October 2022 at 1.88 % 3,021 4,626 Amortizing fixed rate borrowing due October 2023 at 3.24 % 5,865 7,809 Amortizing fixed rate borrowing due December 2023 at 3.22 % 3,096 4,063 Fixed rate term borrowing due December 2023 at 1.95 % 10,000 10,000 Amortizing fixed rate borrowing due December 2023 at 1.73 % 7,616 10,000 Amortizing fixed rate borrowing due April 2024 at 0.91 % 8,359 — $ 42,459 $ 56,438 Contractual maturities and scheduled cash flows of other borrowings at December 31, 2020 are as follows (in thousands): 2021 $ 12,594 2022 11,191 2023 17,826 2024 848 $ 42,459 The Bank’s maximum borrowing capacity with the FHLB was $ 686,360,000 of which $ 42,459,000 was outstanding in the form of advances and $ 100,000,000 was outstanding in the form of letters of credit at December 31, 2020. Advances from the FHLB are secured by qualifying assets of the Bank. |
Operating Leases
Operating Leases | 12 Months Ended |
Dec. 31, 2020 | |
Operating Leases [Abstract] | |
Operating Leases | NOTE 8 – OPERATING LEASES The Company leases eight office locations under operating leases. Several assumptions and judgments were made when applying the requirements of Topic 842 to the Company’s existing lease commitments, including the allocation of consideration in the contracts between lease and nonlease components, determination of the lease term, and determination of the discount rate used in calculating the present value of the lease payments. The Company has elected to account for the variable nonlease components, such as common area maintenance charges, utilities, real estate taxes, and insurance, separately from the lease component. Such variable nonlease components are reported in net occupancy expense on the Consolidated Statements of Income when paid. These variable nonlease components were excluded from the calculation of the present value of the remaining lease payments, therefore, they are not included in other assets and other liabilities on the Consolidated Balance Sheets. The lease cost associated with the operating leases for the year ending December 31, 2020 and 2019, amounted to $ 571,000 and $ 518,000 respectively. The right-of-use asset associated with operating leases amounted to $ 4,938,000 and $ 5,290,000 at December 31, 2020 and 2019, respectively. The lease liability associated with operating leases amounted to $ 4,984,000 and $ 5,316,000 at December 31, 2020 and 2019, respectively. Certain of the Company’s leases contain options to renew the lease after the initial term. Management considers the Company’s historical pattern of exercising renewal options on leases and the positive performance of the leased locations, when determining whether it is reasonably certain that the leases will be renewed. If management concludes that there is reasonable certainty about the renewal option, it is included in the calculation of the remaining term of each applicable lease. The discount rate utilized in calculating the present value of the remaining lease payments for each lease was the Federal Home Loan Bank of Pittsburgh advance rate corresponding to the remaining maturity of the lease. The following table presents the weighted-average remaining lease term and discount rate for the leases outstanding at December 31, 2020. Operating Weighted-average remaining term 12.2 years Weighted-average discount rate 3.20 % The following table presents the undiscounted cash flows due related to operating leases as of December 31, 2020, along with a reconciliation to the discounted amount recorded on the Consolidated Balance Sheets: Undiscounted cash flows due (in thousands) Operating 2021 $ 561 2022 546 2023 534 2024 544 2025 561 2026 and thereafter 3,319 Total undiscounted cash flows 6,065 Discount on cash flows ( 1,081 ) Total lease liabilities $ 4,984 Under Topic 842, the lessee can elect to not record on the Consolidated Balance Sheets a lease whose term is twelve months or less and does not include a purchase option that the lessee is reasonably certain to exercise. As of December 31, 2020, the Company had no leases that had a term of twelve months or less. |
Employee Benefit Plans
Employee Benefit Plans | 12 Months Ended |
Dec. 31, 2020 | |
Employee Benefit Plans [Abstract] | |
Employee Benefit Plans | NOTE 9 – EMPLOYEE BENEFIT PLANS The Company has a defined contributory profit-sharing plan which includes provisions of a 401(k) plan. The plan permits employees to make pre-tax contributions of up to 15 % of the employee’s compensation, not to exceed the limits set by the Internal Revenue Service. The amount of contributions to the plan, including matching contributions, is at the discretion of the Board of Directors. All employees over the age of 21 are eligible to participate in the plan and receive Company contributions after one year of employment. Eligible employees are able to contribute to the Plan at the beginning of the first quarterly period after their date of employment. Employee contributions vest immediately, and any Company contributions are fully vested after five years . The Company’s contributions are expensed as the cost is incurred, funded currently, and amounted to $ 1,049,000 and $ 730,000 for the years ended December 31, 2020 and 2019, respectively. The Company has several non-qualified supplemental executive retirement plans for the benefit of certain executive officers and former officers. At December 31, 2020 and 2019, other liabilities include $ 3,529,000 and $ 3,428,000 accrued under the Plan. Compensation expense includes approximately $ 495,000 and $ 491,000 relating to the supplemental executive retirement plan for 2020 and 2019, respectively. To fund the benefits under this plan, the Company is the owner of single premium life insurance policies on participants in the non-qualified retirement plan. At December 31, 2020 and 2019, the cash value of these policies was $ 39,608,000 and $ 38,763,000 , respectively. The Company provides postretirement benefits in the form of split-dollar life arrangements to employees who meet the eligibility requirements. The net periodic postretirement benefit expense included in salaries and employee benefits was $ 86,000 and $ 101,000 for the years ended December 31, 2020 and 2019, respectively. FASB authoritative guidance on accounting for deferred compensation and postretirement benefit aspects of endorsement split-dollar life insurance arrangements requires the recognition of a liability and related compensation expense for endorsement split-dollar life insurance that provides a benefit to an employee that extends to postretirement periods. The life insurance policies purchased for the purpose of providing such benefits do not effectively settle an entity’s obligation to the employee. Accordingly, the entity must recognize a liability and related compensation expense during the employee’s active service period based on the future cost of insurance to be incurred during the employee’s retirement. This expense is included in the SERP plan expense for 2020 and 2019 discussed above. If the entity has agreed to provide the employee with a death benefit, then the liability for the future death benefit should be recognized by following the FASB authoritative guidance on employer’s accounting for postretirement benefits other than pensions. The accumulated postretirement benefit obligation was $ 1,477,000 and $ 1,392,000 at December 31, 2020 and 2019, respectively. Through its acquisition of Delaware, the Company also has certain director fee deferral and continuation plans. These plans allowed directors to defer director fees and provide a benefit payment for a period of fiv e years to fifteen years . The Company expensed $ 2,000 and $ 3,000 under these plans in 2020 and 2019, respectively. At December 31, 2020 and 2019, the liability under these plans was $ 82,000 and $ 166,000 , respectively. Certain key executives have change in control agreements with the Company. These agreements provide certain potential benefits in the event of termination of employment following a change in control. The Company participates in the Pentegra Mulitemployer Defined Benefit Pension Plan (EIN 13-5645888 and Plan # 333) as a result of its acquisition of North Penn. As of December 31, 2020 and 2019, the Company’s Plan was 94.2 % and 95.0 % funded, respectively, and total contributions made are not more than 5 % of the total contributions to the Plan. The Company’s expense related to the Plan was $ 24,000 in 2020 and $ 29,000 in 2019. During the plan years ending December 31, 2020 and 2019, the Company made contributions of $ 24,000 and $ 29,000 , respectively. As a result of its acquisition of Delaware, the Company is a member of the New York State Bankers Retirement System. Substantially all full-time employees who were former employees of Delaware are covered under this defined benefit pension plan (the “Delaware Plan”). The Company’s funding policy is to contribute at least the minimum required contribution annually. Pension cost is computed using the projected unit credit actuarial cost method. Effective December 31, 2012, the Delaware Plan was closed to new participants and accrued benefits were frozen. The following table sets forth the projected benefit obligation and change in plan assets for the Delaware Plan at December 31: (in Thousands of Dollars) 2020 2019 Change in projected benefit obligation: Projected benefit obligation at beginning of year $ ( 7,515 ) $ ( 7,186 ) Service cost ( 58 ) ( 55 ) Interest cost ( 257 ) ( 312 ) Actuarial (gain) loss ( 767 ) ( 515 ) Benefits paid 532 553 Benefit obligation at end of year $ ( 8,065 ) $ ( 7,515 ) Change in plan assets: Fair value of plan assets at beginning of year $ 6,853 $ 6,136 Actual return on plan assets 1,415 1,275 Benefits paid ( 525 ) ( 558 ) Fair value of assets at end of year 7,743 6,853 Funded status at end of year $ ( 322 ) $ ( 662 ) The Delaware Plan paid $ 532,000 and $ 553,000 in benefit payments in 2020 and 2019, respectively. Estimated benefit payments under the Delaware Plan are expected to be approximately $ 468,000 , $ 468,000 , $ 453,000 , $ 437,000 and $ 428,000 for the next five years. Payments are expected to be approximately $ 2,063,000 in total for the five-year period ending December 31, 2030. The Company was not required to make any contributions to the Delaware Plan in 2020 or 2019. The decrease in the projected discount rate contributed approximately $ 786,000 to the overall increase in the projected benefit obligation for the year ended December 31, 2020. The accumulated benefit obligation for the Delaware Plan was $ 8,065,000 and $ 7,515,000 at December 31, 2020 and 2019, respectively. The following table sets forth the amounts recognized in accumulated other comprehensive income for the years ended December 31 (in thousands): 2020 2019 Transition asset $ — $ — Prior service credit — — Gain 241 375 Total $ 241 $ 375 Net pension cost (income) included the following components (in thousands): 2020 2019 Service cost benefits earned during the period $ 58 $ 55 Interest cost on projected benefit obligation 257 312 Actual return on assets ( 395 ) ( 379 ) Net amortization and deferral ( 20 ) — Net periodic pension cost (income) $ ( 100 ) $ ( 12 ) The weighted average assumptions used to determine the benefit obligation at December 31 are as follows: 2020 2019 Discount rate 2.63 % 3.55 % The weighted average assumptions used to determine the net periodic pension cost at December 31 are as follows: 2,020 2,019 Discount rate 3.55 % 4.54 % Expected long-term return on plan assets 6.00 % 6.50 % Rate of compensation increase — % — % The expected long-term return on plan assets was determined based upon expected returns on individual asset types included in the asset portfolio. The Delaware Plan’s weighted-average asset allocations at December 31, by asset category, are as follows: 2020 2019 Cash equivalents — % — % Equity securities 31.6 % 31.7 % Fixed income securities 62.6 % 57.7 % Other 5.8 % 10.6 % 100.0 % 100.0 % The New York Bankers Retirement System (“System”) overall investment strategy is to invest in a diversified portfolio while managing the variability between the assets and projected liabilities of underfunded pension plans. In 2019, the System’s Board Members approved a migration of substantially all of the System’s assets to one fund, Commingled Pensions Trust Fund (LDI Diversified Balanced) of JPMorgan Chase Bank, N.A. The Fund is a group trust within the meaning of internal Revenue Service Revenue Ruling 81-100, as amended. The growth-oriented portion of the Fund invests in a mix of asset classes that the Fund’s Trustee believes will collectively maximize total risk-adjusted return through a combination of capital appreciation and income. This portion of the Fund will comprise between 35 % and 90 % of the portfolio and will invest directly or indirectly via underlying funds in a broad mix of global equity, global fixed income, real estate and cash-plus strategies. The remaining portion of the Fund, between 10 % and 65 % of the portfolio, is used to minimize volatility relative to a plan’s projected liabilities. At December 31, 2020 and 2019, the System had an investment concentration of approximately 99 % and 98 %, respectively, of its total portfolio in the JPMCB LDI Diversified Balanced Fund, a commingled pension trust fund. Primarily all of the assets of the JPMCD LDI Diversified Balance Fund are valued at Net Asset Value (“NAV”). The NAV of the fund is determined at the last sales price or official market closing price on the primary exchange on which the instrument is traded before the net asset values of the Funds are calculated on a valuation date. In accordance with ASC Subtopic 820-10, certain investments measured at net asset value per share (or its equivalents) are not required to be classified in the fair value hierarchy. The following table sets forth a summary of the changes in the Level 3 assets for the year ended December 31, 2020 and 2019 (in thousands of dollars): 2020 2019 Balance, January 1 $ — $ 601 Realized gain — 187 Purchase — — Sales — ( 610 ) Unrealized gain (loss) — ( 178 ) Balance, December 31 $ — $ — |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2020 | |
Income Taxes [Abstract] | |
Income Taxes | NOTE 10 - INCOME TAXES The components of the provision for federal income taxes are as follows: Years Ended December 31, 2020 2019 (In Thousands) Current $ 7,754 $ 1,620 Deferred ( 4,468 ) 988 $ 3,286 $ 2,608 Deferred income taxes reflect temporary differences in the recognition of revenue and expenses for tax reporting and financial statement purposes, principally because certain items, such as the allowance for loan losses and loan fees are recognized in different periods for financial reporting and tax return purposes. As of December 31, 2020, the Company has a $ 4,252,000 net operating loss carryforward that will begin to expire by December 31, 2035 . A valuation allowance has not been established for deferred tax assets. Realization of the deferred tax assets is dependent on generating sufficient taxable income. Although realization is not assured, management believes it is more likely than not that all of the deferred tax asset will be realized. Deferred tax assets are recorded in other assets. Income tax expense of the Company is less than the amounts computed by applying statutory federal income tax rates to income before income taxes because of the following: Percentage of Income before Income Taxes Years Ended December 31, 2020 2019 Tax at statutory rates 21.0 % 21.0 % Tax exempt interest income, net of interest expense disallowance ( 3.7 ) ( 4.4 ) Non-deductible merger related expenses 1.1 — Earnings and proceeds on life insurance ( 1.0 ) ( 1.0 ) Other 0.5 ( 0.1 ) 17.9 % 15.5 % The net deferred tax asset included in other assets in the accompanying Consolidated Balance Sheets includes the following amounts of deferred tax assets and liabilities: 2020 2019 (In Thousands) Deferred tax assets: Allowance for loan losses $ 2,761 $ 1,787 Deferred compensation 758 797 Core deposit intangible 230 141 Prepaid expenses 20 55 Pension liability 118 360 Foreclosed real estate valuation allowance 17 17 Net operating loss carryforward 893 968 Purchase price adjustment 2,832 — Deferred loan fees 60 — Other 747 122 Total Deferred Tax Assets 8,436 4,247 Deferred tax liabilities: Premises and equipment 920 598 Deferred loan fees — 220 Net unrealized gain on pension liability 272 221 Purchase price adjustment — 327 Net unrealized gain on securities 1,089 94 Total Deferred Tax Liabilities 2,281 1,460 Net Deferred Tax Asset $ 6,155 $ 2,787 The Company’s federal and state income tax returns for taxable years through 2017 have been closed for purposes of examination by the Internal Revenue Service and the Pennsylvania Department of Revenue. |
Regulatory Matters and Stockhol
Regulatory Matters and Stockholders' Equity | 12 Months Ended |
Dec. 31, 2020 | |
Regulatory Matters and Stockholders' Equity [Abstract] | |
Regulatory Matters and Stockholders' Equity | NOTE 11 - REGULATORY MATTERS AND STOCKHOLDERS’ EQUITY The Company and Bank are subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory and possibly additional discretionary actions by regulators that, if undertaken, could have a direct material effect on the Company’s financial statements. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company must meet specific capital guidelines that involve quantitative measures of the Company’s assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. The Company’s capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk-weightings and other factors. Quantitative measures established by regulation to ensure capital adequacy require the Company and the Bank to maintain minimum amounts and ratios (set forth in the table below) of Total, Tier 1 and Common Equity Tier 1 capital (as defined in the regulations) to risk-weighted assets, and of Tier 1 capital to average assets. Management believes, as of December 31, 2020 and 2019, that the Company and the Bank meet all capital adequacy requirements to which they are subject. As of December 31, 2020, the most recent notification from the regulators has categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the Bank’s category. The Company’s actual capital amounts and ratios are presented in the following table: To be Well Capitalized under Prompt For Capital Adequacy Corrective Action Actual Purposes Provision Amount Ratio Amount Ratio Amount Ratio (Dollars in Thousands) As of December 31, 2020: Total capital (to risk-weighted assets) $ 172,103 12.62 % ≥$ 109,123 ≥ 8.00 % ≥$ 136,404 ≥ 10.00 % Tier 1 capital (to risk-weighted assets) 158,953 11.65 ≥ 81,842 ≥ 6.00 ≥ 109,123 ≥ 8.00 Common Equity Tier 1 capital (to risk-weighted assets) 158,953 11.65 ≥ 61,382 ≥ 4.50 ≥ 88,663 ≥ 6.50 Tier 1 capital (to average assets) 158,953 8.71 ≥ 72,994 ≥ 4.00 ≥ 91,243 ≥ 5.00 As of December 31, 2019: Total capital (to risk-weighted assets) $ 132,507 13.98 % ≥$ 75,674 ≥ 8.00 % ≥$ 94,593 ≥ 10.00 % Tier 1 capital (to risk-weighted assets) 123,999 13.08 ≥ 56,756 ≥ 6.00 ≥ 75,674 ≥ 8.00 Common Equity Tier 1 capital (to risk-weighted assets) 123,999 13.08 ≥ 42,567 ≥ 4.50 ≥ 61,485 ≥ 6.50 Tier 1 capital (to average assets) 123,999 10.33 ≥ 48,735 ≥ 4.00 ≥ 60,918 ≥ 5.00 The Bank’s ratios do not differ significantly from the Company’s ratios presented above. The Company and the Bank are subject to regulatory capital rules which, among other things, impose a common equity Tier 1 minimum capital requirement of 4.50 % of risk-weighted assets; set the minimum leverage ratio for all banking organizations at a uniform 4.00 % of total assets; set the minimum Tier 1 capital to risk-based assets requirement at 6.00 % of risk-weighted assets; and assign a risk-weight of 150 % to exposures that are more than 90 days past due or are on nonaccrual status and to certain commercial real estate facilities that finance the acquisition, development or construction of real property. The rules also require unrealized gains and losses on certain “available-for-sale” securities holdings to be included for purposes of calculating regulatory capital requirements unless a one-time opt out is exercised, which the Company and the Bank have done. The rule also limits a banking organization’s dividends, stock repurchases and other capital distributions, and certain discretionary bonus payments to executive officers, if the banking organization does not hold a “capital conservation buffer” consisting of 2.50 % of common equity Tier 1 capital to risk-weighted assets above regulatory minimum risk-based requirements. The Company and the Bank are in compliance with their respective new capital requirements, including the capital conservation buffer, as of December 31, 2020. Under Pennsylvania banking law, the Bank is subject to certain restrictions on the amount of dividends that it may declare without prior regulatory approval. At December 31, 2020, $ 119,465,000 of retained earnings were available for dividends without prior regulatory approval, subject to the regulatory capital requirements discussed above. Under Federal Reserve regulations, the Bank is limited as to the amount it may lend affiliates, including the Company, unless such loans are collateralized by specific obligations. |
Stock Based Compensation
Stock Based Compensation | 12 Months Ended |
Dec. 31, 2020 | |
Stock Based Compensation [Abstract] | |
Stock Based Compensation | NOTE 12 - STOCK BASED COMPENSATION At the Annual Meeting held on April 22, 2014, the Company’s stockholders approved the Norwood Financial Corp 2014 Equity Incentive Plan. An aggregate of 375,000 shares of authorized but unissued Common Stock of the Company were reserved for future issuance under the Plan. This includes up to 60,000 shares for awards to outside directors. The Plan also authorized the Company to award restricted stock to officers and outside directors, limited to 63,000 shares of restricted stock awards for officers and 12,000 shares of restricted stock awards for outside directors. At the Annual Meeting held on April 24, 2018, the Company’s stockholders approved an amendment to the 2014 Equity Incentive Plan to ease certain restrictions on restricted stock awards to outside directors. As a result of this amendment, the number of shares available for restricted stock awards to officers was reduced by 300 shares to 62,700 , while the number of shares available for restricted stock awards to outside directors was increased by 20,300 to 32,300 shares. Under this plan, the Company granted 245,465 shares which included 148,365 options to employees, 10,400 options to directors, 56,625 shares of restricted stock to officers and 30,075 shares of restricted stock to directors. The restricted shares vest over five years . The product of the number of shares granted and the grant date market price of the Company’s common stock determine the fair value of restricted stock under the company’s restricted stock plan. Management recognizes compensation expense for the fair value of restricted stock on a straight-line basis over the requisite service period for the entire award. As of December 31, 2020, there were 129,535 shares available for future awards under this plan, which includes 110,010 shares available for officer awards and 19,525 shares available for awards to outside directors. Included in these totals are 6,075 shares available for restricted stock awards to officers and 2,225 shares available for restricted stock awards to outside directors. All share information has been restated to reflect the 50% stock dividend declared in 2017. Total unrecognized compensation cost related to stock options was $ 214,000 as of December 31, 2020 and $ 203,000 as of December 31, 2019. Salaries and employee benefits expense includes $ 204,000 and $ 208,000 of compensation costs related to options for the years ended December 31, 2020 and 2019, respectively. Compensation costs related to restricted stock amounted to $ 334,000 and $ 289,000 for the years ended December 31, 2020 and 2019, respectively. The expected future compensation expense relating to non-vested restricted stock outstanding as of December 31, 2020 and 2019 was $ 1,202,000 and $ 1,146,000 , respectively. A summary of the Company’s stock option activity and related information for the years ended December 31 follows: 2020 2019 Weighted Weighted Average Average Average Average Exercise Intrinsic Exercise Intrinsic Options Price Value Options Price Value Outstanding, beginning of year 199,825 $ 24.78 208,700 $ 22.54 Granted 33,750 26.93 26,750 36.02 Exercised ( 15,530 ) 17.25 ( 32,350 ) 19.71 Forfeited ( 2,075 ) 16.83 ( 3,275 ) 24.31 Outstanding, end of year 215,970 $ 25.73 $ 742,738 199,825 $ 24.78 $ 2,822,470 Exercisable, end of year 182,220 $ 25.51 $ 742,738 173,075 $ 23.04 $ 2,745,430 Exercise prices for options outstanding as of December 31, 2020 ranged from $ 16.65 to $ 36.02 per share. The weighted average remaining contractual life is 6.0 years. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: Years Ended December 31, 2020 2019 Dividend yield 3.55 % 3.59 % Expected life 10 years 10 years Expected volatility 34.15 % 29.08 % Risk-free interest rate 0.91 % 1.92 % Weighted average fair value of options granted $ 6.34 $ 7.61 The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. Proceeds from stock option exercises totaled $ 268,000 in 2020. Shares issued in connection with stock option exercises are issued from available treasury shares or from available authorized shares. During 2020, for the shares issued in connection with stock option exercises, 15,530 shares in total, all shares were issued from available authorized shares. As of December 31, 2020, outstanding stock options consist of the following: Average Average Options Exercise Remaining Options Exercise Outstanding Price Life, Years Exercisable Price 18,000 $ 16.65 1.0 18,000 $ 16.65 23,100 18.03 2.0 23,100 18.03 1,650 18.36 2.0 1,650 18.36 3,000 19.30 2.8 3,000 19.30 20,125 17.93 3.0 20,125 17.93 8,250 19.39 3.9 8,250 19.39 9,375 19.03 4.9 9,375 19.03 16,120 22.37 6.0 16,120 22.37 29,500 32.81 7.0 29,500 32.81 26,350 32.34 8.0 26,350 32.34 26,750 36.02 9.0 26,750 36.02 33,750 26.93 10.0 — — Total 215,970 182,220 A summary of the Company’s restricted stock activity and related information for the years ended December 31 is as follows: 2020 2019 Weighted-Average Weighted-Average Number of Grant Date Number of Grant Date Shares Fair Value Shares Fair Value Non-vested, beginning of year 36,195 31.65 34,615 27.82 Granted 14,500 26.93 13,100 36.02 Vested ( 11,560 ) 32.89 ( 11,520 ) 25.12 Forfeited — — — — Non-vested at December 31 39,135 30.72 36,195 31.65 |
Earnings Per Share
Earnings Per Share | 12 Months Ended |
Dec. 31, 2020 | |
EARNINGS PER SHARE | |
Earnings Per Share | NOTE 13 - EARNINGS PER SHARE The following table sets forth the computations of basic and diluted earnings per share: Years Ended December 31, 2020 2019 (In Thousands, Except Per Share Data) Numerator, net income $ 15,080 $ 14,215 Denominator: Weighted average shares outstanding 7,239 6,295 Less: Weighted average unvested restricted shares ( 36 ) ( 35 ) Denominator: Basic earnings per share 7,203 6,260 Weighted average shares outstanding, basic 7,203 6,260 Add: Dilutive effect of stock options and restricted stock 27 72 Denominator: Diluted earnings per share 7,230 6,332 Basic earnings per common share $ 2.09 $ 2.27 Diluted earnings per common share $ 2.09 $ 2.25 Stock options which had no intrinsic value because their effect would be anti-dilutive, and therefore would not be included in the diluted EPS calculation, were 116,350 and zero for the years ended December 31, 2020 and 2019, respectively, based on the closing price of the Company’s common stock which was $ 26.17 and $ 38.90 as of December 31, 2020 and 2019, respectively. All share and per share information has been restated to reflect the 50 % stock dividend declared in 2017. |
Off-Balance Sheet Financial Ins
Off-Balance Sheet Financial Instruments and Guarantees | 12 Months Ended |
Dec. 31, 2020 | |
Off-Balance Sheet Financial Instruments and Guarantees [Abstract] | |
Off-Balance Sheet Financial Instruments and Guarantees | NOTE 14 - OFF-BALANCE SHEET FINANCIAL INSTRUMENTS The Bank is a party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the balance sheets. The Bank’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and letters of credit is represented by the contractual amount of those instruments. The Bank uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. A summary of the Bank’s financial instrument commitments is as follows: December 31, 2020 2019 (In Thousands) Commitments to grant loans $ 78,310 $ 44,246 Unfunded commitments under lines of credit 137,965 56,840 Standby letters of credit 5,636 3,668 $ 221,911 $ 104,754 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since some of the commitments are expected to expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Bank evaluates each customer’s credit worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Bank upon extension of credit, is based on management’s credit evaluation of the customer and generally consists of real estate. Standby letters of credit are conditional commitments issued by the Bank to guarantee the performance of a customer to a third party. The majority of these standby letters of credit expire within the next twelve months. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending other loan commitments. The Bank requires collateral supporting these letters of credit when deemed necessary. Management believes that the proceeds obtained through a liquidation of such collateral would be sufficient to cover the maximum potential amount of future payments required under the corresponding guarantees. |
Interest Rate Swaps
Interest Rate Swaps | 12 Months Ended |
Dec. 31, 2020 | |
Interest Rate Swaps [Abstract] | |
Interest Rate Swaps | NOTE 15 – INTEREST RATE SWAPS The Company enters into interest rate swaps that allow our commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate into a fixed-rate. The Company then enters into a corresponding swap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps with both the customers and third parties are not designated as hedges under FASB ASC 815 and are not marked to market through earnings. As the interest rate swaps are structured to offset each other, changes to the underlying benchmark interest rates considered in the valuation of these instruments do not result in an impact to earnings; however, there may be fair value adjustments related to credit quality variations between counterparties, which may impact earnings as required by FASB ASC 820. There was no effect on earnings in any periods presented. At December 31, 2020, based upon the swap contract values, the company pledged cash in the amount of $ 350,000 as collateral for its interest rate swaps with a third-party financial institution which had a fair value $ 276,000 . Summary information regarding these derivatives is presented below: (Amounts in thousands) Notional Amount, December 31, Fair Value December 31, 2020 2019 Interest Rate Paid Interest Rate Received 2020 2019 Customer interest rate swap Maturing November, 2030 $ 7,222 $ - 1 month LIBOR + Margin Fixed $ 165 $ - Maturing December, 2030 4,800 - 1 month LIBOR + Margin Fixed 111 - Total $ 12,022 $ - $ 276 $ - Third party interest rate swap Maturing November, 2030 $ 7,222 $ - Fixed 1 month LIBOR + Margin $ 165 $ - Maturing December, 2030 4,800 - Fixed 1 month LIBOR + Margin 111 - Total $ 12,022 $ - $ 276 $ - The following table presents the fair values of derivative instruments in the Consolidated Balance Sheet. (Amounts in thousands) Assets Liabilities Balance Sheet Location Fair Value Balance Sheet Location Fair Value Decemer 31, 2020 Interest rate derivatives Other assets $ 276 Other liabilities $ 276 Decemer 31, 2019 Interest rate derivatives Other assets - Other liabilities - |
Fair Values of Financial Instru
Fair Values of Financial Instruments | 12 Months Ended |
Dec. 31, 2020 | |
Fair Values of Financial Instruments [Abstract] | |
Fair Values of Financial Instruments | NOTE 16 – FAIR VALUES OF FINANCIAL INSTRUMENTS Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In accordance with fair value accounting guidance, the Company measures, records, and reports various types of assets and liabilities at fair value on either a recurring or non-recurring basis in the Consolidated Financial Statements. Those assets and liabilities are presented in the sections entitled “Assets and Liabilities Required to be Measured and Reported at Fair Value on a Recurring Basis” and “Assets and Liabilities Required to be Measured and Reported at Fair Value on a Non-Recurring Basis”. There are three levels of inputs that may be used to measure fair values: Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2 – Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3 – Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. Assets and Liabilities Required to be Measured and Reported at Fair Value on a Recurring Basis For financial assets measured at fair value on a recurring basis, the fair value measurements by level within the fair value hierarchy used at December 31, 2020 and 2019 are as follows (in thousands): Fair Value Measurement Reporting Date using Description Total Level 1 Level 2 Level 3 December 31, 2020 ASSETS U.S. Government agencies $ 3,969 $ — $ 3,969 $ — States and political subdivisions 73,091 — 73,091 — Corporate obligations 3,032 — 3,032 — Mortgage-backed securities-government sponsored entities 146,494 — 146,494 — Interest rate derivatives 276 — 276 — LIABILITIES Interest rate derivatives 276 — 276 — December 31, 2019 ASSETS U.S. Treasury securities $ — $ — $ — $ — States and political subdivisions 71,305 — 71,305 — Corporate obligations 4,100 — 4,100 — Mortgage-backed securities-government sponsored entities 134,800 — 134,800 — Securities: The fair value of securities available for sale (carried at fair value) are determined by obtaining quoted market prices on nationally recognized securities exchanges (Level 1), or matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities, but rather by relying on the securities’ relationship to other benchmark quoted prices. For certain securities which are not traded in active markets or are subject to transfer restrictions, valuations are adjusted to reflect illiquidity and/or non-transferability, and such adjustments are generally based on available market evidence (Level 3). In the absence of such evidence, management’s best estimate is used. Management’s best estimate consists of both internal and external support on certain Level 3 investments. Internal cash flow models using a present value formula that includes assumptions market participants would use along with indicative exit pricing obtained from broker/dealers (where available) are used to support fair values of certain Level 3 investments, if applicable. Assets and Liabilities Required to be Measured and Reported at Fair Value on a Non-Recurring Basis For financial assets measured at fair value on a nonrecurring basis, the fair value measurements by level within the fair value hierarchy used at December 31, 2020 and 2019 are as follows (in thousands): Fair Value Measurement Reporting Date using Description Total Level 1 Level 2 Level 3 December 31, 2020 Impaired Loans $ 2,662 $ — $ — $ 2,662 Foreclosed real estate 965 — — 965 December 31, 2019 Impaired Loans $ 1,584 $ — $ — $ 1,584 Foreclosed real estate 1,556 — — 1,556 Impaired loans (generally carried at fair value): The Company measures impairment generally based on the fair value of the loan’s collateral. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the lowest level of input that is significant to the fair value measurements. As of December 31, 2020, the fair value investment in impaired loans totaled $ 2,662,000 , which included six loan relationships that did not require a valuation allowance since either the estimated realizable value of the collateral or the discounted cash flows exceeded the recorded investment in the loan. As of December 31, 2020, the Company has recognized charge-offs against the allowance for loan losses on these impaired loans in the amount of $ 652,000 over the life of the loans. There were no loan relationships which required a valuation allowance. As of December 31, 2019, the fair value investment in impaired loans totaled $ 2,144,000 which included two loan relationships that did not require a valuation allowance since either the estimated realizable value of the collateral or the discounted cash flows exceeded the recorded investment in the loan. As of December 31, 2019, the Company has recognized charge-offs against the allowance for loan losses on these impaired loans in the amount of $ 251,000 over the life of the loans. Additionally, there were two loan relationships which totaled $ 2,001,000 which required a valuation allowance of $ 417,000 since either the estimated realizable value of the collateral or the discounted cash flows were below the recorded investment in the loan. As of December 31, 2019, the Company has no t recognized a charge-off against the allowance for loan losses on these impaired loans. Foreclosed real estate owned (carried at fair value): Real estate properties acquired through, or in lieu of, loan foreclosure are to be sold and are carried at fair value less estimated cost to sell. Fair value is based upon independent market prices, appraised value of the collateral or management’s estimation of the value of the collateral. These assets are included in Level 3 fair value based upon the lowest level of input that is significant to the fair value measurement. The following tables present additional quantitative information about assets measured at fair value on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value: Quantitative Information about Level 3 Fair Value Measurements (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average) December 31, 2020 Impaired loans $ 2,662 Appraisal of collateral(1) Appraisal adjustments(2) 0 %- 10.59 % ( 9.75 %) Foreclosed real estate owned $ 965 Appraisal of collateral(1) Liquidation Expenses(2) 7.00 % ( 7.00 %) Quantitative Information about Level 3 Fair Value Measurements (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average) December 31, 2019 Impaired loans $ 1,531 Appraisal of collateral(1) Appraisal adjustments(2) 10.00 % ( 10.00 %) Impaired loans $ 53 Present value of future cash flows Loan discount rate 4.00 - 6.97 % ( 5.55 %) Foreclosed real estate owned $ 1,556 Appraisal of collateral(1) Liquidation Expenses(2) 0 - 7.00 % ( 4.34 %) (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level 3 inputs which are not identifiable, less any associated allowance. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. Assets and Liabilities Not Required to be Measured or Reported at Fair Value The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The estimated fair values of the Bank’s financial instruments not required to be measured or reported at fair value were as follows at December 31, 2020 and December 31, 2019. (In thousands): Fair Value Measurements at December 31, 2020 Carrying Fair Amount Value Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents (1) $ 111,693 $ 111,693 $ 111,693 $ — $ — Loans receivable, net 1,397,582 1,493,480 — — 1,493,480 Mortgage servicing rights 337 476 — — 476 Regulatory stock (1) 3,981 3,981 3,981 — — Bank owned life insurance (1) 39,608 39,608 39,608 — — Accrued interest receivable (1) 6,232 6,232 6,232 — — Financial liabilities: Deposits 1,535,385 1,540,661 1,001,555 — 539,106 Short-term borrowings (1) 63,303 63,303 63,303 — — Other borrowings 42,459 43,452 — — 43,452 Accrued interest payable (1) 1,601 1,601 1,601 — — Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit — — — — — Fair Value Measurements at December 31, 2019 Carrying Fair Amount Value Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents (1) $ 15,415 $ 15,415 $ 15,415 $ — $ — Loans receivable, net 916,072 943,143 — — 943,143 Mortgage servicing rights 187 226 — — 226 Regulatory stock (1) 4,844 4,844 4,844 — — Bank owned life insurance (1) 38,763 38,763 38,763 — — Accrued interest receivable (1) 3,719 3,719 3,719 — — Financial liabilities: Deposits 957,529 961,120 596,811 — 364,309 Short-term borrowings (1) 62,256 62,256 62,256 — — Other borrowings 56,438 56,618 — — 56,618 Accrued interest payable (1) 2,432 2,432 2,432 — — Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit — — — — — (1) This financial instrument is carried at cost, which approximates the fair value of the instrument. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income | 12 Months Ended |
Dec. 31, 2020 | |
Accumulated Other Comprehensive Income [Abstract] | |
Accumulated Other Comprehensive Income | NOTE 17 – ACCUMULATED OTHER COMPREHENSIVE INCOME The following tables present the changes in accumulated other comprehensive income (loss) (in thousands) by component, net of tax, for the years ended December 31, 2020 and 2019: Unrealized gains on available for sale securities (a) Unrealized gain on pension liability (a) Total (a) Balance as of December 31, 2019 $ 354 $ 833 $ 1,187 Other comprehensive income (loss) before reclassification 3,798 190 3,988 Amount reclassified from accumulated other comprehensive loss ( 56 ) — ( 56 ) Total other comprehensive income 3,742 190 3,932 Balance as of December 31, 2020 $ 4,096 $ 1,023 $ 5,119 Unrealized gains on available for sale securities (a) Unrealized gain on pension liability (a) Balance as of December 31, 2018 $ ( 5,558 ) $ 538 $ ( 5,020 ) Other comprehensive income (loss) before reclassification 6,113 295 6,408 Amount reclassified from accumulated other comprehensive loss ( 201 ) — ( 201 ) Total other comprehensive 5,912 295 6,207 Balance as of December 31, 2019 $ 354 $ 833 $ 1,187 (a) All amounts are net of tax. Amounts in parentheses indicate debits. The following table presents significant amounts reclassified out of each component of accumulated other comprehensive income (loss) (in thousands) for the years ended December 31, 2020 and 2019: Amount Reclassified From Accumulated Affected Line Item in Other Consolidated Comprehensive Statements of Details about other comprehensive income Income (a) Income Twelve months Twelve months ended ended December 31, December 31, 2020 2019 Unrealized gains on available for sale securities $ 71 $ 254 Net realized gains on sales of securities ( 15 ) ( 53 ) Income tax expense $ 56 $ 201 (a) Amounts in parentheses indicate debits to net income. |
Acquisition of UpState New York
Acquisition of UpState New York Bancorp, Inc. and USNY Bank. | 12 Months Ended |
Dec. 31, 2020 | |
Acquisition of UpState New York Bancorp, Inc. and USNY Bank. [Abstract] | |
Acquisition of UpState New York Bancorp, Inc. and USNY Bank. | NOTE 18 – ACQUISITION OF UPSTATE NEW YORK BANCORP, INC. AND USNY BANK On January 8, 2020, the Company and the Bank, and UpState and its wholly owned subsidiary, USNY Bank entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which UpState would merge with and into the Company, with the Company as the surviving corporation (“the Merger”). The Merger was completed on July 7, 2020. Pursuant to the terms of the Merger Agreement, UpState was merged with and into the Company, with the Company as the surviving corporation of the Merger. Immediately following the Merger, USNY Bank was merged with and into Wayne Bank, with Wayne Bank as the surviving entity. USNY Bank conducted its business from two Bank of the Finger Lakes offices in Geneva and Penn Yan, New York, and two Bank of Cooperstown offices in Cooperstown and Oneonta, New York. At June 30, 2020, UpState had total assets of $ 463.8 million, total deposits of $ 412.8 million and total stockholders’ equity of $ 44.8 million. Pursuant to the terms of the Merger Agreement, shareholders of UpState elected to receive for each share of UpState common stock they owned, either 0.9390 shares of the Company’s common stock or $ 33.33 in cash, or a combination of both. All shareholder elections were subject to the allocation and proration procedures set forth in the Merger Agreement which were intended to ensure that 90 % of the shares of UpState would be exchanged for the Company’s common stock and 10 % of the shares of UpState would be exchanged for cash. In addition, under the terms of the Merger Agreement, UpState shareholders received an additional $ 0.67 per share in cash for each share of UpState common stock held. In the aggregate, the merger consideration paid to UpState shareholders consisted of approximately $ 8,845,198 in cash and 1,865,738 shares of the Company’s common stock. The senior management of the Company and Wayne Bank remained the same following the completion of the Merger. UpState directors Jeffrey S. Gifford and Alexandra K. Nolan have been appointed to the boards of directors of the Company and Wayne Bank. In addition, the remaining former directors of UpState have been invited to join a regional advisory board. UpState President and CEO R. Michael Briggs has entered into a consulting agreement with Wayne Bank. The Company has retained the brand names of USNY Bank’s two units, Bank of the Finger Lakes and Bank of Cooperstown, and has also retained USNY Bank’s administration center in Geneva, New York. Scott D. White, unit President of Bank of Cooperstown, and Jeffrey E. Franklin, unit President of Bank of the Finger Lakes, will also remain in place as executives of their units. The acquired assets and assumed liabilities were measured at estimated fair values. Management made significant estimates and exercised significant judgement in accounting for the acquisition. Management measured loan fair values based on loan file reviews, appraised collateral values , expected cash flows, and historical loss factors. The Company also recorded and identifiable asset representing the core deposit base of UpState based on management’s evaluation of the cost of such deposits relative to alternative funding sources. Management used significant estimates including the average lives of depository accounts, future interest rate levels, and the cost of servicing various depository products. Management used market quotations to determine the fair value of investment securities. The business combination resulted in the acquisition of loans with and without evidence of credit quality deterioration. UpState loans were deemed impaired at the acquisition date if the Company did not expect to receive all contractually required cash flows due to concerns about credit quality. Such loans were fair valued and the difference between contractually required payments at the acquisition date and cash flows expected to be collected was recorded as a non-accretable difference. At the acquisition date, the Company recorded $ 15,410,000 of purchased credit-impaired loans subject to a non-accretable difference of $ 5,213,000 . The method of measuring carrying value of purchased loans differs from loans originated by the Company (originated loans), and as such, the Company identifies purchased loans and purchased loans with a credit quality discount and originated loans at amortized cost. UpState’s loans without evidence of credit deterioration were fair valued by discounting both expected principal and interest cash flows using an observable discount rate for similar instruments that a market participant would consider in determining fair value. Additionally, consideration was given to management’s best estimates of default rates and payment speeds. At acquisition, UpState’s loan portfolio without evidence of deterioration totaled $ 400,127,000 and was recorded at a fair value of $ 393,580,000 . The allocation of purchase consideration related to the Merger is considered preliminary, primarily with respect to certain tax-related assets and liabilities. Subsequent to the closing date of the acquisition, final tax returns were prepared and filed for UpState which are expected to result in tax refunds which relate to the operations of UpState and USNY Bank. In accordance with ASC 805 the acquiring Company shall adjust the provisional amounts recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. A provisional amount is necessary when the buyer must issue financial statements prior to completing its accounting for the business combination (i.e. prior to the end of the measurement period). The measurement period begins on the acquisition date and ends on the earlier of either: (a) the buyer obtaining the information needed to finish the accounting for the business combination or (b) one year from the acquisition date. Adjustments to preliminary allocations related to certain tax-related assets and liabilities occurred in the fourth quarter of 2020. The change to provisional amounts resulted in a reduction in goodwill of $ 923,000 and no impact to results of operations during the fourth quarter. The Company expects to finalize the allocation of purchase price within the one-year measurement-period following the acquisition. The following table summarizes the purchase of UpState as of July 7, 2020: (Dollars in Thousands, Except Per Share Data) Purchase Price Consideration in Common Stock UpState New York Bancorp, Inc. common shares settled for stock 1,987,206 Exchange Ratio 0.9390 Norwood Financial Corp shares issued 1,865,738 Value assigned to each Norwood Financial Corp common share $ 24.30 Purchase price assigned to UpState New York Bancorp, Inc. common shares $ 45,337 exchanged for Norwood Financial Corp shares Purchase Price Consideration - Cash for Common Stock UpState New York Bancorp, Inc. shares exchanged for cash, excluding fractional shares 220,794 Purchase price paid to each UpState New York Bancorp, Inc. common share exchanged for cash $ 33.33 Purchase price assigned to UpState New York Bancorp, Inc. common shares exchanged for cash $ 7,359 Purchase price additional cash consideration per share 1,479 Purchase price consideration - Cash-in-lieu of Fractional Shares 6 Total Purchase Price $ 54,181 Net Assets Acquired: UpState New York Bancorp, Inc. shareholders' equity $ 44,803 UpState New York Bancorp, Inc. goodwill and intangibles - Total tangible equity 44,803 Adjustments to reflect assets acquired at fair value: Investments ( 112 ) Loans Interest rate 3,982 General credit ( 10,529 ) Specific credit - non-amortizing ( 5,213 ) Specific credit - amortizing ( 1,724 ) Core deposit intangible 409 Deferred loan fees ( 812 ) Premises and equipment ( 1,211 ) Allowance for loan and lease losses 5,982 Deferred tax assets 3,449 Other ( 48 ) Adjustments to reflect liabilities acquired at fair value: Time deposits ( 2,754 ) Net assets acquired 36,222 Goodwill resulting from merger $ 17,959 The following condensed statement reflects the values assigned to UpState New York Bancorp, Inc. net assets as of the acquisition date: (In Thousands) Total purchase price $ 54,181 Net assets acquired: Cash $ 24,037 Securities available for sale 13,836 Loans 405,221 Premises and equipment, net 4,318 Regulatory stock 2,487 Accrued interest receivable 1,426 Core deposit intangible 564 Other assets 5,117 Deposits ( 414,113 ) Accrued interest payable ( 175 ) Other liabilities ( 6,496 ) Total identifiable net assets acquired 36,222 Goodwill resulting from UpState New York Bancorp, Inc. Merger $ 17,959 The Company recorded goodwill and other intangibles associated with the acquisition of UpState totaling $ 17,959,000 . Goodwill is not amortized, but is periodically evaluated for impairment. The Company did no t recognize any impairment during the year ended December 31, 2020. The carrying amount of the goodwill at December 31, 2020 related to the UpState acquisition was $ 17,959,000 . Identifiable intangibles are amortized to their estimated residual values over the expected useful lives. Such lives are also periodically reassessed to determine if any amortization period adjustments are required. During the year ended December 31, 2020, no such adjustments were recorded. The identifiable intangible assets consist of a core deposit intangible which is being amortized on an accelerated basis over the useful life of such asset. The gross carrying amount of the core deposit intangible at December 31, 2020 was $ 409,000 with $ 37,000 accumulated depreciation as of that date. As of December 31, 2020, the current year and estimated future amortization expense for the core deposit intangible associated with the UpState acquisition is: (In thousands) 2020 $ 37 2021 71 2022 63 2023 56 2024 48 After five years 134 $ 409 The following table presents financial information for the former UpState included in the Consolidated Statements of Income from the date of acquisition through December 31, 2020: Actual From Acquisition Date Through December 31,2020 (in thousands) Net interest income after provision for loan losses $ 7,291 Noninterest income $ 313 The following table presents pro forma information for the years ended December 31, 2020 and 2019, as if the acquisition of UpState had occurred on January 1, 2019. This table has been prepared for comparative purposes only, and is not indicative of the actual results that would have been attained had the acquisition occurred as of the beginning of the periods presented, nor is it indicative of future results: Pro Forma Twelve Months Ended December 31, (In Thousands, Except Per Share Data) 2020 2019 Net interest income after provision for loan losses $ 52,897 $ 50,487 Noninterest income 8,726 7,959 Net income 20,613 18,842 Pro forma earnings per share: Basic $ 2.52 $ 2.31 Diluted $ 2.52 $ 2.30 |
Risks and Uncertainties
Risks and Uncertainties | 12 Months Ended |
Dec. 31, 2020 | |
Risks and Uncertainties [Abstract] | |
Risks and Uncertainties | NOTE 19 - RISKS AND UNCERTAINTIES The Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was signed into law on March 27, 2020, and provided over $2.0 trillion in emergency economic relief to individuals and businesses impacted by the COVID-19 pandemic. The CARES Act authorized the Small Business Administration (“SBA”) to temporarily guarantee loans under a new 7(a) loan program called the Paycheck Protection Program (“PPP”). As a qualified SBA lender, we were automatically authorized to originate PPP loans. Under the original terms of the PPP, an eligible business can apply for a PPP loan up to the greater of: (1) 2.5 times its average monthly payroll costs; or (2) $10.0 million. PPP loans will have: (a) an interest rate of 1.0%, (b) a two-year or five-year loan term to maturity; and (c) principal and interest payments deferred for ten months from the end of the coverage period. The SBA will guarantee 100% of the PPP loans made to eligible borrowers. The entire principal amount of the borrower’s PPP loan, including any accrued interest, is eligible to be reduced by the loan forgiveness amount under the PPP so long as employee and compensation levels of the business are maintained and 60% of the loan proceeds are used for payroll expenses, with the remaining 40% of the loan proceeds used for other qualifying expenses. As of December 31, 2020, the Company approved over 1,100 applications for $ 95.0 million of loans under the PPP. Since the opening of the PPP, several larger banks have been subject to litigation regarding the process and procedures that such banks used in processing applications for the PPP. Norwood may be exposed to the risk of similar litigation, from both customers and non-customers that approached the bank regarding PPP loans, regarding the process and procedures used in processing applications for the PPP. If any such litigation is filed against and is not resolved in a manner favorable to Norwood, it may result in significant financial liability or adversely affect reputation. In addition, litigation can be costly, regardless of outcome. Any financial liability, litigation costs or reputational damage caused by PPP-related litigation could have a material adverse impact on our business, financial condition and results of operations. The Company also has credit risk on PPP loans if a determination is made by the SBA that there is a deficiency in the manner in which the loan was originated, funded, or serviced by, such as an issue with the eligibility of a borrower to receive a PPP loan, which may or may not be related to the ambiguity in the laws, rules and guidance regarding the operation of the PPP. In the event of a loss resulting from a default on a PPP loan and a determination by the SBA that there was a deficiency in the manner in which the PPP loan was originated, funded, or serviced by the Company , the SBA may deny its liability under the guaranty, reduce the amount of the guaranty, or, if it has already paid under the guaranty, seek recovery of any loss related to the deficiency from the Company. COVID-19 Loan Forbearance Programs . Section 4013 of the CARES Act provides that banks may elect not to categorize a loan modification as a TDR if the loan modification is (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (A) 60 days after the date on which the national emergency concerning the novel coronavirus disease (COVID–19) outbreak declared by the President on March 13, 2020, under the National Emergencies Act terminates, or (B) December 31, 2020. According to the Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus (Revised) issued by the federal bank regulatory agencies on April 7, 2020, short-term loan modifications not otherwise eligible under Section 4013 that are made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. See Note 8 of the financial statements for additional disclosure of TDRs at December 31, 2020. The following table presents a summary of loans that were granted forbearance by type of loan during the year ended December 31, 2020: Loan Type Number of Loans Balance (in thousands) Real Estate Loans: Residential 118 $ 10,883 Commercial 385 218,984 Agricultural 16 5,267 Construction 24 4,125 Commercial 186 23,801 Other agricultural loans — - Consumer loans to individuals 486 11,130 Total 1,215 $ 274,190 The following table presents a summary of loans that remain in forbearance by type of loan as of December 31, 2020: Loan Type Number of Loans Balance (in thousands) Real Estate Loans: Residential 14 $ 2,163 Commercial 67 39,925 Agricultural 2 428 Construction 3 7,240 Commercial 47 3,773 Other agricultural loans - - Consumer loans to individuals 88 2,117 Total 314 $ 55,646 |
Norwood Financial Corp (Parent
Norwood Financial Corp (Parent Company Only) Financial Information | 12 Months Ended |
Dec. 31, 2020 | |
Norwood Financial Corp (Parent Company Only) Financial Information [Abstract] | |
Norwood Financial Corp (Parent Company Only) Financial | NOTE 20 - NORWOOD FINANCIAL CORP (PARENT COMPANY ONLY) FINANCIAL INFORMATION BALANCE SHEETS December 31, 2020 2019 (In Thousands) ASSETS Cash on deposit in bank subsidiary $ 854 $ 2,848 Investment in bank subsidiary 195,035 135,433 Other assets 2,337 1,875 Total assets $ 198,226 $ 140,156 LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities $ 3,441 $ 2,728 Stockholders’ equity 194,785 137,428 Total liabilities and stockholders' equity $ 198,226 $ 140,156 STATEMENTS OF INCOME Years Ended December 31, 2020 2019 Income: (In Thousands) Dividends from bank subsidiary $ 15,319 $ 6,113 Expenses 1,704 637 13,615 5,476 Income tax benefit ( 180 ) ( 232 ) 13,795 5,708 Equity in undistributed earnings of subsidiary 1,285 8,507 Net Income $ 15,080 $ 14,215 Comprehensive Income $ 19,012 $ 20,422 STATEMENTS OF CASH FLOWS Years Ended December 31, 2020 2019 (In Thousands) CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 15,080 $ 14,215 Adjustments to reconcile net income to net cash provided by operating activities: Undistributed earnings of bank subsidiary ( 1,285 ) ( 8,507 ) Other, net 28 335 Net Cash Provided by Operating Activities 13,823 6,043 CASH FLOWS FROM INVESTING ACTIVITIES Outlays for business combinations ( 8,844 ) — Net Cash (Used in) Provided by Investing Activities ( 8,844 ) — CASH FLOWS FROM FINANCING ACTIVITIES Stock options exercised 268 638 Sale of treasury stock for ESOP 130 127 Acquisition of treasury stock ( 108 ) ( 428 ) Cash dividends paid ( 7,263 ) ( 6,041 ) Net Cash Used in Financing Activities ( 6,973 ) ( 5,704 ) Net (Decrease) Increase in Cash and Cash Equivalents ( 1,994 ) 339 CASH AND CASH EQUIVALENTS - BEGINNING 2,848 2,509 CASH AND CASH EQUIVALENTS - ENDING $ 854 $ 2,848 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2020 | |
Summary of Significant Accounting Policies [Abstract] | |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, the Bank, and the Bank’s wholly-owned subsidiaries, WCB Realty Corp., Norwood Investment Corp. and WTRO Properties. All significant intercompany accounts and transactions have been eliminated in consolidation. The year ended December 31, 2020 includes the acquisition of UpState New York Bancorp, Inc. effective July 7, 2020. |
Estimates | Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of deferred tax assets, the determination of other-than-temporary impairment on securities, the determination of goodwill impairment and the fair value of financial instruments. |
Significant Group Concentrations of Credit Risk and Concentrations of Credit Risk | Significant Group Concentrations of Credit Risk Most of the Company’s activities are with customers located within its markets in Northeastern Pennsylvania and the New York Counties of Delaware, Sullivan, Ontario, Otsego and Yates. Note 3 discusses the types of securities that the Company invests in. Note 4 discusses the types of lending that the Company engages in. The Company does not have any significant concentrations to any one industry or customer. Concentrations of Credit Risk The Bank operates primarily in Wayne, Pike, Lackawanna, Luzerne and Monroe Counties, Pennsylvania and Delaware, Sullivan, Ontario, Otsego and Yates Counties, New York. Accordingly, the Bank has extended credit primarily to commercial entities and individuals in these areas whose ability to honor their contracts is influenced by the region’s economy. These customers are also the primary depositors of the Bank. The Bank is limited in extending credit by legal lending limits to any single borrower or group of related borrowers. |
Securities | Securities Securities classified as available for sale are those securities that the Company intends to hold for an indefinite period of time but not necessarily to maturity. Any decision to sell a security classified as available for sale would be based on various factors, including significant movement in interest rates, changes in maturity mix of the Company’s assets and liabilities, liquidity needs, regulatory capital considerations and other similar factors. Securities available for sale are carried at fair value. Unrealized gains and losses are reported in other comprehensive income, net of the related deferred tax effect. Realized gains or losses, determined on the basis of the cost of the specific securities sold, are included in earnings. Premiums and discounts are recognized in interest income using a method which approximates the interest method over the term of the security. Bonds, notes and debentures for which the Company has the positive intent and ability to hold to maturity are reported at cost, adjusted for premiums and discounts that are recognized in interest income using the interest method over the term of the security. Management determines the appropriate classification of debt securities at the time of purchase and re-evaluates such designation as of each Consolidated Balance Sheet date. Declines in the fair value of available for sale securities below their cost that are deemed to be other than temporary are reflected in earnings as realized losses. In estimating other-than-temporary impairment losses, management considers (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent of the Company to not sell the securities and it is more likely than not that it will not have to sell the securities before recovery of their cost basis. |
Regulatory Stock | Regulatory Stock The Company, as a member of the Federal Home Loan Bank (FHLB) system is required to maintain an investment in capital stock of its district FHLB according to a predetermined formula. This regulatory stock has no quoted market value and is carried at cost. Management evaluates the regulatory stock for impairment. Management’s determination of whether these investments are impaired is based on their assessment of the ultimate recoverability of their cost rather than by recognizing temporary declines in value. The determination of whether a decline affects the ultimate recoverability of their cost is influenced by criteria such as (1) the significance of the decline in net assets of the FHLB as compared to the capital stock amount for the FHLB and the length of time this situation has persisted, (2) commitments by the FHLB to make payments required by law or regulation and the level of such payments in relation to the operating performance of the FHLB, and (3) the impact of legislative and regulatory changes on institutions and, accordingly, on the customer base of the FHLB. Management considers the FHLB’s regulatory capital ratios, liquidity, and the fact that new shares of FHLB stock continue to change hands at the $ 100 par value. Management believes no impairment charge is necessary related to FHLB stock as of December 31, 2020. |
Loans Receivable | Loans Receivable Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are stated at their outstanding unpaid principal balances, net of an allowance for loan losses and any deferred fees. Interest income is accrued on the unpaid principal balance. Loan origination fees are deferred and recognized as an adjustment of the yield (interest income) of the related loans. The Company is generally amortizing these amounts over the contractual life of the loan. The accrual of interest is generally discontinued when the contractual payment of principal or interest has become 90 days past due or management has serious doubts about further collectability of principal or interest, even though the loan is currently performing. A loan may remain on accrual status if it is in the process of collection and is either guaranteed or well secured. When a loan is placed on nonaccrual status, unpaid interest credited to income in the current year is reversed and unpaid interest accrued in prior years is charged against the allowance for loan losses. Interest received on nonaccrual loans generally is either applied against principal or reported as interest income, according to management’s judgment as to the collectability of principal. Generally, loans are restored to accrual status when the obligation is brought current, has performed in accordance with the contractual terms for a reasonable period of time and the ultimate collectability of the total contractual principal and interest is no longer in doubt. |
Troubled Debt Restructurings | Troubled Debt Restructurings A loan is considered to be a troubled debt restructuring (TDR) loan when the Company grants a concession to the borrower because of the borrower’s financial condition that it would not otherwise consider. Such concessions include the reduction of interest rates, forgiveness of principal or interest, or other modifications of interest rates that are less than the current market rate for new obligations with similar risk. |
Loans Acquired | Loans Acquired Loans acquired including loans that have evidence of deterioration of credit quality since origination and for which it is probable, at acquisition, that the Company will be unable to collect all contractually required payments receivable, are initially recorded at fair value (as determined by the present value of expected future cash flows) with no valuation allowance. Loans are evaluated individually to determine if there is evidence of deterioration of credit quality since origination. The difference between the undiscounted cash flows expected at acquisition and the investment in the loan, or the “accretable yield,” is recognized as interest income on a level-yield method over the life of the loan. Contractually required payments for interest and principal that exceed the undiscounted cash flows expected at acquisition, or the “non-accretable difference,” are not recognized as a yield adjustment or as a loss accrual or a valuation allowance. Increases in expected cash flows subsequent to the initial investment are recognized prospectively through adjustment of the yield on the loan over its remaining estimated life. Decreases in expected cash flows are recognized immediately as impairment. Any valuation allowances on these impaired loans reflect only losses incurred after the acquisition. For purchased loans acquired that are not deemed impaired at acquisition, credit discounts representing the principal losses expected over the life of the loan are a component of the initial fair value. Loans may be aggregated and accounted for as a pool of loans if the loans being aggregated have common risk characteristics. Subsequent to the purchase date, the methods utilized to estimate the required allowance for credit losses for these loans is similar to originated loans; however, the Company records a provision for loan losses only when the required allowance exceeds any remaining credit discounts. The remaining differences between the purchase price and the unpaid principal balance at the date of acquisition are recorded in interest income over the life of the loans. |
Mortgage Servicing Rights | Mortgage Servicing Rights Servicing assets are recognized as separate assets when rights are acquired through purchase or through the sale of financial assets. Capitalized servicing rights are reported in other assets and are amortized into noninterest income in proportion to, and over the period of, the estimated future net servicing income of the underlying financial assets. Servicing assets are evaluated for impairment based upon a third party appraisal. Fair value is determined using prices for similar assets with similar characteristics, when available, or based upon discounted cash flows using market-based assumptions. Impairment is recognized through a valuation allowance to the extent that fair value is less than the capitalized amount. The Company’s loan servicing assets at December 31, 2020 and 2019, respectively, were no t impaired. Total servicing assets included in other assets as of December 31, 2020 and 2019, were $ 337,000 and $ 187,000 , respectively. |
Allowance for Loan Losses | Allowance for Loan Losses The allowance for loan losses is established through provisions for loan losses charged against income. Loans deemed to be uncollectible are charged against the allowance for loan losses, and subsequent recoveries, if any, are credited to the allowance. The allowance for loan losses is maintained at a level considered adequate to provide for losses that can be reasonably anticipated. Management’s periodic evaluation of the adequacy of the allowance is based on the Company’s past loan loss experience, known and inherent risks in the portfolio, adverse situations that may affect the borrower’s ability to repay, the estimated value of any underlying collateral, composition of the loan portfolio, current economic conditions and other relevant factors. This evaluation is inherently subjective as it requires material estimates that may be susceptible to significant revision as more information becomes available. The allowance consists of specific and general components. The specific component relates to loans that are classified as substandard. For such loans that are also classified as impaired, an allowance is established when the discounted cash flows (or collateral value or observable market price) of the impaired loan is lower than the carrying value of that loan. The general component covers non-classified loans and is based on historical loss experience adjusted for qualitative factors. A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. Management determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis for commercial and construction loans by either the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, the Company does not separately identify individual consumer and residential real estate loans for impairment disclosures, unless such loans were acquired with impairment or are the subject of a restructuring agreement. |
Premises and Equipment | Premises and Equipment Land is carried at cost. Premises and equipment are stated at cost less accumulated depreciation. Depreciation expense is calculated principally on the straight-line method over the respective assets estimated useful lives as follows: Years Buildings and improvements 10 - 40 Furniture and equipment 3 - 10 |
Leases | Leases The Company applies a right-of-use (ROU) model that requires a lessee to record, for all leases with a lease term of more than 12 months, an asset representing its right to use the underlying asset and a liability to make lease payments. For leases with a term of 12 months or less, a practical expedient is available whereby a lessee may elect, by class of underlying asset, not to recognize an ROU asset or lease liability. At inception, lessees must classify all leases as either finance or operating based on five criteria. Balance sheet recognition of finance and operating leases is similar, but the pattern of expense recognition in the income statement, as well as the effect on the statement of cash flows, differs depending on the lease classification. See Note 8 for related disclosures. |
Transfers of Financial Assets | Transfers of Financial Assets Transfers of financial assets, including loan and loan participation sales, are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when (1) the assets have been isolated from the Company, (2) the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets and (3) the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity or the ability to unilaterally cause the holder to return specific assets. |
Foreclosed Real Estate | Foreclosed Real Estate Real estate properties acquired through, or in lieu of, loan foreclosure are to be sold and are initially recorded at fair value less cost to sell at the date of foreclosure establishing a new cost basis. After foreclosure, valuations are periodically performed by management and the real estate is carried at the lower of its carrying amount or fair value less cost to sell. Revenue and expenses from operations and changes in the valuation allowance are included in other expenses. |
Bank Owned Life Insurance | Bank Owned Life Insurance The Company invests in bank owned life insurance (BOLI) as a source of funding for employee benefit expenses. BOLI involves the purchasing of life insurance by the Bank on a select group of employees. The Company is the owner and beneficiary of the policies. This life insurance investment is carried at the cash surrender value of the underlying policies. Income from the increase in cash surrender value of the policies or from death benefits realized is included in other income on the Consolidated Statements of Income. |
Goodwill | Goodwill In connection with three acquisitions the Company recorded goodwill in the amount of $29.3 million, representing the excess of amounts paid over the fair value of net assets of the institutions acquired. Goodwill is tested and deemed impaired when the carrying value of goodwill exceeds its implied fair value. The value of the goodwill can change in the future. We expect the value of the goodwill to decrease if there is a significant decrease in the franchise value of the Bank. If an impairment loss is determined in the future, we will reflect the loss as an expense for the period in which the impairment is determined, leading to a reduction of our net income for that period by the amount of the impairment loss. No impairment was recognized for the years ended December 31, 2020 and 2019. |
Other Intangible Assets | Other Intangible Assets At December 31, 2020, the Company had other intangible assets of $ 530,000 , which is net of accumulated amortization of $ 1,224,000 . These intangible assets will continue to be amortized using the sum-of-the-years digits method of amortization over ten years . At December 31, 2019, the Company had other intangible assets of $ 235,000 which was net of accumulated amortization of $ 1,110,000 . Amortization expense related to other intangible assets was $ 114,000 and $ 101,000 for the years ended December 31, 2020 and 2019, respectively. As of December 31, 2020, the estimated future amortization expense for the core deposit intangible is as follows (in thousands): 2021 $ 123 2022 101 2023 85 2024 69 2025 54 Thereafter 98 $ 530 |
Income Taxes | Income Taxes Deferred income tax assets and liabilities are determined based on the differences between financial statement carrying amounts and the tax basis of existing assets and liabilities. These differences are measured at the enacted tax rates that will be in effect when these differences reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion of the deferred tax assets will not be realized. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. The Company and its subsidiary file a consolidated federal income tax return. The Company recognizes interest and penalties on income taxes as a component of income tax expense. The Company analyzes each tax position taken in its tax returns and determines the likelihood that the position will be realized. Only tax positions that are “more-likely-than-not” to be realized can be recognized in an entity’s financial statements. For tax positions that do not meet this recognition threshold, an entity will record an unrecognized tax benefit for the difference between the position taken on the tax return and the amount recognized in the financial statements. The Company does no t have any unrecognized tax benefits at December 31, 2020 or 2019, or during the years then ended. No unrecognized tax benefits are expected to arise within the next twelve months. |
Advertising Costs | Advertising Costs Advertising costs are expensed as incurred. |
Earnings Per Share | Earnings per Share Basic earnings per share represents income available to common stockholders divided by the weighted average number of common shares outstanding during the period less any unvested restricted shares. Diluted earnings per share reflects additional common shares that would have been outstanding if dilutive potential common shares had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential common shares that may be issued by the Company relate solely to outstanding stock options and are determined using the treasury stock method. Treasury shares are not deemed outstanding for earnings per share calculations. |
Employee Benefit Plans | Employee Benefit Plans The Company has a defined contributory profit-sharing plan which includes provisions of a 401(k) plan. The Company’s contributions are expensed as the cost is incurred. The Company has several supplemental executive retirement plans. To fund the benefits under these plans, the Company is the owner of single premium life insurance policies on the participants. The Company provides pension benefits to eligible employees. The Company’s funding policy is to contribute at least the minimum required contributions annually. |
Interest Rate Derivatives | Interest Rate Derivatives The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments. |
Stock Option Plans | Stock Option Plans The Company recognizes the value of share-based payment transactions as compensation costs in the financial statements over the period that an employee provides service in exchange for the award. The fair value of the share-based payments for stock options is estimated using the Black-Scholes option-pricing model. The Company used the modified-prospective transition method to record compensation expense. Under the modified-prospective method, companies are required to record compensation cost for new and modified awards over the related vesting period of such awards and record compensation cost prospectively for the unvested portion, at the date of adoption, of previously issued and outstanding awards over the remaining vesting period of such awards. No change to prior periods presented is permitted under the modified-prospective method. |
Restricted Stock | Restricted Stock The Company recognizes compensation cost related to restricted stock based on the market price of the stock at the grant date over the vesting period. The product of the number of shares granted and the grant date market price of the Company’s common stock determines the fair value of restricted stock under the Company’s 2014 Equity Incentive Plan. The Company recognizes compensation expense for the fair value of the restricted stock on a straight-line basis over the requisite service period for the entire award. |
Cash Flow Information | Cash Flow Information For the purposes of reporting cash flows, cash and cash equivalents include cash on hand, amounts due from banks, interest-bearing deposits with banks and federal funds sold. |
Off-Balance Sheet Financial Instruments | Off-Balance Sheet Financial Instruments In the ordinary course of business, the Company has entered into off-balance sheet financial instruments consisting of commitments to extend credit, letters of credit and commitments to sell loans. Such financial instruments are recorded on the balance sheets when they become receivable or payable. |
Trust Assets | Trust Assets Assets held by the Company in a fiduciary capacity for customers are not included in the financial statements since such items are not assets of the Company. Trust income is reported on the accrual method. |
Treasury Stock | Treasury Stock Common shares repurchased are recorded as treasury stock at cost. |
Comprehensive Income | Comprehensive Income Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net income. Certain changes in assets and liabilities, such as unrealized gains and losses on available for sale securities and defined benefit pension obligations, are reported as a separate component of the equity section of the balance sheet. Such items, along with net income, are components of comprehensive income as presented in the Consolidated Statement of Comprehensive Income. |
Segment Reporting | Segment Reporting The Company acts as an independent community financial services provider and offers traditional banking related financial services to individual, business and government customers. Through its Community Office and automated teller machine network, the Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and mortgage loans; and the providing of safe deposit services. The Company also performs personal, corporate, pension and fiduciary services through its Trust Department. Management does not separately allocate expenses, including the cost of funding loan demand, between the commercial, retail, mortgage banking and trust operations of the Company. As such, discrete information is not available and segment reporting would not be meaningful. |
Reclassification of Comparative Amounts | Reclassification of Comparative Amounts Certain comparative amounts for the prior year have been reclassified to conform to current-year classifications. Such reclassifications had no material effect on net income or stockholders’ equity. |
New Accounting Pronouncements Not Yet Adopted | New Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This Update is effective for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment . To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The Update is effective for smaller reporting companies and all other entities for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years . This Update is not expected to have a significant impact on the Company’s financial statements. In August 2018, the FASB issued ASU 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contract s. This Update is intended to improve financial reporting for insurance companies that issue long-duration contracts, such as life insurance, disability income, long-term care, and annuities, by requiring updated assumptions for liability measurement, standardizing the liability discount rate, simplifying and improving the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts by requiring those benefits to be measured at fair value instead of using two different measurement models, simplifying the amortization of deferred acquisition costs, and increasing transparency by improving the effectiveness of disclosures. This Update is effective for public business entities for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits (Topic 715-20). This Update amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The Update eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The Update also removes the disclosure requirements for the effects of a one-percentage-point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. This Update is effective for public business entities for fiscal years ending after December 15, 2020, and must be applied on a retrospective basis. For all other entities, this Update is effective for fiscal years ending after December 15, 2021. This Update is not expected to have a significant impact on the Company’s financial statements. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments ‒ Credit Losses , which, in addition to addressing other matters, ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20. The effective date and transition requirements for ASU 2018-19 are the same as those in ASU 2016-13. This Update is not expected to have a significant impact on the Company’s financial statements. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives, and Hedging (Topic 815); and Financial Instruments (Topic 825), which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. ASU 2019-04 makes clarifying amendments to certain financial instrument standards. For entities that have not yet adopted ASU 2016-13, the effective dates for the amendments related to ASU 2016-13 are the same as the effective dates in ASU 2016-13. For entities that have adopted ASU 2016-13, the amendments related to ASU 2016-13 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. For entities that have not yet adopted ASU 2017-12 as of April 25, 2019, the effective dates for the amendments to Topic 815 are the same as the effective dates in ASU 2017-12. For entities that have adopted ASU 2017-12 as of April 25, 2019, the effective date is as of the beginning of the first annual period beginning after April 25, 2019. The amendments related to ASU 2016-01 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326) , which allows entities to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost upon adoption of the new credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for applying the fair value option in ASC 825-10.3. The election must be applied on an instrument-by-instrument basis and is not available for either available-for-sale or held-to-maturity debt securities. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings. For entities that have not yet adopted the credit losses standard, the ASU is effective when they implement the credit losses standard. For entities that already have adopted the credit losses standard, the ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt ASU 2016-13. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), which deferred the effective date for ASC 944 , Financial Services – Insurance , for public business entities that are SEC filers, except for smaller reporting companies, to fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, and for all other entities, including smaller reporting companies, to fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. This Update is not expected to have a significant impact on the Company’s financial statements. In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , to clarify its new credit impairment guidance in ASC 326, based on implementation issues raised by stakeholders. This Update clarified, among other things, that expected recoveries are to be included in the allowance for credit losses for these financial assets; an accounting policy election can be made to adjust the effective interest rate for existing troubled debt restructurings based on the prepayment assumptions instead of the prepayment assumptions applicable immediately prior to the restructuring event; and extends the practical expedient to exclude accrued interest receivable from all additional relevant disclosures involving amortized cost basis. For entities that have not yet adopted ASU 2016-13 as of November 26, 2019, the effective dates for ASU 2019-11 are the same as the effective dates and transition requirements in ASU 2016-13. For entities that have adopted ASU 2016-13, ASU 2019-11 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) , to simplify the accounting for income taxes, change the accounting for certain tax transactions, and make minor improvements to the codification. This Update provides a policy election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax and provides guidance to evaluate whether a step-up in tax basis of goodwill relates to a business combination in which book goodwill was recognized or was a separate transaction. The Update also changes current guidance for making an intraperiod allocation if there is a loss in continuing operations and gains outside of continuing operations, determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting, accounting for tax law changes and year-to-date losses in interim periods, and determining how to apply the income tax guidance to franchise taxes that are partially based on income. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements. In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) , to clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting, for the purposes of applying the measurement alternative, in accordance with Topic 321, immediately before applying or upon discontinuing the equity method. The amendments also clarify that, for the purpose of applying paragraph 815-10-15-141 (a), an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option, in accordance with the financial instruments guidance in Topic 825. An entity also would evaluate the remaining characteristics in paragraph 815-10-15-141 to determine the accounting for those forward contracts and purchased options. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements. In March 2020, the FASB issued ASU 2020-03 , Codification Improvements to Financial Instruments. This ASU was issued to improve and clarify various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven issues that describe the areas of improvement and the related amendments to GAAP; they are intended to make the standards easier to understand and apply and to eliminate inconsistencies, and they are narrow in scope and are not expected to significantly change practice for most entities. Among its provisions, the ASU clarifies that all entities, other than public business entities that elected the fair value option, are required to provide certain fair value disclosures under ASC 825, Financial Instruments , in both interim and annual financial statements. It also clarifies that the contractual term of a net investment in a lease under Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. Amendments related to ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is not permitted before an entity’s adoption of ASU 2016-01. Amendments related to ASU 2016-13 for entities that have not yet adopted that guidance are effective upon adoption of the amendments in ASU 2016-13. Early adoption is not permitted before an entity’s adoption of ASU 2016-13. Amendments related to ASU 2016-13 for entities that have adopted that guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Other amendments are effective upon issuance of this ASU. This Update is not expected to have a significant impact on the Company’s financial statements In January 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020 , to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls “reference rate reform” if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. It is too early to predict whether a new rate index replacement and the adoption of the ASU will have a material impact on the Company’s financial statements. In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This ASU removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. This ASU requires entities to provide expanded disclosures about the terms and features of convertible instruments, how the instruments have been reported in the entity’s financial statements, and information about events, conditions, and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The amendments in this ASU are effective for public business entities that are not smaller reporting companies, for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. For all other entities, this ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs, which clarifies that, for each reporting period, an entity should reevaluate whether a callable debt security is within the scope of ASC 310-20-35-33. For public business entities, ASU 2020-08 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is not permitted. For all other entities, ASU 2020-08 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements, In October 2020, the FASB issued ASU 2020-09, Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762 , which codifies, as appropriate, the amended financial statement disclosure requirements in Regulation S-X Rules 13-01 and 13-02. The amendments are effective January 4, 2021. This Update did not have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-10, Codification Improvements , which makes minor technical corrections and clarifications to the ASC. The amendments in Sections B and C of the ASU are effective for annual periods beginning after December 15, 2020, for public business entities. For all other entities, the amendments are effective for annual periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848) , which provides optional temporary guidance for entities transitioning away from the London Interbank Offered Rate (LIBOR) and other interbank offered rates (IBORs) to new references rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. ASU 2021-01 clarifies that the derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments in this update do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations. |
Nature of Operations (Tables)
Nature of Operations (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Nature of Operations [Abstract] | |
Noninterest Income | (dollars in thousands) 2020 2019 Noninterest Income In-scope of Topic 606: Service charges on deposit accounts $ 377 $ 336 ATM Fees 457 384 Overdraft Fees 985 1,380 Safe deposit box rental 102 94 Loan related service fees 1,288 614 Debit card 1,656 1,424 Fiduciary activities 682 610 Commissions on mutual funds & annuities 122 141 Other income 540 465 Noninterest Income (in-scope of Topic 606) 6,209 5,448 Out-of-scope of Topic 606: Net realized gains on sales of securities 71 254 Loan servicing fees 128 77 Gain on sales of loans 527 169 Earnings on and proceeds from bank-owned life insurance 845 830 Noninterest Income (out-of-scope of Topic 606) 1,571 1,330 Total Noninterest Income $ 7,780 $ 6,778 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Summary of Significant Accounting Policies [Abstract] | |
Schedule of Estimated Useful Lives | Years Buildings and improvements 10 - 40 Furniture and equipment 3 - 10 |
Schedule of Estimated Future Amortization Expense for the Core Deposit Intangible | 2021 $ 123 2022 101 2023 85 2024 69 2025 54 Thereafter 98 $ 530 |
Securities (Tables)
Securities (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Securities [Abstract] | |
Schedule of Amortized Cost Gross Unrealized Gains and Losses, and Fair Values of Securities | December 31, 2020 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains Losses Value (In Thousands) AVAILABLE FOR SALE: U.S. Government agencies $ 3,998 $ — $ ( 29 ) $ 3,969 States and political subdivisions 70,672 2,419 — 73,091 Corporate obligations 3,019 13 — 3,032 Mortgage-backed securities- government sponsored entities 143,712 2,809 ( 27 ) 146,494 Total debt securities $ 221,401 $ 5,241 $ ( 56 ) $ 226,586 December 31, 2019 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains Losses Value (In Thousands) AVAILABLE FOR SALE: States and political subdivisions $ 70,015 $ 1,293 $ ( 3 ) $ 71,305 Corporate obligations 4,097 3 — 4,100 Mortgage-backed securities- government sponsored entities 135,646 238 ( 1,084 ) 134,800 Total debt securities $ 209,758 $ 1,534 $ ( 1,087 ) $ 210,205 |
Schedule of Investments' Gross Unrealized Losses and Fair Value Aggregated by Security Type and Length of Time that Individual Securities have been in a Continous Unrealized Loss Position | December 31, 2020 Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. Government agencies $ 3,969 ( 29 ) — — 3,969 ( 29 ) Mortgage-backed securities-government sponsored entities $ 4,980 $ ( 27 ) $ — $ — $ 4,980 $ ( 27 ) $ 8,949 $ ( 56 ) $ — $ — $ 8,949 $ ( 56 ) December 31, 2019 Less than 12 Months 12 Months or More Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses States and political subdivisions $ 1,296 $ ( 2 ) $ 481 $ ( 1 ) $ 1,777 $ ( 3 ) Mortgage-backed securities-government sponsored entities 32,415 ( 241 ) 61,096 ( 843 ) 93,511 ( 1,084 ) $ 33,711 $ ( 243 ) $ 61,577 $ ( 844 ) $ 95,288 $ ( 1,087 ) |
Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity | Amortized Fair Cost Value (In Thousands) Due in one year or less $ 5,498 $ 5,532 Due after one year through five years 5,373 5,510 Due after five years through ten years 23,276 23,676 Due after ten years 43,542 45,374 77,689 80,092 Mortgage-backed securities - government sponsored entities 143,712 146,494 $ 221,401 $ 226,586 |
Loans Receivable and Allowanc_2
Loans Receivable and Allowance for Loan Losses (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Loans Receivable and Allowance for Loan Losses [Abstract] | |
Composition of the Loan Portfolio | December 31, 2020 December 31, 2019 Real Estate: Residential $ 263,127 18.6 % $ 229,781 24.9 % Commercial 579,104 41.0 391,327 42.3 Agricultural 66,334 4.7 — — Construction 21,005 1.5 17,732 1.9 Commercial loans 283,741 20.1 134,150 14.5 Other agricultural loans 40,929 2.9 — — Consumer loans to individuals 158,049 11.2 151,686 16.4 Total loans 1,412,289 100.0 % 924,676 100.0 % Deferred fees, net ( 1,557 ) ( 95 ) Total loans receivable 1,410,732 924,581 Allowance for loan losses ( 13,150 ) ( 8,509 ) Net loans receivable $ 1,397,582 $ 916,072 |
Changes in the Accretable Yield for Purchased Credit-impaired Loans | 2020 2019 Balance at beginning of period $ — $ 29 Additions 1,724 — Accretion ( 353 ) ( 29 ) Reclassification and other ( 6 ) — Balance at end of period $ 1,365 $ — |
Information Regarding Loans Acquired and Accounted for in Accordance With ASC 310-30 | December 31, 2020 December 31, 2019 Outstanding Balance $ 15,570 $ 793 Carrying Amount $ 9,281 $ 696 |
Components Of Purchase Accounting Adjustments Related To Purchased Credit-impaired Loans Acquired | (In Thousands) July 7, 2020 Contractually required principal and interest $ 15,410 Non-accretable discount ( 5,213 ) Expected cash flows 10,197 Accretable discount ( 1,724 ) Estimated fair value $ 8,473 |
Summary of Amount of Loans in Each Category that were Individually and Collectively Evaluated for Impairment | Real Estate Loans Commercial Other Consumer Residential Commercial Agricultural Construction Loans Agricultural Loans Total (In thousands) December 31, 2020 Individually evaluated for impairment $ — $ 2,582 $ — $ — $ 80 $ — $ — $ 2,662 Loans acquired with deteriorated credit quality 591 3,995 2,043 194 246 2,212 — 9,281 Collectively evaluated for impairment 262,536 572,527 64,291 20,811 283,415 38,717 158,049 1,400,346 Total Loans $ 263,127 $ 579,104 $ 66,334 $ 21,005 $ 283,741 $ 40,929 $ 158,049 $ 1,412,289 Real Estate Loans Commercial Other Consumer Residential Commercial Agricultural Construction Loans Agricultural Loans Total (In thousands) December 31, 2019 Individually evaluated for impairment $ — $ 2,144 $ — $ — $ — $ — $ — $ 2,144 Loans acquired with deteriorated credit quality 476 220 — — — — — 696 Collectively evaluated for impairment 229,305 388,963 — 17,732 134,150 — 151,686 921,836 Total Loans $ 229,781 $ 391,327 $ — $ 17,732 $ 134,150 $ — $ 151,686 $ 924,676 |
Impaired Loans and Related Interest Income by Loan Portfolio Class | The following table includes the recorded investment and unpaid principal balances for impaired loans with the associated allowance amount, if applicable. Unpaid Principal Recorded Principal Associated Investment Balance Allowance December 31, 2020 (In thousands) With no related allowance recorded: Real Estate Loans Commercial $ 2,582 $ 3,234 $ — Commercial loans 80 80 — Subtotal 2,662 3,314 — Total: Real Estate Loans Commercial $ 2,582 $ 3,234 $ — Commercial loans 80 80 — Total Impaired Loans $ 2,662 $ 3,314 $ — Unpaid Recorded Principal Associated Investment Balance Allowance December 31, 2019 (In thousands) With no related allowance recorded: Real Estate Loans Commercial $ 143 $ 394 $ — Subtotal 143 394 — With an allowance recorded: Real Estate Loans Commercial 2,001 2,001 417 Subtotal 2,001 2,001 417 Total: Real Estate Loans Commercial 2,144 2,395 417 Total Impaired Loans $ 2,144 $ 2,395 $ 417 The following information for impaired loans is presented for the years ended December 31, 2020 and 2019: Average Recorded Interest Income Investment Recognized 2020 2019 2020 2019 (In thousands) Total: Real Estate Loans Commercial $ 2,105 $ 1,036 $ 14 $ 233 Commercial loans 16 — — — Total Loans $ 2,121 $ 1,036 $ 14 $ 233 |
Classes of the Loan Portfolio Summarized by the Aggregate Risk Rating | Special Pass Mention Substandard Doubtful Loss Total December 31, 2020 Commercial real estate loans $ 566,418 $ 6,346 $ 6,340 $ — $ — $ 579,104 Real estate - agricultural 58,322 5,111 2,901 — — 66,334 Commercial loans 282,915 437 389 — — 283,741 Other agricultural loans 35,772 2,786 2,371 — — 40,929 Total $ 943,427 $ 14,680 $ 12,001 $ — $ — $ 970,108 Special Pass Mention Substandard Doubtful Loss Total December 31, 2019 Commercial real estate loans $ 376,109 $ 12,268 $ 2,950 $ - $ - $ 391,327 Commercial 133,695 248 207 - - 134,150 Total $ 509,804 $ 12,516 $ 3,157 $ - $ - $ 525,477 For residential real estate loans, construction loans and consumer loans, the Company evaluates credit quality based on the performance of the individual credits. Nonperforming loans include loans that have been placed on nonaccrual status and loans remaining in accrual status on which the contractual payment of principal and interest has become 90 days past due. The following table presents the recorded investment in the loan classes based on payment activity as of December 31, 2020 and December 31, 2019 (in thousands): Performing Nonperforming Total December 31, 2020 Residential real estate loans $ 262,556 $ 571 $ 263,127 Construction 21,005 — 21,005 Consumer loans to individuals 157,864 185 158,049 Total $ 441,425 $ 756 $ 442,181 Performing Nonperforming Total December 31, 2019 Residential real estate loans $ 229,214 $ 567 $ 229,781 Construction 17,732 — 17,732 Consumer loans to individuals 151,607 79 151,686 Total $ 398,553 $ 646 $ 399,199 |
Loan Portfolio Summarized by the Past Due Status | Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Purchased Credit Impaired Loans Total Loans December 31, 2020 Real Estate loans Residential $ 261,406 $ 355 $ 204 $ — $ 571 $ 1,130 $ 591 $ 263,127 Commercial 573,376 59 — — 1,674 1,733 3,995 579,104 Agricultural 63,615 — — — 676 676 2,043 66,334 Construction 20,811 — — — — — 194 21,005 Commercial loans 282,374 1,009 90 — 22 1,121 246 283,741 Other agricultural loans 38,454 — — — 263 263 2,212 40,929 Consumer loans 157,538 233 93 — 185 511 - 158,049 Total $ 1,397,574 $ 1,656 $ 387 $ — $ 3,391 $ 5,434 $ 9,281 $ 1,412,289 Current 31-60 Days Past Due 61-90 Days Past Due Greater than 90 Days Past Due and still accruing Non-Accrual Total Past Due and Non-Accrual Purchased Credit Impaired Loans Total Loans December 31, 2019 Real Estate loans Residential $ 227,766 $ 727 $ 245 $ — $ 567 $ 1,539 $ 476 $ 229,781 Commercial 387,897 176 2,935 — 99 3,210 220 391,327 Construction 17,695 — 37 — — 37 — 17,732 Commercial loans 134,018 82 — — 50 132 — 134,150 Consumer loans 151,309 233 65 — 79 377 — 151,686 Total $ 918,685 $ 1,218 $ 3,282 $ — $ 795 $ 5,295 $ 696 $ 924,676 |
Allowance for Loan Losses and Recorded Investment in Financing Receivables | The following table presents the allowance for loan losses by the classes of the loan portfolio: (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total Beginning balance, December 31, 2019 $ 1,552 $ 4,687 $ 95 $ 949 $ 1,226 $ 8,509 Charge Offs ( 41 ) ( 452 ) — ( 18 ) ( 431 ) ( 942 ) Recoveries 6 39 — 44 44 133 Provision for loan losses 443 3,730 55 385 837 5,450 Ending balance, December 31, 2020 $ 1,960 $ 8,004 $ 150 $ 1,360 $ 1,676 $ 13,150 Ending balance individually evaluated for impairment $ — $ — $ — $ — $ — $ — Ending balance collectively evaluated for impairment $ 1,960 $ 8,004 $ 150 $ 1,360 $ 1,676 $ 13,150 (In thousands) Residential Real Estate Commercial Real Estate Construction Commercial Consumer Total Beginning balance, December 31, 2018 $ 1,328 $ 5,455 $ 93 $ 712 $ 864 $ 8,452 Charge Offs ( 102 ) ( 627 ) — ( 284 ) ( 420 ) ( 1,433 ) Recoveries 24 125 — 48 43 240 Provision for loan losses 302 ( 266 ) 2 473 739 1,250 Ending balance, December 31, 2019 $ 1,552 $ 4,687 $ 95 $ 949 $ 1,226 $ 8,509 Ending balance individually evaluated for impairment $ — $ 417 $ — $ — $ — $ 417 Ending balance collectively evaluated for impairment $ 1,552 $ 4,270 $ 95 $ 949 $ 1,226 $ 8,092 |
Premises and Equipment (Tables)
Premises and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Premises and Equipment [Abstract] | |
Componenets of Premises and Equipment | Components of premises and equipment at December 31 are as follows: 2020 2019 (In Thousands) Land and improvements $ 3,878 $ 2,806 Buildings and improvements 21,545 17,914 Furniture and equipment 9,717 8,164 35,140 28,884 Accumulated depreciation ( 17,326 ) ( 14,656 ) $ 17,814 $ 14,228 |
Deposits (Tables)
Deposits (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Deposits [Abstract] | |
Schedule of Maturities of Time Deposits | 2021 $ 353,950 2022 106,898 2023 40,440 2024 24,131 2025 8,412 $ 533,831 |
Borrowings (Tables)
Borrowings (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Borrowings [Abstract] | |
Short-Term Borrowings | Short-term borrowings at December 31 consist of the following: 2020 2019 (In Thousands) Securities sold under agreements to repurchase $ 63,303 $ 30,505 Federal Home Loan Bank short-term borrowings — 31,751 $ 63,303 $ 62,256 The outstanding balances and related information of short-term borrowings are summarized as follows: Years Ended December 31, 2020 2019 (Dollars In Thousands) Average balance during the year $ 57,014 $ 48,945 Average interest rate during the year 0.55 % 0.96 % Maximum month-end balance during the year $ 69,294 $ 62,256 Weighted average interest rate at the end of the year 0.43 % 1.30 % |
Collateral Pledged for Repurchase Agreements | As of December 31, 2020 Remaining Contractual Maturity of the Agreements Overnight and continuous Up to 30 days 30-90 days Greater than 90 days Total Repurchase Agreements: Mortgage-backed securities - government sponsored entities $ 64,429 $ — $ — $ — $ 64,429 Total liability recognized for repurchase agreements 63,303 As of December 31, 2019 Remaining Contractual Maturity of the Agreements Overnight and continuous Up to 30 days 30-90 days Greater than 90 days Total Repurchase Agreements: Mortgage-backed securities - government sponsored entities $ 36,195 $ — $ — $ — $ 36,195 Total liability recognized for repurchase agreements 30,505 |
Other Borrowings | 2020 2019 (In Thousands) Fixed rate term borrowing due May 2020 at 1.85 % $ — $ 5,000 Amortizing fixed rate borrowing due June 2020 at 1.49 % — 1,034 Amortizing fixed rate borrowing due July 2020 at 2.77 % — 2,974 Amortizing fixed rate borrowing due December 2020 at 1.71 % — 2,538 Amortizing fixed rate borrowing due December 2020 at 3.06 % — 1,034 Amortizing fixed rate borrowing due March 2022 at 1.75 % 1,126 2,009 Amortizing fixed rate borrowing due August 2022 at 1.94 % 3,376 5,351 Amortizing fixed rate borrowing due October 2022 at 1.88 % 3,021 4,626 Amortizing fixed rate borrowing due October 2023 at 3.24 % 5,865 7,809 Amortizing fixed rate borrowing due December 2023 at 3.22 % 3,096 4,063 Fixed rate term borrowing due December 2023 at 1.95 % 10,000 10,000 Amortizing fixed rate borrowing due December 2023 at 1.73 % 7,616 10,000 Amortizing fixed rate borrowing due April 2024 at 0.91 % 8,359 — $ 42,459 $ 56,438 |
Contractual Maturities of Other Borrowings | 2021 $ 12,594 2022 11,191 2023 17,826 2024 848 $ 42,459 |
Operating Leases (Tables)
Operating Leases (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Operating Leases [Abstract] | |
Lease Cost | Operating Weighted-average remaining term 12.2 years Weighted-average discount rate 3.20 % |
Undiscounted Cash Flows Due | Undiscounted cash flows due (in thousands) Operating 2021 $ 561 2022 546 2023 534 2024 544 2025 561 2026 and thereafter 3,319 Total undiscounted cash flows 6,065 Discount on cash flows ( 1,081 ) Total lease liabilities $ 4,984 |
Employee Benefit Plans (Tables)
Employee Benefit Plans (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Employee Benefit Plans [Abstract] | |
Schedule Of Projected Benefit Obligation And Changes In Plan Assets For The Defined Benefit Pension Plan | (in Thousands of Dollars) 2020 2019 Change in projected benefit obligation: Projected benefit obligation at beginning of year $ ( 7,515 ) $ ( 7,186 ) Service cost ( 58 ) ( 55 ) Interest cost ( 257 ) ( 312 ) Actuarial (gain) loss ( 767 ) ( 515 ) Benefits paid 532 553 Benefit obligation at end of year $ ( 8,065 ) $ ( 7,515 ) Change in plan assets: Fair value of plan assets at beginning of year $ 6,853 $ 6,136 Actual return on plan assets 1,415 1,275 Benefits paid ( 525 ) ( 558 ) Fair value of assets at end of year 7,743 6,853 Funded status at end of year $ ( 322 ) $ ( 662 ) |
Schedule of Amounts Recognized in Accumulated Other Comprehensive Income | 2020 2019 Transition asset $ — $ — Prior service credit — — Gain 241 375 Total $ 241 $ 375 |
Components Of Net Pension Cost (Income) | 2020 2019 Service cost benefits earned during the period $ 58 $ 55 Interest cost on projected benefit obligation 257 312 Actual return on assets ( 395 ) ( 379 ) Net amortization and deferral ( 20 ) — Net periodic pension cost (income) $ ( 100 ) $ ( 12 ) |
Schedule of Weighted Average Assumptions Used to Determine the Benefit Obligation and the Net Periodic Cost | The weighted average assumptions used to determine the benefit obligation at December 31 are as follows: 2020 2019 Discount rate 2.63 % 3.55 % The weighted average assumptions used to determine the net periodic pension cost at December 31 are as follows: 2,020 2,019 Discount rate 3.55 % 4.54 % Expected long-term return on plan assets 6.00 % 6.50 % Rate of compensation increase — % — % |
Schedule Of Target Asset Allocations | 2020 2019 Cash equivalents — % — % Equity securities 31.6 % 31.7 % Fixed income securities 62.6 % 57.7 % Other 5.8 % 10.6 % 100.0 % 100.0 % |
Schedule of Changes in Level 3 Assets | 2020 2019 Balance, January 1 $ — $ 601 Realized gain — 187 Purchase — — Sales — ( 610 ) Unrealized gain (loss) — ( 178 ) Balance, December 31 $ — $ — |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Income Taxes [Abstract] | |
Schedule of Components of the Provision for Federal Income Taxes | Years Ended December 31, 2020 2019 (In Thousands) Current $ 7,754 $ 1,620 Deferred ( 4,468 ) 988 $ 3,286 $ 2,608 |
Schedule of Effective Income Tax Rate Reconciliation | Percentage of Income before Income Taxes Years Ended December 31, 2020 2019 Tax at statutory rates 21.0 % 21.0 % Tax exempt interest income, net of interest expense disallowance ( 3.7 ) ( 4.4 ) Non-deductible merger related expenses 1.1 — Earnings and proceeds on life insurance ( 1.0 ) ( 1.0 ) Other 0.5 ( 0.1 ) 17.9 % 15.5 % |
Schedule of Deferred Tax Assets and Liabilties | 2020 2019 (In Thousands) Deferred tax assets: Allowance for loan losses $ 2,761 $ 1,787 Deferred compensation 758 797 Core deposit intangible 230 141 Prepaid expenses 20 55 Pension liability 118 360 Foreclosed real estate valuation allowance 17 17 Net operating loss carryforward 893 968 Purchase price adjustment 2,832 — Deferred loan fees 60 — Other 747 122 Total Deferred Tax Assets 8,436 4,247 Deferred tax liabilities: Premises and equipment 920 598 Deferred loan fees — 220 Net unrealized gain on pension liability 272 221 Purchase price adjustment — 327 Net unrealized gain on securities 1,089 94 Total Deferred Tax Liabilities 2,281 1,460 Net Deferred Tax Asset $ 6,155 $ 2,787 |
Regulatory Matters and Stockh_2
Regulatory Matters and Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Regulatory Matters and Stockholders' Equity [Abstract] | |
Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations | To be Well Capitalized under Prompt For Capital Adequacy Corrective Action Actual Purposes Provision Amount Ratio Amount Ratio Amount Ratio (Dollars in Thousands) As of December 31, 2020: Total capital (to risk-weighted assets) $ 172,103 12.62 % ≥$ 109,123 ≥ 8.00 % ≥$ 136,404 ≥ 10.00 % Tier 1 capital (to risk-weighted assets) 158,953 11.65 ≥ 81,842 ≥ 6.00 ≥ 109,123 ≥ 8.00 Common Equity Tier 1 capital (to risk-weighted assets) 158,953 11.65 ≥ 61,382 ≥ 4.50 ≥ 88,663 ≥ 6.50 Tier 1 capital (to average assets) 158,953 8.71 ≥ 72,994 ≥ 4.00 ≥ 91,243 ≥ 5.00 As of December 31, 2019: Total capital (to risk-weighted assets) $ 132,507 13.98 % ≥$ 75,674 ≥ 8.00 % ≥$ 94,593 ≥ 10.00 % Tier 1 capital (to risk-weighted assets) 123,999 13.08 ≥ 56,756 ≥ 6.00 ≥ 75,674 ≥ 8.00 Common Equity Tier 1 capital (to risk-weighted assets) 123,999 13.08 ≥ 42,567 ≥ 4.50 ≥ 61,485 ≥ 6.50 Tier 1 capital (to average assets) 123,999 10.33 ≥ 48,735 ≥ 4.00 ≥ 60,918 ≥ 5.00 |
Stock Based Compensation (Table
Stock Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Stock Based Compensation [Abstract] | |
Summary of Stock Option Activity | 2020 2019 Weighted Weighted Average Average Average Average Exercise Intrinsic Exercise Intrinsic Options Price Value Options Price Value Outstanding, beginning of year 199,825 $ 24.78 208,700 $ 22.54 Granted 33,750 26.93 26,750 36.02 Exercised ( 15,530 ) 17.25 ( 32,350 ) 19.71 Forfeited ( 2,075 ) 16.83 ( 3,275 ) 24.31 Outstanding, end of year 215,970 $ 25.73 $ 742,738 199,825 $ 24.78 $ 2,822,470 Exercisable, end of year 182,220 $ 25.51 $ 742,738 173,075 $ 23.04 $ 2,745,430 |
Schedule of Fair Value Assumptions | Years Ended December 31, 2020 2019 Dividend yield 3.55 % 3.59 % Expected life 10 years 10 years Expected volatility 34.15 % 29.08 % Risk-free interest rate 0.91 % 1.92 % Weighted average fair value of options granted $ 6.34 $ 7.61 |
Schedule of Outstanding Stock Options | Average Average Options Exercise Remaining Options Exercise Outstanding Price Life, Years Exercisable Price 18,000 $ 16.65 1.0 18,000 $ 16.65 23,100 18.03 2.0 23,100 18.03 1,650 18.36 2.0 1,650 18.36 3,000 19.30 2.8 3,000 19.30 20,125 17.93 3.0 20,125 17.93 8,250 19.39 3.9 8,250 19.39 9,375 19.03 4.9 9,375 19.03 16,120 22.37 6.0 16,120 22.37 29,500 32.81 7.0 29,500 32.81 26,350 32.34 8.0 26,350 32.34 26,750 36.02 9.0 26,750 36.02 33,750 26.93 10.0 — — Total 215,970 182,220 |
Summary of Restricted Stock Activity | 2020 2019 Weighted-Average Weighted-Average Number of Grant Date Number of Grant Date Shares Fair Value Shares Fair Value Non-vested, beginning of year 36,195 31.65 34,615 27.82 Granted 14,500 26.93 13,100 36.02 Vested ( 11,560 ) 32.89 ( 11,520 ) 25.12 Forfeited — — — — Non-vested at December 31 39,135 30.72 36,195 31.65 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
EARNINGS PER SHARE | |
Computations of Basic and Diluted Earnings Per Share | Years Ended December 31, 2020 2019 (In Thousands, Except Per Share Data) Numerator, net income $ 15,080 $ 14,215 Denominator: Weighted average shares outstanding 7,239 6,295 Less: Weighted average unvested restricted shares ( 36 ) ( 35 ) Denominator: Basic earnings per share 7,203 6,260 Weighted average shares outstanding, basic 7,203 6,260 Add: Dilutive effect of stock options and restricted stock 27 72 Denominator: Diluted earnings per share 7,230 6,332 Basic earnings per common share $ 2.09 $ 2.27 Diluted earnings per common share $ 2.09 $ 2.25 |
Off-Balance Sheet Financial I_2
Off-Balance Sheet Financial Instruments and Guarantees (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Off-Balance Sheet Financial Instruments and Guarantees [Abstract] | |
Schedule of Fair Value, Off-balance Sheet Risks | December 31, 2020 2019 (In Thousands) Commitments to grant loans $ 78,310 $ 44,246 Unfunded commitments under lines of credit 137,965 56,840 Standby letters of credit 5,636 3,668 $ 221,911 $ 104,754 |
Interest Rate Swaps (Tables)
Interest Rate Swaps (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Interest Rate Swaps [Abstract] | |
Summary of Derivatives | (Amounts in thousands) Notional Amount, December 31, Fair Value December 31, 2020 2019 Interest Rate Paid Interest Rate Received 2020 2019 Customer interest rate swap Maturing November, 2030 $ 7,222 $ - 1 month LIBOR + Margin Fixed $ 165 $ - Maturing December, 2030 4,800 - 1 month LIBOR + Margin Fixed 111 - Total $ 12,022 $ - $ 276 $ - Third party interest rate swap Maturing November, 2030 $ 7,222 $ - Fixed 1 month LIBOR + Margin $ 165 $ - Maturing December, 2030 4,800 - Fixed 1 month LIBOR + Margin 111 - Total $ 12,022 $ - $ 276 $ - |
Fair Value of Derivative Instruments | (Amounts in thousands) Assets Liabilities Balance Sheet Location Fair Value Balance Sheet Location Fair Value Decemer 31, 2020 Interest rate derivatives Other assets $ 276 Other liabilities $ 276 Decemer 31, 2019 Interest rate derivatives Other assets - Other liabilities - |
Fair Values of Financial Inst_2
Fair Values of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Fair Values of Financial Instruments [Abstract] | |
Fair Value, Assets Measured on Recurring Basis | Fair Value Measurement Reporting Date using Description Total Level 1 Level 2 Level 3 December 31, 2020 ASSETS U.S. Government agencies $ 3,969 $ — $ 3,969 $ — States and political subdivisions 73,091 — 73,091 — Corporate obligations 3,032 — 3,032 — Mortgage-backed securities-government sponsored entities 146,494 — 146,494 — Interest rate derivatives 276 — 276 — LIABILITIES Interest rate derivatives 276 — 276 — December 31, 2019 ASSETS U.S. Treasury securities $ — $ — $ — $ — States and political subdivisions 71,305 — 71,305 — Corporate obligations 4,100 — 4,100 — Mortgage-backed securities-government sponsored entities 134,800 — 134,800 — |
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis | Fair Value Measurement Reporting Date using Description Total Level 1 Level 2 Level 3 December 31, 2020 Impaired Loans $ 2,662 $ — $ — $ 2,662 Foreclosed real estate 965 — — 965 December 31, 2019 Impaired Loans $ 1,584 $ — $ — $ 1,584 Foreclosed real estate 1,556 — — 1,556 |
Additional Qualitative Information about Level 3 Assets | Quantitative Information about Level 3 Fair Value Measurements (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average) December 31, 2020 Impaired loans $ 2,662 Appraisal of collateral(1) Appraisal adjustments(2) 0 %- 10.59 % ( 9.75 %) Foreclosed real estate owned $ 965 Appraisal of collateral(1) Liquidation Expenses(2) 7.00 % ( 7.00 %) Quantitative Information about Level 3 Fair Value Measurements (dollars in thousands) Fair Value Estimate Valuation Techniques Unobservable Input Range (Weighted Average) December 31, 2019 Impaired loans $ 1,531 Appraisal of collateral(1) Appraisal adjustments(2) 10.00 % ( 10.00 %) Impaired loans $ 53 Present value of future cash flows Loan discount rate 4.00 - 6.97 % ( 5.55 %) Foreclosed real estate owned $ 1,556 Appraisal of collateral(1) Liquidation Expenses(2) 0 - 7.00 % ( 4.34 %) (1) Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level 3 inputs which are not identifiable, less any associated allowance. (2) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal. |
Fair Value, by Balance Sheet Grouping | Fair Value Measurements at December 31, 2020 Carrying Fair Amount Value Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents (1) $ 111,693 $ 111,693 $ 111,693 $ — $ — Loans receivable, net 1,397,582 1,493,480 — — 1,493,480 Mortgage servicing rights 337 476 — — 476 Regulatory stock (1) 3,981 3,981 3,981 — — Bank owned life insurance (1) 39,608 39,608 39,608 — — Accrued interest receivable (1) 6,232 6,232 6,232 — — Financial liabilities: Deposits 1,535,385 1,540,661 1,001,555 — 539,106 Short-term borrowings (1) 63,303 63,303 63,303 — — Other borrowings 42,459 43,452 — — 43,452 Accrued interest payable (1) 1,601 1,601 1,601 — — Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit — — — — — Fair Value Measurements at December 31, 2019 Carrying Fair Amount Value Level 1 Level 2 Level 3 Financial assets: Cash and cash equivalents (1) $ 15,415 $ 15,415 $ 15,415 $ — $ — Loans receivable, net 916,072 943,143 — — 943,143 Mortgage servicing rights 187 226 — — 226 Regulatory stock (1) 4,844 4,844 4,844 — — Bank owned life insurance (1) 38,763 38,763 38,763 — — Accrued interest receivable (1) 3,719 3,719 3,719 — — Financial liabilities: Deposits 957,529 961,120 596,811 — 364,309 Short-term borrowings (1) 62,256 62,256 62,256 — — Other borrowings 56,438 56,618 — — 56,618 Accrued interest payable (1) 2,432 2,432 2,432 — — Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit — — — — — (1) This financial instrument is carried at cost, which approximates the fair value of the instrument. |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Accumulated Other Comprehensive Income [Abstract] | |
Summary of Changes In Accumulated Other Comprehensive Income (Loss) | Unrealized gains on available for sale securities (a) Unrealized gain on pension liability (a) Total (a) Balance as of December 31, 2019 $ 354 $ 833 $ 1,187 Other comprehensive income (loss) before reclassification 3,798 190 3,988 Amount reclassified from accumulated other comprehensive loss ( 56 ) — ( 56 ) Total other comprehensive income 3,742 190 3,932 Balance as of December 31, 2020 $ 4,096 $ 1,023 $ 5,119 Unrealized gains on available for sale securities (a) Unrealized gain on pension liability (a) Balance as of December 31, 2018 $ ( 5,558 ) $ 538 $ ( 5,020 ) Other comprehensive income (loss) before reclassification 6,113 295 6,408 Amount reclassified from accumulated other comprehensive loss ( 201 ) — ( 201 ) Total other comprehensive 5,912 295 6,207 Balance as of December 31, 2019 $ 354 $ 833 $ 1,187 (a) All amounts are net of tax. Amounts in parentheses indicate debits. |
Significant Amounts Reclassified Out of Each Component of Accumulated Other Comprehensive Income (Loss) | Amount Reclassified From Accumulated Affected Line Item in Other Consolidated Comprehensive Statements of Details about other comprehensive income Income (a) Income Twelve months Twelve months ended ended December 31, December 31, 2020 2019 Unrealized gains on available for sale securities $ 71 $ 254 Net realized gains on sales of securities ( 15 ) ( 53 ) Income tax expense $ 56 $ 201 (a) Amounts in parentheses indicate debits to net income. |
Acquisition of UpState New Yo_2
Acquisition of UpState New York Bancorp, Inc. and USNY Bank (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Business Acquisition [Line Items] | |
Future Amortization Expense | 2021 $ 123 2022 101 2023 85 2024 69 2025 54 Thereafter 98 $ 530 |
UpState New York Bancorp, Inc. [Member] | |
Business Acquisition [Line Items] | |
Summary of Purchase | (Dollars in Thousands, Except Per Share Data) Purchase Price Consideration in Common Stock UpState New York Bancorp, Inc. common shares settled for stock 1,987,206 Exchange Ratio 0.9390 Norwood Financial Corp shares issued 1,865,738 Value assigned to each Norwood Financial Corp common share $ 24.30 Purchase price assigned to UpState New York Bancorp, Inc. common shares $ 45,337 exchanged for Norwood Financial Corp shares Purchase Price Consideration - Cash for Common Stock UpState New York Bancorp, Inc. shares exchanged for cash, excluding fractional shares 220,794 Purchase price paid to each UpState New York Bancorp, Inc. common share exchanged for cash $ 33.33 Purchase price assigned to UpState New York Bancorp, Inc. common shares exchanged for cash $ 7,359 Purchase price additional cash consideration per share 1,479 Purchase price consideration - Cash-in-lieu of Fractional Shares 6 Total Purchase Price $ 54,181 Net Assets Acquired: UpState New York Bancorp, Inc. shareholders' equity $ 44,803 UpState New York Bancorp, Inc. goodwill and intangibles - Total tangible equity 44,803 Adjustments to reflect assets acquired at fair value: Investments ( 112 ) Loans Interest rate 3,982 General credit ( 10,529 ) Specific credit - non-amortizing ( 5,213 ) Specific credit - amortizing ( 1,724 ) Core deposit intangible 409 Deferred loan fees ( 812 ) Premises and equipment ( 1,211 ) Allowance for loan and lease losses 5,982 Deferred tax assets 3,449 Other ( 48 ) Adjustments to reflect liabilities acquired at fair value: Time deposits ( 2,754 ) Net assets acquired 36,222 Goodwill resulting from merger $ 17,959 |
Schedule of Business Acquisitions, by Acquisition | (In Thousands) Total purchase price $ 54,181 Net assets acquired: Cash $ 24,037 Securities available for sale 13,836 Loans 405,221 Premises and equipment, net 4,318 Regulatory stock 2,487 Accrued interest receivable 1,426 Core deposit intangible 564 Other assets 5,117 Deposits ( 414,113 ) Accrued interest payable ( 175 ) Other liabilities ( 6,496 ) Total identifiable net assets acquired 36,222 Goodwill resulting from UpState New York Bancorp, Inc. Merger $ 17,959 |
Future Amortization Expense | (In thousands) 2020 $ 37 2021 71 2022 63 2023 56 2024 48 After five years 134 $ 409 |
Proforma | Actual From Acquisition Date Through December 31,2020 (in thousands) Net interest income after provision for loan losses $ 7,291 Noninterest income $ 313 |
Nonrecurring Adjustments | Pro Forma Twelve Months Ended December 31, (In Thousands, Except Per Share Data) 2020 2019 Net interest income after provision for loan losses $ 52,897 $ 50,487 Noninterest income 8,726 7,959 Net income 20,613 18,842 Pro forma earnings per share: Basic $ 2.52 $ 2.31 Diluted $ 2.52 $ 2.30 |
Risks and Uncertainties (Tables
Risks and Uncertainties (Tables) | 12 Months Ended |
Dec. 31, 2020 | |
Risks and Uncertainties [Abstract] | |
Summary of Loan Forbearance | Loan Type Number of Loans Balance (in thousands) Real Estate Loans: Residential 118 $ 10,883 Commercial 385 218,984 Agricultural 16 5,267 Construction 24 4,125 Commercial 186 23,801 Other agricultural loans — - Consumer loans to individuals 486 11,130 Total 1,215 $ 274,190 |
Summary Of Loans That Remain In Forbearance | Loan Type Number of Loans Balance (in thousands) Real Estate Loans: Residential 14 $ 2,163 Commercial 67 39,925 Agricultural 2 428 Construction 3 7,240 Commercial 47 3,773 Other agricultural loans - - Consumer loans to individuals 88 2,117 Total 314 $ 55,646 |
Norwood Financial Corp (Paren_2
Norwood Financial Corp (Parent Company Only) Financial Information (Tables) - Parent Company [Member] | 12 Months Ended |
Dec. 31, 2020 | |
Condensed Financial Statements, Captions [Line Items] | |
Parent Company Only – Balance Sheets | BALANCE SHEETS December 31, 2020 2019 (In Thousands) ASSETS Cash on deposit in bank subsidiary $ 854 $ 2,848 Investment in bank subsidiary 195,035 135,433 Other assets 2,337 1,875 Total assets $ 198,226 $ 140,156 LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities $ 3,441 $ 2,728 Stockholders’ equity 194,785 137,428 Total liabilities and stockholders' equity $ 198,226 $ 140,156 |
Parent Company Only – Statements of Income | STATEMENTS OF INCOME Years Ended December 31, 2020 2019 Income: (In Thousands) Dividends from bank subsidiary $ 15,319 $ 6,113 Expenses 1,704 637 13,615 5,476 Income tax benefit ( 180 ) ( 232 ) 13,795 5,708 Equity in undistributed earnings of subsidiary 1,285 8,507 Net Income $ 15,080 $ 14,215 Comprehensive Income $ 19,012 $ 20,422 |
Parent Company Only – Statements of Cash Flows | STATEMENTS OF CASH FLOWS Years Ended December 31, 2020 2019 (In Thousands) CASH FLOWS FROM OPERATING ACTIVITIES Net income $ 15,080 $ 14,215 Adjustments to reconcile net income to net cash provided by operating activities: Undistributed earnings of bank subsidiary ( 1,285 ) ( 8,507 ) Other, net 28 335 Net Cash Provided by Operating Activities 13,823 6,043 CASH FLOWS FROM INVESTING ACTIVITIES Outlays for business combinations ( 8,844 ) — Net Cash (Used in) Provided by Investing Activities ( 8,844 ) — CASH FLOWS FROM FINANCING ACTIVITIES Stock options exercised 268 638 Sale of treasury stock for ESOP 130 127 Acquisition of treasury stock ( 108 ) ( 428 ) Cash dividends paid ( 7,263 ) ( 6,041 ) Net Cash Used in Financing Activities ( 6,973 ) ( 5,704 ) Net (Decrease) Increase in Cash and Cash Equivalents ( 1,994 ) 339 CASH AND CASH EQUIVALENTS - BEGINNING 2,848 2,509 CASH AND CASH EQUIVALENTS - ENDING $ 854 $ 2,848 |
Nature of Operations (Nonintere
Nature of Operations (Noninterest Income) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Noninterest Income (in scope of Topic 606) | $ 6,209 | $ 5,448 |
Net realized gains on sales of securities | 71 | 254 |
Loan servicing fees | 128 | 77 |
Gain on sales of loans | 527 | 169 |
Earnings on and proceeds from bank-owned life insurance | 845 | 830 |
Noninterest Income (out-of-scope of Topic 606) | 1,571 | 1,330 |
Total Other Income | 7,780 | 6,778 |
Service Charges On Deposit Accounts [Member] | ||
Noninterest Income (in scope of Topic 606) | 377 | 336 |
ATM Fees [Member] | ||
Noninterest Income (in scope of Topic 606) | 457 | 384 |
Overdraft Fees [Member] | ||
Noninterest Income (in scope of Topic 606) | 985 | 1,380 |
Safe Deposit Box Rental [Member] | ||
Noninterest Income (in scope of Topic 606) | 102 | 94 |
Loan Related Service Fees [Member] | ||
Noninterest Income (in scope of Topic 606) | 1,288 | 614 |
Debit Card [Member] | ||
Noninterest Income (in scope of Topic 606) | 1,656 | 1,424 |
Fiduciary Activities [Member] | ||
Noninterest Income (in scope of Topic 606) | 682 | 610 |
Commissions On Mutual Funds And Annuities [Member] | ||
Noninterest Income (in scope of Topic 606) | 122 | 141 |
Other Income [Member] | ||
Noninterest Income (in scope of Topic 606) | $ 540 | $ 465 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Jul. 07, 2020 | |
Summary of Significant Accounting Policies [Abstract] | |||
Regulatory Stock, Par Value | $ 100 | ||
Impairment of investments | $ 0 | ||
Loan servicing assets, impairment | 0 | $ 0 | |
Servicing Assets | 337,000 | 187,000 | |
Goodwill | 29,290,000 | 11,331,000 | $ 17,959,000 |
Goodwill, Impairment Loss | 0 | 0 | |
Intangible Assets, Net (Excluding Goodwill) | 530,000 | 235,000 | |
Finite-Lived Intangible Assets, Accumulated Amortization | $ 1,224,000 | 1,110,000 | |
Finite-Lived Intangible Assets, Amortization Method | sum-of-the-years digits method | ||
Finite-Lived Intangible Asset, Useful Life | 10 years | ||
Amortization of Intangibles | $ 114,000 | 101,000 | |
Unrecognized Tax Benefits | 0 | $ 0 | |
Unrecognized tax benefits expected within next twelve months | $ 0 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Schedule of Estimated Useful Lives ) (Details) | 12 Months Ended |
Dec. 31, 2020 | |
Minimum [Member] | Buildings and improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 10 years |
Minimum [Member] | Furniture and equipment [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 3 years |
Maximum [Member] | Buildings and improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 40 years |
Maximum [Member] | Furniture and equipment [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 10 years |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Schedule of Estimated Future Amortization Expense for the Core Deposit Intangible) (Details) $ in Thousands | Dec. 31, 2020USD ($) |
Summary of Significant Accounting Policies [Abstract] | |
2021 | $ 123 |
2022 | 101 |
2023 | 85 |
2024 | 69 |
2025 | 54 |
Thereafter | 98 |
Amortization Expense for the Core Deposit Intangible, Total | $ 530 |
Securities (Narrative) (Details
Securities (Narrative) (Details) | 12 Months Ended | |
Dec. 31, 2020USD ($)security | Dec. 31, 2019USD ($) | |
Securities [Abstract] | ||
Debt securities in unrealized loss position in the less than twelve months category | security | 6 | |
Debt securities in unrealized loss position in the twelve months or more category | security | 0 | |
Impairment of investments | $ 0 | |
Available-for-sale Securities Pledged as Collateral | 199,361,000 | $ 157,233,000 |
Gross realized gains | 71,000 | 254,000 |
Gross realized losses | $ 0 | $ 0 |
Securities (Schedule of Amortiz
Securities (Schedule of Amortized Cost Gross Unrealized Gains and Losses, and Fair Values of Securities) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Schedule of Investments [Line Items] | ||
Available for Sale, Fair Value | $ 226,586 | $ 210,205 |
Fixed income [Member] | ||
Schedule of Investments [Line Items] | ||
Available for Sale, Amortized Cost | 221,401 | 209,758 |
Available for Sale, Gross Unrealized Gains | 5,241 | 1,534 |
Available for Sale, Gross Unrealized Losses | (56) | (1,087) |
Available for Sale, Fair Value | 226,586 | 210,205 |
U.S. Government Agencies [Member] | ||
Schedule of Investments [Line Items] | ||
Available for Sale, Amortized Cost | 3,998 | |
Available for Sale, Gross Unrealized Losses | (29) | |
Available for Sale, Fair Value | 3,969 | |
States And Political Subdivisions [Member] | ||
Schedule of Investments [Line Items] | ||
Available for Sale, Amortized Cost | 70,672 | 70,015 |
Available for Sale, Gross Unrealized Gains | 2,419 | 1,293 |
Available for Sale, Gross Unrealized Losses | (3) | |
Available for Sale, Fair Value | 73,091 | 71,305 |
Corporate Obligations [Member] | ||
Schedule of Investments [Line Items] | ||
Available for Sale, Amortized Cost | 3,019 | 4,097 |
Available for Sale, Gross Unrealized Gains | 13 | 3 |
Available for Sale, Fair Value | 3,032 | 4,100 |
Mortgage-backed Securities-Government Sponsored Entities [Member] | ||
Schedule of Investments [Line Items] | ||
Available for Sale, Amortized Cost | 143,712 | 135,646 |
Available for Sale, Gross Unrealized Gains | 2,809 | 238 |
Available for Sale, Gross Unrealized Losses | (27) | (1,084) |
Available for Sale, Fair Value | $ 146,494 | $ 134,800 |
Securities (Schedule of Investm
Securities (Schedule of Investments' Gross Unrealized Losses and Fair Value Aggregated by Security Type and Length of Time that Individual Securities have been in a Continuous Unrealized Loss Position) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
States And Political Subdivisions [Member] | ||
Schedule of Investments [Line Items] | ||
Less than 12 Months, Fair Value | $ 3,969 | $ 1,296 |
Less than 12 Months, Unrealized Losses | (29) | (2) |
12 Months or More, Fair Value | 0 | 481 |
12 Months or More, Unrealized Losses | 0 | (1) |
Total, Fair Value | 3,969 | 1,777 |
Total, Unrealized Losses | (29) | (3) |
Mortgage-backed Securities-Government Sponsored Entities [Member] | ||
Schedule of Investments [Line Items] | ||
Less than 12 Months, Fair Value | 4,980 | 32,415 |
Less than 12 Months, Unrealized Losses | (27) | (241) |
12 Months or More, Fair Value | 0 | 61,096 |
12 Months or More, Unrealized Losses | 0 | (843) |
Total, Fair Value | 4,980 | 93,511 |
Total, Unrealized Losses | (27) | (1,084) |
Fixed income [Member] | ||
Schedule of Investments [Line Items] | ||
Less than 12 Months, Fair Value | 8,949 | 33,711 |
Less than 12 Months, Unrealized Losses | (56) | (243) |
12 Months or More, Fair Value | 0 | 61,577 |
12 Months or More, Unrealized Losses | 0 | (844) |
Total, Fair Value | 8,949 | 95,288 |
Total, Unrealized Losses | $ (56) | $ (1,087) |
Securities (Schedule of Amort_2
Securities (Schedule of Amortized Cost and Fair Value Of Debt Securities by Contractual Maturity) (Details) $ in Thousands | Dec. 31, 2020USD ($) |
Securities [Abstract] | |
Available for Sale, Amortized Cost, Due in one year or less | $ 5,498 |
Available for Sale, Amortized Cost, Due after one year through five years | 5,373 |
Available for Sale, Amortized Cost, Due after five years through ten years | 23,276 |
Available for Sale, Amortized Cost, Due after ten years | 43,542 |
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis, Total | 77,689 |
Available for Sale, Amortized Cost, Mortgage-backed securities-government sponsored agencies | 143,712 |
Available for Sale, Amortized Cost, Total | 221,401 |
Available for Sale, Fair Value, Due in one year or less | 5,532 |
Available for Sale, Fair Value, Due after one year through five years | 5,510 |
Available for Sale, Fair Value, Due after five years through ten years | 23,676 |
Available for Sale, Fair Value, Due after ten years | 45,374 |
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Total | 80,092 |
Available for Sale, Fair Value, Mortgage-backed securities-government sponsored agencies | 146,494 |
Available for Sale, Fair Value, Total | $ 226,586 |
Loans Receivable and Allowanc_3
Loans Receivable and Allowance for Loan Losses (Narrative) (Details) | 12 Months Ended | ||
Dec. 31, 2020USD ($)loan | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Certain Loans and Debt Securities Acquired in Transfer, Allowance for Credit Losses Due to Subsequent Impairment | $ 0 | ||
Loans acquired with credit deterioration | 15,410,000 | ||
Real Estate Acquired Through Foreclosure | 965,000 | $ 1,556,000 | |
Impaired Financing Receivable, Related Allowance | 417,000 | ||
Annual Loan Review threshold, amount | 1,500,000 | ||
Loans and Leases Receivable, Gross | 1,412,289,000 | 924,676,000 | |
Allowance for Loan and Lease Losses, Adjustments, Other | 2,300,000 | 417,000 | |
Allowance for Loan and Lease Losses, Period Increase (Decrease) | 4,641,000 | 57,000 | |
Allowance for Loan and Lease Losses, Adjustment Related To Economic Conditions | 447,000 | ||
Loans and Leases Receivable, Impaired, Interest Lost on Nonaccrual Loans | 727,000 | 101,000 | |
Allowance for Loan and Lease Losses, Real Estate | 13,150,000 | $ 8,509,000 | $ 8,452,000 |
Historical loss factor | 0.15% | 0.26% | |
Servicing Asset at Amortized Cost | 72,500,000 | $ 28,500,000 | |
Outstanding Balance | 15,570,000 | 793,000 | |
Mortgage loans originated for sale | 12,312,000 | 4,715,000 | |
Commercial Rentals [Member] | Loans Receivable [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Loans and Leases Receivable, Gross | $ 125,300,000 | ||
Concentration Risk, Percentage | 86.40% | ||
Hospitality Lodging Industry [Member] | Loans Receivable [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Loans and Leases Receivable, Gross | $ 117,800,000 | ||
Concentration Risk, Percentage | 81.20% | ||
Residential Real Estate Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Number Of Properties Under Foreclosure Proceedings | loan | 4 | ||
Mortgage Loans in Process of Foreclosure, Amount | $ 454,000 | ||
Loans and Leases Receivable, Gross | 263,127,000 | 229,781,000 | |
Proceeds from Sale of Mortgage Loans Held-for-sale | 12,839,000 | 4,838,000 | |
Gross Realized Gains on Loans | 527,000 | 169,000 | |
Gross Realized Losses on Loans | 0 | 0 | |
Commercial Real Estate Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Impaired Financing Receivable, Related Allowance | 417,000 | ||
Loans and Leases Receivable, Gross | 579,104,000 | 391,327,000 | |
Troubled Debt Restructured Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Financing Receivable, Modifications, Post-Modification Recorded Investment | 75,000 | 99,000 | $ 977,000 |
Financing Receivables, Impaired, Troubled Debt Restructuring, Write-down | 20,000 | $ 977,000 | |
PPP Loan [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Loans and Leases Receivable, Gross | 95,043,000 | ||
Fee income | 2,500,000 | ||
UpState New York Bancorp, Inc. [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Assets, Fair Value Adjustment | 6,937,000 | ||
Outstanding Balance | 15,410,000 | ||
COVID [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Allowance for Loan and Lease Losses, Period Increase (Decrease) | $ 2,200,000 |
Loans Receivable and Allowanc_4
Loans Receivable and Allowance for Loan Losses (Composition of the Loan Portfolio) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 1,412,289 | $ 924,676 | |
Deferred fees, net | (1,557) | (95) | |
Total loans receivable | 1,410,732 | 924,581 | |
Allowance for loan losses | (13,150) | (8,509) | $ (8,452) |
Net loans receivable | $ 1,397,582 | $ 916,072 | |
Percent of Loans | 100.00% | 100.00% | |
Residential Real Estate Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 263,127 | $ 229,781 | |
Allowance for loan losses | $ (1,960) | $ (1,552) | (1,328) |
Percent of Loans | 18.60% | 24.90% | |
Commercial Real Estate Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 579,104 | $ 391,327 | |
Allowance for loan losses | $ (8,004) | $ (4,687) | (5,455) |
Percent of Loans | 41.00% | 42.30% | |
Agricultural Real Estate Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 66,334 | ||
Percent of Loans | 4.70% | ||
Construction Real Estate Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 21,005 | $ 17,732 | |
Allowance for loan losses | $ (150) | $ (95) | (93) |
Percent of Loans | 1.50% | 1.90% | |
Commercial [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 283,741 | $ 134,150 | |
Allowance for loan losses | $ (1,360) | $ (949) | (712) |
Percent of Loans | 20.10% | 14.50% | |
Other Agricultural Loans [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 40,929 | ||
Percent of Loans | 2.90% | ||
Consumer Loans To Individuals [Member] | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Total Loans | $ 158,049 | $ 151,686 | |
Allowance for loan losses | $ (1,676) | $ (1,226) | $ (864) |
Percent of Loans | 11.20% | 16.40% |
Loans Receivable and Allowanc_5
Loans Receivable and Allowance for Loan Losses (Changes in the Accretable Yield for Purchased Credit Impaired Loans) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Loans Receivable and Allowance for Loan Losses [Abstract] | ||
Balance at beginning of period | $ 29 | |
Additions | 1,724 | |
Accretion | (353) | (29) |
Reclassification and other | (6) | |
Balance at end of period | $ 1,365 |
Loans Receivable and Allowanc_6
Loans Receivable and Allowance for Loan Losses (Information Regarding Loans Acquired and Accounted for in Accordance with ASC 310-30) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Loans Receivable and Allowance for Loan Losses [Abstract] | ||
Outstanding Balance | $ 15,570 | $ 793 |
Carrying Amount | $ 9,281 | $ 696 |
Loans Receivable and Allowanc_7
Loans Receivable and Allowance for Loan Losses (Components of Purchase Accounting Adjustments Related to Purchased Credit-impaired Loans Acquired) (Details) $ in Thousands | Jul. 07, 2020USD ($) |
Loans Receivable and Allowance for Loan Losses [Abstract] | |
Contractually required principal and interest | $ 15,410 |
Non-accretable discount | (5,213) |
Expected cash flows | 10,197 |
Accretable discount | (1,724) |
Estimated fair value | $ 8,473 |
Loans Receivable and Allowanc_8
Loans Receivable and Allowance for Loan Losses (Summary of Amount of Loans in Each Category that were Individually and Collectively Evaluated for Impairment) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Individually evaluated for impairment | $ 2,662 | $ 2,144 |
Loans acquired with deteriorated credit quality | 9,281 | 696 |
Collectively evaluated for impairment | 1,400,346 | 921,836 |
Total Loans | 1,412,289 | 924,676 |
Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 9,281 | 696 |
Residential Real Estate Loans [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans acquired with deteriorated credit quality | 591 | 476 |
Collectively evaluated for impairment | 262,536 | 229,305 |
Total Loans | 263,127 | 229,781 |
Residential Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 591 | 476 |
Commercial Real Estate Loans [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Individually evaluated for impairment | 2,582 | 2,144 |
Loans acquired with deteriorated credit quality | 3,995 | 220 |
Collectively evaluated for impairment | 572,527 | 388,963 |
Total Loans | 579,104 | 391,327 |
Commercial Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 3,995 | 220 |
Agricultural Real Estate Loans [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans acquired with deteriorated credit quality | 2,043 | |
Collectively evaluated for impairment | 64,291 | |
Total Loans | 66,334 | |
Agricultural Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 2,043 | |
Construction Real Estate Loans [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans acquired with deteriorated credit quality | 194 | |
Collectively evaluated for impairment | 20,811 | 17,732 |
Total Loans | 21,005 | 17,732 |
Construction Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 194 | |
Commercial [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Individually evaluated for impairment | 80 | |
Loans acquired with deteriorated credit quality | 246 | |
Collectively evaluated for impairment | 283,415 | 134,150 |
Total Loans | 283,741 | 134,150 |
Commercial [Member] | Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 246 | |
Other Agricultural Loans [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Loans acquired with deteriorated credit quality | 2,212 | |
Collectively evaluated for impairment | 38,717 | |
Total Loans | 40,929 | |
Other Agricultural Loans [Member] | Purchased Credit-Impaired [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Total Loans | 2,212 | |
Consumer Loans To Individuals [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Collectively evaluated for impairment | 158,049 | 151,686 |
Total Loans | $ 158,049 | $ 151,686 |
Loans Receivable and Allowanc_9
Loans Receivable and Allowance for Loan Losses (Impaired Loans and Related Interest Income by Loan Portfolio Class) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Financing Receivable, Impaired [Line Items] | ||
Impaired Financing Receivable, with No Related Allowance, Recorded Investment | $ 143 | |
Impaired Financing Receivable, with Related Allowance, Recorded Investment | 2,001 | |
Impaired Financing Receivable, Recorded Investment | 2,144 | |
Unpaid Principal Balance, With no related allowance recorded | 394 | |
Unpaid Principal Balance, With an allowance recorded | 2,001 | |
Unpaid Principal Balance, Total | 2,395 | |
Associated Allowance | 417 | |
Average Recorded Investment, Total | $ 2,121 | 1,036 |
Interest Income Recognized, Total | 14 | 233 |
Impaired Loans [Member] | ||
Financing Receivable, Impaired [Line Items] | ||
Impaired Financing Receivable, with No Related Allowance, Recorded Investment | 2,662 | |
Impaired Financing Receivable, Recorded Investment | 2,662 | 2,144 |
Unpaid Principal Balance, With no related allowance recorded | 3,314 | |
Unpaid Principal Balance, Total | 3,314 | |
Commercial [Member] | ||
Financing Receivable, Impaired [Line Items] | ||
Average Recorded Investment, Total | 16 | |
Commercial [Member] | Impaired Loans [Member] | ||
Financing Receivable, Impaired [Line Items] | ||
Impaired Financing Receivable, with No Related Allowance, Recorded Investment | 2,582 | |
Impaired Financing Receivable, Recorded Investment | 2,582 | |
Unpaid Principal Balance, With no related allowance recorded | 3,234 | |
Unpaid Principal Balance, Total | 3,234 | |
Commercial Real Estate Loans [Member] | ||
Financing Receivable, Impaired [Line Items] | ||
Impaired Financing Receivable, with No Related Allowance, Recorded Investment | 143 | |
Impaired Financing Receivable, with Related Allowance, Recorded Investment | 2,001 | |
Impaired Financing Receivable, Recorded Investment | 2,144 | |
Unpaid Principal Balance, With no related allowance recorded | 394 | |
Unpaid Principal Balance, With an allowance recorded | 2,001 | |
Unpaid Principal Balance, Total | 2,395 | |
Associated Allowance | 417 | |
Average Recorded Investment, Total | 2,105 | 1,036 |
Interest Income Recognized, Total | 14 | $ 233 |
Commercial Real Estate Loans [Member] | Impaired Loans [Member] | ||
Financing Receivable, Impaired [Line Items] | ||
Impaired Financing Receivable, with No Related Allowance, Recorded Investment | 80 | |
Impaired Financing Receivable, Recorded Investment | 80 | |
Unpaid Principal Balance, With no related allowance recorded | 80 | |
Unpaid Principal Balance, Total | $ 80 |
Loans Receivable and Allowan_10
Loans Receivable and Allowance for Loan Losses (Classes of the Loan Portfolio Summarized by the Aggregate Risk Rating) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Performing [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | $ 441,425 | $ 398,553 |
Nonperforming [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 756 | 646 |
Summarized by Aggregate Risk Rating [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 970,108 | 525,477 |
Pass [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 943,427 | 509,804 |
Special Mention [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 14,680 | 12,516 |
Substandard [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 12,001 | 3,157 |
Doubtful Or Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 0 | |
Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 0 | |
Summarized by Performance of Individual Credits [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 442,181 | 399,199 |
Commercial Real Estate Loans [Member] | Summarized by Aggregate Risk Rating [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 579,104 | 391,327 |
Commercial Real Estate Loans [Member] | Pass [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 566,418 | 376,109 |
Commercial Real Estate Loans [Member] | Special Mention [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 6,346 | 12,268 |
Commercial Real Estate Loans [Member] | Substandard [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 6,340 | 2,950 |
Commercial Real Estate Loans [Member] | Doubtful Or Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 0 | |
Commercial Real Estate Loans [Member] | Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 0 | |
Agricultural Real Estate Loans [Member] | Summarized by Aggregate Risk Rating [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 66,334 | |
Agricultural Real Estate Loans [Member] | Pass [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 58,322 | |
Agricultural Real Estate Loans [Member] | Special Mention [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 5,111 | |
Agricultural Real Estate Loans [Member] | Substandard [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 2,901 | |
Commercial [Member] | Summarized by Aggregate Risk Rating [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 283,741 | 134,150 |
Commercial [Member] | Pass [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 282,915 | 133,695 |
Commercial [Member] | Special Mention [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 437 | 248 |
Commercial [Member] | Substandard [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 389 | 207 |
Commercial [Member] | Doubtful Or Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 0 | |
Commercial [Member] | Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 0 | |
Other Agricultural Loans [Member] | Summarized by Aggregate Risk Rating [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 40,929 | |
Other Agricultural Loans [Member] | Pass [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 35,772 | |
Other Agricultural Loans [Member] | Special Mention [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 2,786 | |
Other Agricultural Loans [Member] | Substandard [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 2,371 | |
Other Agricultural Loans [Member] | Doubtful Or Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | ||
Other Agricultural Loans [Member] | Loss [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | ||
Residential Real Estate Loans [Member] | Performing [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 262,556 | 229,214 |
Residential Real Estate Loans [Member] | Nonperforming [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 571 | 567 |
Residential Real Estate Loans [Member] | Summarized by Performance of Individual Credits [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 263,127 | 229,781 |
Construction Real Estate Loans [Member] | Performing [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 21,005 | 17,732 |
Construction Real Estate Loans [Member] | Nonperforming [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | ||
Construction Real Estate Loans [Member] | Summarized by Performance of Individual Credits [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 21,005 | 17,732 |
Consumer Loans To Individuals [Member] | Performing [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 157,864 | 151,607 |
Consumer Loans To Individuals [Member] | Nonperforming [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | 185 | 79 |
Consumer Loans To Individuals [Member] | Summarized by Performance of Individual Credits [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Carrying Amount | $ 158,049 | $ 151,686 |
Loans Receivable and Allowan_11
Loans Receivable and Allowance for Loan Losses (Loan Portfolio Summarized by the Past Due Status) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Financing Receivable, Past Due [Line Items] | ||
Total Loans | $ 1,412,289 | $ 924,676 |
Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 1,397,574 | 918,685 |
Non-Accrual | 3,391 | 795 |
Total Past Due and Non-Accrual | 5,434 | 5,295 |
Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 9,281 | 696 |
Financing Receivables, 31 to 60 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,656 | 1,218 |
Financing Receivables, 61 to 90 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 387 | 3,282 |
Residential Real Estate Loans [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 263,127 | 229,781 |
Residential Real Estate Loans [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 261,406 | 227,766 |
Non-Accrual | 571 | 567 |
Total Past Due and Non-Accrual | 1,130 | 1,539 |
Residential Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 591 | 476 |
Residential Real Estate Loans [Member] | Financing Receivables, 31 to 60 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 355 | 727 |
Residential Real Estate Loans [Member] | Financing Receivables, 61 to 90 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 204 | 245 |
Commercial Real Estate Loans [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 579,104 | 391,327 |
Commercial Real Estate Loans [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 573,376 | 387,897 |
Non-Accrual | 1,674 | 99 |
Total Past Due and Non-Accrual | 1,733 | 3,210 |
Commercial Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 3,995 | 220 |
Commercial Real Estate Loans [Member] | Financing Receivables, 31 to 60 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 59 | 176 |
Commercial Real Estate Loans [Member] | Financing Receivables, 61 to 90 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 2,935 | |
Agricultural Real Estate Loans [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 66,334 | |
Agricultural Real Estate Loans [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 63,615 | |
Non-Accrual | 676 | |
Total Past Due and Non-Accrual | 676 | |
Agricultural Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 2,043 | |
Construction Real Estate Loans [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 21,005 | 17,732 |
Construction Real Estate Loans [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 20,811 | 17,695 |
Total Past Due and Non-Accrual | 37 | |
Construction Real Estate Loans [Member] | Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 194 | |
Construction Real Estate Loans [Member] | Financing Receivables, 61 to 90 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 37 | |
Commercial [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 283,741 | 134,150 |
Commercial [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 282,374 | 134,018 |
Non-Accrual | 22 | 50 |
Total Past Due and Non-Accrual | 1,121 | 132 |
Commercial [Member] | Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 246 | |
Commercial [Member] | Financing Receivables, 31 to 60 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,009 | 82 |
Commercial [Member] | Financing Receivables, 61 to 90 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 90 | |
Other Agricultural Loans [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 40,929 | |
Other Agricultural Loans [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 38,454 | |
Non-Accrual | 263 | |
Total Past Due and Non-Accrual | 263 | |
Other Agricultural Loans [Member] | Purchased Credit-Impaired [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 2,212 | |
Consumer Loans To Individuals [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Total Loans | 158,049 | 151,686 |
Consumer Loans To Individuals [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 157,538 | 151,309 |
Non-Accrual | 185 | 79 |
Total Past Due and Non-Accrual | 511 | 377 |
Consumer Loans To Individuals [Member] | Financing Receivables, 31 to 60 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 233 | 233 |
Consumer Loans To Individuals [Member] | Financing Receivables, 61 to 90 Days Past Due [Member] | Company Originated [Member] | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | $ 93 | $ 65 |
Loans Receivable and Allowan_12
Loans Receivable and Allowance for Loan Losses (Allowance for Loan Losses and Recorded Investment in Financing Receivables) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Beginning balance, | $ 8,509 | $ 8,452 |
Charge Offs | (942) | (1,433) |
Recoveries | 133 | 240 |
Provision for loan losses | 5,450 | 1,250 |
Ending balance, | 13,150 | 8,509 |
Ending balance individually evaluated for impairment | 417 | |
Ending balance collectively evaluated for impairment | 13,150 | 8,092 |
Residential Real Estate Loans [Member] | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Beginning balance, | 1,552 | 1,328 |
Charge Offs | (41) | (102) |
Recoveries | 6 | 24 |
Provision for loan losses | 443 | 302 |
Ending balance, | 1,960 | 1,552 |
Ending balance individually evaluated for impairment | ||
Ending balance collectively evaluated for impairment | 1,960 | 1,552 |
Commercial Real Estate Loans [Member] | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Beginning balance, | 4,687 | 5,455 |
Charge Offs | (452) | (627) |
Recoveries | 39 | 125 |
Provision for loan losses | 3,730 | (266) |
Ending balance, | 8,004 | 4,687 |
Ending balance individually evaluated for impairment | 417 | |
Ending balance collectively evaluated for impairment | 8,004 | 4,270 |
Construction Real Estate Loans [Member] | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Beginning balance, | 95 | 93 |
Charge Offs | ||
Recoveries | ||
Provision for loan losses | 55 | 2 |
Ending balance, | 150 | 95 |
Ending balance individually evaluated for impairment | ||
Ending balance collectively evaluated for impairment | 150 | 95 |
Commercial [Member] | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Beginning balance, | 949 | 712 |
Charge Offs | (18) | (284) |
Recoveries | 44 | 48 |
Provision for loan losses | 385 | 473 |
Ending balance, | 1,360 | 949 |
Ending balance individually evaluated for impairment | ||
Ending balance collectively evaluated for impairment | 1,360 | 949 |
Consumer Loans To Individuals [Member] | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Beginning balance, | 1,226 | 864 |
Charge Offs | (431) | (420) |
Recoveries | 44 | 43 |
Provision for loan losses | 837 | 739 |
Ending balance, | 1,676 | 1,226 |
Ending balance individually evaluated for impairment | ||
Ending balance collectively evaluated for impairment | $ 1,676 | $ 1,226 |
Premises and Equipment (Narrati
Premises and Equipment (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Premises and Equipment [Abstract] | ||
Depreciation expense | $ 1,322 | $ 1,005 |
Premises and Equipment (Compone
Premises and Equipment (Components of Premises and Equipment) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 35,140 | $ 28,884 |
Accumulated depreciation | (17,326) | (14,656) |
Property, Plant and Equipment, Net, Total | 17,814 | 14,228 |
Land and Improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | 3,878 | 2,806 |
Buildings and improvements [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | 21,545 | 17,914 |
Furniture and equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Property, Plant and Equipment, Gross | $ 9,717 | $ 8,164 |
Deposits (Narrative) (Details)
Deposits (Narrative) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Deposits [Abstract] | ||
Time Deposits, $250,000 or More | $ 205,376 | $ 137,108 |
Deposits (Schedule of Maturitie
Deposits (Schedule of Maturities of Time Deposits) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Deposits [Abstract] | ||
2021 | $ 353,950 | |
2022 | 106,898 | |
2023 | 40,440 | |
2024 | 24,131 | |
2025 | 8,412 | |
Time Deposits, Total | $ 533,831 | $ 360,718 |
Borrowings (Narrative) (Details
Borrowings (Narrative) (Details) - USD ($) | Dec. 31, 2020 | Dec. 31, 2019 |
Debt Instrument [Line Items] | ||
Available-for-sale Securities Pledged as Collateral | $ 199,361,000 | $ 157,233,000 |
FHLB of Pittsburgh [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Line of Credit | 31,751,000 | |
Line of Credit Facility, Maximum Borrowing Capacity | 150,000,000 | |
Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available | 686,360,000 | |
Advances from Federal Home Loan Banks | 42,459,000 | |
Outstanding letter of credit amount | 100,000,000 | |
Atlantic Community Bankers Bank [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Line of Credit | 0 | 0 |
Line of Credit Facility, Maximum Borrowing Capacity | 7,000,000 | |
PNC Bank [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Line of Credit | 0 | 0 |
Line of Credit Facility, Maximum Borrowing Capacity | 16,000,000 | |
Zion Bank [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Line of Credit | 0 | 0 |
Line of Credit Facility, Maximum Borrowing Capacity | 17,000,000 | |
Securities Sold under Agreements to Repurchase [Member] | ||
Debt Instrument [Line Items] | ||
Available-for-sale securities pledged as collateral, amortized cost | 63,462,000 | 36,313,000 |
Available-for-sale Securities Pledged as Collateral | $ 64,429,000 | $ 36,195,000 |
Borrowings (Short-Term Borrowin
Borrowings (Short-Term Borrowings) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Short-term Debt [Line Items] | ||
Short-term borrowings | $ 63,303 | $ 62,256 |
Securities Sold under Agreements to Repurchase [Member] | ||
Short-term Debt [Line Items] | ||
Short-term borrowings | $ 63,303 | 30,505 |
FHLB of Pittsburgh [Member] | Federal Home Loan Bank Advances [Member] | ||
Short-term Debt [Line Items] | ||
Short-term borrowings | $ 31,751 |
Borrowings (Outstanding Balance
Borrowings (Outstanding Balances and Related Information of Short-Term Borrowings) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Borrowings [Abstract] | ||
Short-term Debt, Average Balance During the Year | $ 57,014 | $ 48,945 |
Short-term Debt, Average Interest Rate During the Year | 0.55% | 0.96% |
Short-term Debt, Maximum Month-end Balance During The Year | $ 69,294 | $ 62,256 |
Short-term Debt, Weighted Average Interest Rate at the End of the Year | 0.43% | 1.30% |
Borrowings (Collateral Pledged
Borrowings (Collateral Pledged for Repurchase Agreements) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Assets Sold under Agreements to Repurchase [Line Items] | ||
Available-for-sale Securities Pledged as Collateral | $ 199,361 | $ 157,233 |
Short-term Borrowings | 63,303 | 62,256 |
Mortgage-backed Securities-Government Sponsored Entities [Member] | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Available-for-sale Securities Pledged as Collateral | 64,429 | 36,195 |
Maturity Overnight [Member] | Mortgage-backed Securities-Government Sponsored Entities [Member] | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Available-for-sale Securities Pledged as Collateral | 64,429 | 36,195 |
Securities Sold under Agreements to Repurchase [Member] | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Available-for-sale Securities Pledged as Collateral | 64,429 | 36,195 |
Short-term Borrowings | $ 63,303 | $ 30,505 |
Borrowings (Other Borrowings) (
Borrowings (Other Borrowings) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 42,459 | $ 56,438 |
Fixed Rate Term Borrowing Due May 2020 At 1.85% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | 5,000 | |
Debt Instrument, Interest Rate, Stated Percentage | 1.85% | |
Amortizing fixed rate borrowing due June 2020 at 1.49% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | 1,034 | |
Debt Instrument, Interest Rate, Stated Percentage | 1.49% | |
Amortizing fixed rate borrowing due July 2020 at 2.77% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | 2,974 | |
Debt Instrument, Interest Rate, Stated Percentage | 2.77% | |
Amortizing fixed rate borrowing due December 2020 at 1.71% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | 2,538 | |
Debt Instrument, Interest Rate, Stated Percentage | 1.71% | |
Amortizing fixed rate borrowing due December 2020 at 3.06% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | 1,034 | |
Debt Instrument, Interest Rate, Stated Percentage | 3.06% | |
Amortizing fixed rate borrowing due March 2022 at 1.75% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 1,126 | 2,009 |
Debt Instrument, Interest Rate, Stated Percentage | 1.75% | |
Amortizing fixed rate borrowing due August 2022 at 1.94% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 3,376 | 5,351 |
Debt Instrument, Interest Rate, Stated Percentage | 1.94% | |
Amortizing fixed rate borrowing due October 2022 at 1.88% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 3,021 | 4,626 |
Debt Instrument, Interest Rate, Stated Percentage | 1.88% | |
Amortizing fixed rate borrowing due October 2023 at 3.24% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 5,865 | 7,809 |
Debt Instrument, Interest Rate, Stated Percentage | 3.24% | |
Amortizing fixed rate borrowing due December 2023 at 3.22% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 3,096 | 4,063 |
Debt Instrument, Interest Rate, Stated Percentage | 3.22% | |
Fixed Rate Term Borrowing Due December 2023 At 1.95% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 10,000 | 10,000 |
Debt Instrument, Interest Rate, Stated Percentage | 1.95% | |
Amortizing Fixed Rate Borrowing Due December 2023 At 1.73% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 7,616 | $ 10,000 |
Debt Instrument, Interest Rate, Stated Percentage | 1.73% | |
Amortizing Fixed Rate Borrowing Due April 2024 At 0.91% [Member] | ||
Debt Instrument [Line Items] | ||
Long-term Federal Home Loan Bank Advances | $ 8,359 | |
Debt Instrument, Interest Rate, Stated Percentage | 0.91% |
Borrowings (Contractual Maturit
Borrowings (Contractual Maturities of Other Borrowings) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Borrowings [Abstract] | ||
2021 | $ 12,594 | |
2022 | 11,191 | |
2023 | 17,826 | |
2024 | 848 | |
Long-term Federal Home Loan Bank Advances, Total | $ 42,459 | $ 56,438 |
Operating Leases (Narrative) (D
Operating Leases (Narrative) (Details) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020USD ($)item | Dec. 31, 2019USD ($) | |
Operating Leases [Abstract] | ||
Number of operating leases | item | 8 | |
Lease, Cost | $ 571 | $ 518 |
Right-of-use assets | 4,938 | 5,290 |
Lease liability | $ 4,984 | $ 5,316 |
Operating Leases (Lease Cost) (
Operating Leases (Lease Cost) (Details) | Dec. 31, 2020 |
Operating Leases [Abstract] | |
Weighted-average remaining term | 12 years 2 months 12 days |
Weighted-average discount rate | 3.20% |
Operating Leases (Undiscounted
Operating Leases (Undiscounted Cash Flows Due) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Operating Leases [Abstract] | ||
2021 | $ 561 | |
2022 | 546 | |
2023 | 534 | |
2024 | 544 | |
2025 | 561 | |
2026 and thereafter | 3,319 | |
Total undiscounted cash flows | 6,065 | |
Discount on cash flows | (1,081) | |
Total lease liabilities | $ 4,984 | $ 5,316 |
Employee Benefit Plans (Narrati
Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | 15.00% | ||
Defined Contribution Plan, Employer Contributions, Vesting Period | 5 years | ||
Defined Contribution Plan, Cost | $ 1,049 | $ 730 | |
Defined Benefit Plan, Benefit Obligation | 8,065 | 7,515 | $ 7,186 |
Defined Benefit Plan, Net Periodic Benefit Cost | (100) | (12) | |
Defined Benefit Plan, Benefits Paid | 532 | 553 | |
Defined Benefit Plan, Expected Future Benefit Payments, Next Twelve Months | 468 | ||
Defined Benefit Plan, Expected Future Benefit Payments, Year Five | 428 | ||
Defined Benefit Plan, Expected Future Benefit Payments, Year Four | 437 | ||
Defined Benefit Plan, Expected Future Benefit Payments, Year Three | 453 | ||
Defined Benefit Plan, Expected Future Benefit Payments, Year Two | 468 | ||
Defined Benefit Plan, Expected Future Benefit Payment | 2,063 | ||
Change in Projected Benefit Obligation from Change in Projected Discount Rate | 786 | ||
Defined Benefit Plan, Accumulated Benefit Obligation | $ 8,065 | $ 7,515 | |
Defined Benefit Plan, Target Plan Asset Allocations | 100.00% | 100.00% | |
Accumulated Postretirement Benefit Obligation | $ 1,477 | $ 1,392 | |
Supplemental Employee Retirement Plan, Defined Benefit [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Benefit Obligation | 3,529 | 3,428 | |
Pension and Other Postretirement Benefits Cost (Reversal of Cost) | 495 | 491 | |
Cash Surrender Value of Life Insurance | 39,608 | 38,763 | |
Defined Benefit Plan, Net Periodic Benefit Cost | 86 | 101 | |
Other Postretirement Benefits [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Net Periodic Benefit Cost | 24 | 29 | |
Defined Benefit Plan, Contributions by Employer | $ 24 | $ 29 | |
Defined Benefit Plan, Percentage of Plan Funded | 94.20% | 95.00% | |
Domestic equities [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 31.60% | 31.70% | |
Fixed Income Securities [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 62.60% | 57.70% | |
Other Investments [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 5.80% | 10.60% | |
JPMCB LDI Diversified Balanced Fund [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Investment concentration | 99.00% | 98.00% | |
Maximum [Member] | Other Postretirement Benefits [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Contribution Percentage | 5.00% | ||
Commingled Pensions Trust Fund [Member] | Minimum [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 10.00% | ||
Commingled Pensions Trust Fund [Member] | Minimum [Member] | Global Equity, Global Fixed Income, Real Estate And Cash-Plus [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 35.00% | ||
Commingled Pensions Trust Fund [Member] | Maximum [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 65.00% | ||
Commingled Pensions Trust Fund [Member] | Maximum [Member] | Global Equity, Global Fixed Income, Real Estate And Cash-Plus [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Target Plan Asset Allocations | 90.00% | ||
Delaware Bancshares, Inc. [Member] | Director Fee Deferral and Continuation Plan [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined Benefit Plan, Benefit Obligation | $ 82 | $ 166 | |
Pension and Other Postretirement Benefits Cost (Reversal of Cost) | $ 2 | $ 3 | |
Delaware Bancshares, Inc. [Member] | Director Fee Deferral and Continuation Plan [Member] | Minimum [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit Payment Period | 5 years | ||
Delaware Bancshares, Inc. [Member] | Director Fee Deferral and Continuation Plan [Member] | Maximum [Member] | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Benefit Payment Period | 15 years |
Employee Benefit Plans (Schedul
Employee Benefit Plans (Schedule of Projected Benefit Obligation and Changes in Plan Assets for the Defined Benefit Pension Plan) (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | |
Change in benefit obligation: | ||||
Projected benefit obligation at beginning of year | $ (7,515) | $ (7,186) | ||
Service cost | (58) | (55) | ||
Interest cost | (257) | (312) | ||
Actuarial (gain) loss | (767) | (515) | ||
Benefits paid | 532 | 553 | ||
Benefit obligation at end of year | (8,065) | (7,515) | ||
Change in plan assets: | ||||
Balance | 6,853 | 6,136 | ||
Actual return on plan assets | 1,415 | 1,275 | ||
Benefits paid | (525) | (558) | ||
Fair value of plan assets at end of year | $ 6,853 | $ 6,136 | $ 7,743 | $ 6,853 |
Funded status at end of year | $ (322) | $ (662) |
Employee Benefit Plans (Sched_2
Employee Benefit Plans (Schedule of Amounts Recognized in Accumulated Other Comprehensive Income) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Pension Plans And Other Postretirement Benefits [Abstract] | ||
Gain | $ 241 | $ 375 |
Total | $ 241 | $ 375 |
Employee Benefit Plans (Compone
Employee Benefit Plans (Components of Net Pension Cost (Income)) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost benefits earned during the period | $ 58 | $ 55 |
Interest cost on projected benefit obligation | 257 | 312 |
Actual return on assets | (395) | (379) |
Net amortization and deferral | (20) | |
Net periodic pension cost | (100) | (12) |
Other Postretirement Benefits [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Net periodic pension cost | $ 24 | $ 29 |
Employee Benefit Plans (Sched_3
Employee Benefit Plans (Schedule of Weighted Average Assumptions Used to Determine the Benefit Obligation And the Net Periodic Cost) (Details) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Pension Plans And Other Postretirement Benefits [Abstract] | ||
Discount rate, benefit obligation | 2.63% | 3.55% |
Discount rate, net periodic pension cost | 3.55% | 4.54% |
Expected long-term return on plan assets | 6.00% | 6.50% |
Employee Benefit Plans (Sched_4
Employee Benefit Plans (Schedule Of Target Asset Allocations) (Details) | Dec. 31, 2020 | Dec. 31, 2019 |
Defined Benefit Plan Disclosure [Line Items] | ||
Defined Benefit Plan, Target Plan Asset Allocations | 100.00% | 100.00% |
Domestic equities [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined Benefit Plan, Target Plan Asset Allocations | 31.60% | 31.70% |
Fixed Income Securities [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined Benefit Plan, Target Plan Asset Allocations | 62.60% | 57.70% |
Other Investments [Member] | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined Benefit Plan, Target Plan Asset Allocations | 5.80% | 10.60% |
Employee Benefit Plans (Sched_5
Employee Benefit Plans (Schedule of Changes in Level 3 Assets) (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2019USD ($) | |
Defined Benefit Plan Disclosure [Line Items] | |
Balance | $ 6,136 |
Balance | 6,853 |
Level 3 [Member] | |
Defined Benefit Plan Disclosure [Line Items] | |
Balance | 601 |
Realized gain | 187 |
Sales | (610) |
Unrealized gain (loss) | (178) |
Balance |
Income Taxes (Narrative) (Detai
Income Taxes (Narrative) (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Operating Loss Carryforwards [Line Items] | |
Net operating loss carryforward | $ 4,252 |
Net operating loss carryforward, expiration date | Dec. 31, 2035 |
Earliest Tax Year [Member] | |
Operating Loss Carryforwards [Line Items] | |
Open Tax Year | 2017 |
Income Taxes (Schedule of Compo
Income Taxes (Schedule of Components of the Provision for Federal Income Taxes) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Income Taxes [Abstract] | ||
Current | $ 7,754 | $ 1,620 |
Deferred | (4,468) | 988 |
Income Tax Expense (Benefit), Total | $ 3,286 | $ 2,608 |
Income Taxes (Schedule of Effec
Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Income Taxes [Abstract] | ||
Tax at statutory rates | 21.00% | 21.00% |
Tax exempt interest income, net of interest expense disallowance | (3.70%) | (4.40%) |
Non-deductible merger related expenses | 1.10% | |
Earnings and proceeds on life insurance | (1.00%) | (1.00%) |
Other | 0.50% | (0.10%) |
Effective Income Tax Rate, Continuing Operations, Total | 17.90% | 15.50% |
Income Taxes (Schedule of Defer
Income Taxes (Schedule of Deferred Tax Assets and Liabilties) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Income Taxes [Abstract] | ||
Deferred tax assets, Allowance for loan losses | $ 2,761 | $ 1,787 |
Deferred tax assets, Deferred compensation | 758 | 797 |
Deferred tax assets, Core deposit intangible | 230 | 141 |
Deferred tax assets, Prepaid expenses | 20 | 55 |
Deferred tax assets, Pension liability | 118 | 360 |
Deferred tax assets, Foreclosed real estate valuance allowance | 17 | 17 |
Deferred tax assets, Net operating loss carryforward | 893 | 968 |
Deferred Tax Assets, Purchase Price Adjustment | 2,832 | 0 |
Deferred Tax Assets, Deferred loan fees | 60 | 0 |
Deferred tax assets, Other | 747 | 122 |
Total Deferred Tax Assets | 8,436 | 4,247 |
Deferred tax liabilities, Premises and equipment | 920 | 598 |
Deferred tax liablities, Deferred loan fees | 0 | 220 |
Deferred tax liabilities, Net unrealized gain on pension liability | 272 | 221 |
Deferred tax liabilities, Purchase price adjustment | 0 | 327 |
Deferred Tax Liabilities, Net unrealized gain on securities | 1,089 | 94 |
Total Deferred Tax Liabilities | 2,281 | 1,460 |
Net Deferred Tax Asset | $ 6,155 | $ 2,787 |
Regulatory Matters and Stockh_3
Regulatory Matters and Stockholders' Equity (Narrative) (Details) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020USD ($) | Dec. 31, 2019 | |
Regulatory Matters and Stockholders' Equity [Abstract] | ||
Tier 1 capital (to risk weighted assets) For Capital Adequacy Purposes, Ratio | 0.0600 | 0.0600 |
Common Equity Tier 1 capital (to risk-weighted assets) For Capital Adequacy Purposes, Ratio | 0.0450 | 0.0450 |
Tier 1 capital (to average assets) For Capital Adequacy Purposes, Ratio | 0.0400 | 0.0400 |
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 119,465 | |
Risk weight assigned to exposures | 150.00% | |
Capital conservation buffer | 2.50% |
Regulatory Matters and Stockh_4
Regulatory Matters and Stockholders' Equity (Schedule of Compliance with Regulatory Capital Requirements under Banking Regulations) (Details) $ in Thousands | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) |
Regulatory Matters and Stockholders' Equity [Abstract] | ||
Total capital (to risk weighted assets), Amount | $ 172,103 | $ 132,507 |
Total capital (to risk weighted assets) For Capital Adequacy Purposes, Amount | 109,123 | 75,674 |
Total capital (to risk weighted assets) To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 136,404 | $ 94,593 |
Total capital (to risk weighted assets), Ratio | 0.1262 | 0.1398 |
Total capital (to risk weighted assets) For Capital Adequacy Purposes, Ratio | 0.0800 | 0.0800 |
Total capital (to risk weighted assets) To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 0.1000 | 0.1000 |
Tier 1 capital (to risk weighted assets), Amount | $ 158,953 | $ 123,999 |
Tier 1 capital (to risk weighted assets) For Capital Adequacy Purposes, Amount | 81,842 | 56,756 |
Tier 1 capital (to risk weighted assets) To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 109,123 | $ 75,674 |
Tier 1 capital (to risk weighted assets), Ratio | 0.1165 | 0.1308 |
Tier 1 capital (to risk weighted assets) For Capital Adequacy Purposes, Ratio | 0.0600 | 0.0600 |
Tier 1 capital (to risk weighted assets) To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 0.0800 | 0.0800 |
Common Equity Tier 1 capital (to risk-weighted assets), amount | $ 158,953 | $ 123,999 |
Common Equity Tier 1 capital (to risk-weighted assets), for Capital Adequacy Purposes, amount | 61,382 | 42,567 |
Common Equity Tier 1 capital (to risk-weighted assets) to be Well Capitalized under Prompt Corrective Action Provision, amount | $ 88,663 | $ 61,485 |
Common Equity Tier 1 capital (to risk-weighted assets), Ratio | 0.1165 | 0.1308 |
Common Equity Tier 1 capital (to risk-weighted assets) For Capital Adequacy Purposes, Ratio | 0.0450 | 0.0450 |
Common Equity Tier 1 capital (to risk-weighted assets) to be Well Capitalized under Prompt Corrective Action Provision | 0.0650 | 0.0650 |
Tier 1 capital (to average assets), Amount | $ 158,953 | $ 123,999 |
Tier 1 capital (to average assets) For Capital Adequacy Purposes, Amount | 72,994 | 48,735 |
Tier 1 capital (to average assets) To Be Well Capitalized Under Prompt Corrective Action Provisions, Amount | $ 91,243 | $ 60,918 |
Tier 1 capital (to average assets), Ratio | 0.0871 | 0.1033 |
Tier 1 capital (to average assets) For Capital Adequacy Purposes, Ratio | 0.0400 | 0.0400 |
Tier 1 capital (to average assets) To Be Well Capitalized Under Prompt Corrective Action Provisions, Ratio | 0.0500 | 0.0500 |
Stock Based Compensation (Narra
Stock Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Apr. 22, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Exercise price, min | $ 16.65 | ||||
Exercise price, max | $ 36.02 | ||||
Allocated Share-based Compensation Expense | $ 204 | $ 208 | |||
Future compensation expense of non-vested restricted stock outstanding | 1,202 | 1,146 | |||
Unrecognized Salaries And Employee Benefits Expense | $ 214 | 203 | |||
Common Stock, Dividend Rate, Percentage | 50.00% | ||||
Weighted Average Remaining Contractual Term, Outstanding | 6 years | ||||
Stock options exercised | $ 268 | $ 638 | |||
Stock options exercised, shares | 15,530 | 32,350 | |||
Restricted Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Allocated Share-based Compensation Expense | $ 334 | $ 289 | |||
Non-vested stock outstanding | 39,135 | 36,195 | 34,615 | ||
Restricted stock, granted | 14,500 | 13,100 | |||
Common Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Stock options exercised, shares | 15,530 | 32,350 | |||
Norwood Financial Corp 2014 Equity Incentive Plan [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 375,000 | ||||
Shares available for awards | 129,535 | ||||
Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Restricted Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 63,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 5 years | ||||
Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Officer [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Shares available for awards | 110,010 | ||||
Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Officer [Member] | Restricted Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Shares available for awards | 6,075 | ||||
Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Outside Directors [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 60,000 | ||||
Shares available for awards | 19,525 | ||||
Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Outside Directors [Member] | Restricted Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 12,000 | ||||
Shares available for awards | 2,225 | ||||
Amended Norwood Financial Corp 2014 Equity Incentive Plan [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Options and restricted stock, granted | 245,465 | ||||
Amended Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Officer [Member] | Restricted Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 62,700 | ||||
Options and restricted stock, granted | 56,625 | ||||
Shares increased (decrased) | (300) | ||||
Amended Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Outside Directors [Member] | Restricted Stock [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 32,300 | ||||
Options and restricted stock, granted | 30,075 | ||||
Shares increased (decrased) | 20,300 | ||||
Amended Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Employees [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Options and restricted stock, granted | 148,365 | ||||
Amended Norwood Financial Corp 2014 Equity Incentive Plan [Member] | Director [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Options and restricted stock, granted | 10,400 |
Stock Based Compensation (Summa
Stock Based Compensation (Summary of Stock Option Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Stock Based Compensation [Abstract] | ||
Options, beginning of year | 199,825 | 208,700 |
Options, Granted | 33,750 | 26,750 |
Options, Exercised | (15,530) | (32,350) |
Options, Forfeited | (2,075) | (3,275) |
Options, end of year | 215,970 | 199,825 |
Options, Exercisable, end of period | 182,220 | 173,075 |
Weighted Average Exercise Price Per Share, Outstanding, beginning of period | $ 24.78 | $ 22.54 |
Weighted Average Exercise Price Per Share, Granted | 26.93 | 36.02 |
Weighted Average Exercise Price Per Share, Exercised | 17.25 | 19.71 |
Weighted Average Exercise Price Per Share, Forfeited | 16.83 | 24.31 |
Weighted Average Exercise Price Per Share, Outstanding, end of period | 25.73 | 24.78 |
Weighted Average Exercise Price Per Share, Exercisable, end of period | $ 25.51 | $ 23.04 |
Aggregate Intrinsic Value, Outstanding, beginning of period | $ 2,822,470 | |
Aggregate Intrinsic Value, Outstanding, end of period | 742,738 | $ 2,822,470 |
Aggregate Intrinsic Value, Exercisable at end of period | $ 742,738 | $ 2,745,430 |
Stock Based Compensation (Sched
Stock Based Compensation (Schedule of Fair Value Assumptions) (Details) - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Stock Based Compensation [Abstract] | ||
Dividend yield | 3.55% | 3.59% |
Expected life | 10 years | 10 years |
Expected volatility | 34.15% | 29.08% |
Risk-free interest rate | 0.91% | 1.92% |
Weighted average fair value of options granted | $ 6.34 | $ 7.61 |
Stock Based Compensation (Sch_2
Stock Based Compensation (Schedule of Outstanding Stock Options) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 215,970 | 199,825 | 208,700 |
Average Exercise Price | $ 25.73 | $ 24.78 | $ 22.54 |
Remaining Life, Years | 6 years | ||
Options Exercisable | 182,220 | 173,075 | |
Average Exercise Price | $ 25.51 | $ 23.04 | |
Average Exercise Price - $16.65 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 18,000 | ||
Average Exercise Price | $ 16.65 | ||
Remaining Life, Years | 1 year | ||
Options Exercisable | 18,000 | ||
Average Exercise Price | $ 16.65 | ||
Average Exercise Price - $18.03 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 23,100 | ||
Average Exercise Price | $ 18.03 | ||
Remaining Life, Years | 2 years | ||
Options Exercisable | 23,100 | ||
Average Exercise Price | $ 18.03 | ||
Average Exercise Price - $18.36 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 1,650 | ||
Average Exercise Price | $ 18.36 | ||
Remaining Life, Years | 2 years | ||
Options Exercisable | 1,650 | ||
Average Exercise Price | $ 18.36 | ||
Average Exercise Price - $19.30 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 3,000 | ||
Average Exercise Price | $ 19.30 | ||
Remaining Life, Years | 2 years 9 months 18 days | ||
Options Exercisable | 3,000 | ||
Average Exercise Price | $ 19.30 | ||
Average Exercise Price - $17.93 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 20,125 | ||
Average Exercise Price | $ 17.93 | ||
Remaining Life, Years | 3 years | ||
Options Exercisable | 20,125 | ||
Average Exercise Price | $ 17.93 | ||
Average Exercise Price - $19.39 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 8,250 | ||
Average Exercise Price | $ 19.39 | ||
Remaining Life, Years | 3 years 10 months 24 days | ||
Options Exercisable | 8,250 | ||
Average Exercise Price | $ 19.39 | ||
Average Exercise Price - $19.03 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 9,375 | ||
Average Exercise Price | $ 19.03 | ||
Remaining Life, Years | 4 years 10 months 24 days | ||
Options Exercisable | 9,375 | ||
Average Exercise Price | $ 19.03 | ||
Average Exercise Price - $22.37 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 16,120 | ||
Average Exercise Price | $ 22.37 | ||
Remaining Life, Years | 6 years | ||
Options Exercisable | 16,120 | ||
Average Exercise Price | $ 22.37 | ||
Average Exercise Price - $32.81 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 29,500 | ||
Average Exercise Price | $ 32.81 | ||
Remaining Life, Years | 7 years | ||
Options Exercisable | 29,500 | ||
Average Exercise Price | $ 32.81 | ||
Average Exercise Price - $32.34 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 26,350 | ||
Average Exercise Price | $ 32.34 | ||
Remaining Life, Years | 8 years | ||
Options Exercisable | 26,350 | ||
Average Exercise Price | $ 32.34 | ||
Average Exercise Price - $36.02 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 26,750 | ||
Average Exercise Price | $ 36.02 | ||
Remaining Life, Years | 9 years | ||
Options Exercisable | 26,750 | ||
Average Exercise Price | $ 36.02 | ||
Average Exercise Price - $26.93 [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding | 33,750 | ||
Average Exercise Price | $ 26.93 | ||
Remaining Life, Years | 10 years |
Stock Based Compensation (Sum_2
Stock Based Compensation (Summary of Restricted Stock Activity) (Details) - Restricted Stock [Member] - $ / shares | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Restricted stock Non-vested, beginning balance | 36,195 | 34,615 |
Restricted stock, granted | 14,500 | 13,100 |
Restricted stock, vested | (11,560) | (11,520) |
Restricted stock, forfeited | 0 | |
Restricted stock Non-vested, ending balance | 39,135 | 36,195 |
Restricted stock Non-vested, weighted-average grant date fair value, beginning balance | $ 31.65 | $ 27.82 |
Restricted stock, granted, weighted-average grant date fair value | 26.93 | 36.02 |
Restricted stock, vested, weighted-average grant date fair value | 32.89 | 25.12 |
Restricted stock, forfeited, weighted-average grant date fair value | ||
Restricted stock Non-vested, weighted-average grant date fair value, ending balance | $ 30.72 | $ 31.65 |
Earnings Per Share (Narrative)
Earnings Per Share (Narrative) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2017 | |
EARNINGS PER SHARE | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 116,350 | 0 | |
Share price | $ 26.17 | $ 38.90 | |
Common Stock, Dividend Rate, Percentage | 50.00% |
Earnings Per Share (Schedule of
Earnings Per Share (Schedule of Weighted Average Shares Outstanding Used in the Computations of Basic and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
EARNINGS PER SHARE | ||
Numerator, net income | $ 15,080 | $ 14,215 |
Weighted Average Number of Shares Outstanding, Basic [Abstract] | ||
Weighted average shares outstanding | 7,239 | 6,295 |
Less: Weighted average unvested restricted shares | (36) | (35) |
Basic EPS weighted average shares outstanding | 7,203 | 6,260 |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | ||
Weighted Average Number of Shares Outstanding, Basic | 7,203 | 6,260 |
Add: Dilutive effect of stock options and restricted shares | 27 | 72 |
Diluted EPS weighted average shares outstanding | 7,230 | 6,332 |
Basic earnings per common share | $ 2.09 | $ 2.27 |
Diluted earnings per common share | $ 2.09 | $ 2.25 |
Off-Balance Sheet Financial I_3
Off-Balance Sheet Financial Instruments and Guarantees (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Loss Contingencies [Line Items] | ||
Financial instrument commitments | $ 221,911 | $ 104,754 |
Commitments to grant loans [Member] | ||
Loss Contingencies [Line Items] | ||
Financial instrument commitments | 78,310 | 44,246 |
Unfunded commitments under lines of credit [Member] | ||
Loss Contingencies [Line Items] | ||
Financial instrument commitments | 137,965 | 56,840 |
Standby letters of credit [Member] | ||
Loss Contingencies [Line Items] | ||
Financial instrument commitments | $ 5,636 | $ 3,668 |
Interest Rate Swaps (Narrative)
Interest Rate Swaps (Narrative) (Details) | 12 Months Ended |
Dec. 31, 2020USD ($) | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Effect on earnings | $ 0 |
Interest Rate Contract [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Pledged cash as collateral | 350,000 |
Derivative Asset | $ 276,000 |
Interest Rate Swaps (Summary of
Interest Rate Swaps (Summary of Derivatives) (Details) $ in Thousands | Dec. 31, 2020USD ($) |
Customer Interest Rate Swap [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Derivative, Notional Amount | $ 12,022 |
Fair Value | 276 |
Customer Interest Rate Swap [Member] | London Interbank Offered Rate (LIBOR) Swap Rate [Member] | Maturing November, 2030 [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Derivative, Notional Amount | 7,222 |
Fair Value | 165 |
Customer Interest Rate Swap [Member] | London Interbank Offered Rate (LIBOR) Swap Rate [Member] | Maturing December, 2030 [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Derivative, Notional Amount | 4,800 |
Fair Value | 111 |
Third Party Interest Rate Swap [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Derivative, Notional Amount | 12,022 |
Fair Value | 276 |
Third Party Interest Rate Swap [Member] | London Interbank Offered Rate (LIBOR) Swap Rate [Member] | Maturing November, 2030 [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Derivative, Notional Amount | 7,222 |
Fair Value | 165 |
Third Party Interest Rate Swap [Member] | London Interbank Offered Rate (LIBOR) Swap Rate [Member] | Maturing December, 2030 [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Derivative, Notional Amount | 4,800 |
Fair Value | $ 111 |
Interest Rate Swaps (Fair Value
Interest Rate Swaps (Fair Value of Derivative Instruments) (Details) - Interest Rate Contract [Member] $ in Thousands | Dec. 31, 2020USD ($) |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Assets | $ 276 |
Other Assets [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Assets | 276 |
Other Liabilities [Member] | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |
Liabilities | $ 276 |
Fair Values of Financial Inst_3
Fair Values of Financial Instruments (Narrative) (Details) | 12 Months Ended | |
Dec. 31, 2020USD ($)itemloan | Dec. 31, 2019USD ($)item | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Impaired Financing Receivable, Recorded Investment | $ 2,144,000 | |
Valuation allowance | $ 417,000 | |
Loan [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Number of impaired loans requiring a valuation allowance | item | 0 | |
Number of loans with related allowance | item | 2 | |
Valuation allowance | $ 2,001,000 | |
Impaired Loans, Cumulative Charge-Offs | 417,000 | |
Impaired Loans [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Impaired Financing Receivable, Recorded Investment | $ 2,662,000 | $ 2,144,000 |
Number of impaired loans not requiring a valuation allowance | 6 | 2 |
Impaired Loans, Cumulative Charge-Offs | $ 652,000 | $ 251,000 |
Amount recognized | $ 0 |
Fair Values of Financial Inst_4
Fair Values of Financial Instruments (Fair Value, Assets Measured on Recurring Basis) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | $ 226,586 | $ 210,205 |
US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
US Treasury Securities [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
U.S. Government Agencies [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 3,969 | |
U.S. Government Agencies [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 3,969 | |
U.S. Government Agencies [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
U.S. Government Agencies [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 3,969 | |
U.S. Government Agencies [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
States And Political Subdivisions [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 73,091 | 71,305 |
States And Political Subdivisions [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 73,091 | 71,305 |
States And Political Subdivisions [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
States And Political Subdivisions [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 73,091 | 71,305 |
States And Political Subdivisions [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Corporate Obligations [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 3,032 | 4,100 |
Corporate Obligations [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 3,032 | 4,100 |
Corporate Obligations [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Corporate Obligations [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 3,032 | 4,100 |
Corporate Obligations [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Mortgage-backed Securities-Government Sponsored Entities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 146,494 | 134,800 |
Mortgage-backed Securities-Government Sponsored Entities [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 146,494 | 134,800 |
Mortgage-backed Securities-Government Sponsored Entities [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Mortgage-backed Securities-Government Sponsored Entities [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 146,494 | 134,800 |
Mortgage-backed Securities-Government Sponsored Entities [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Interest Rate Swap Asset [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 276 | |
Interest Rate Swap Asset [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Interest Rate Swap Asset [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 276 | |
Interest Rate Swap Asset [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Interest Rate Swap Liability [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 276 | |
Interest Rate Swap Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | ||
Interest Rate Swap Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities | 276 | |
Interest Rate Swap Liability [Member] | Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available-for-sale Securities |
Fair Values of Financial Inst_5
Fair Values of Financial Instruments (Fair Value, Assets and Liabilities Measured on Nonrecurring Basis) (Details) - Fair Value, Nonrecurring [Member] - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 |
Impaired Loans [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | $ 2,662 | $ 1,584 |
Impaired Loans [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | ||
Impaired Loans [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | ||
Impaired Loans [Member] | Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | 2,662 | 1,584 |
Foreclosed Real Estate Owned [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | 965 | 1,556 |
Foreclosed Real Estate Owned [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | ||
Foreclosed Real Estate Owned [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | ||
Foreclosed Real Estate Owned [Member] | Level 3 [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | $ 965 | $ 1,556 |
Fair Values of Financial Inst_6
Fair Values of Financial Instruments (Additional Qualitative Information about Level 3 Assets) (Details) $ in Thousands | Dec. 31, 2020USD ($)item | Dec. 31, 2019USD ($)item |
Impaired Loans [Member] | Appraisal of collateral [Member] | Measurement Input, Appraised Value [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | $ | $ 2,662 | $ 1,531 |
Servicing Asset, Measurement Input | 10 | |
Impaired Loans [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | $ | $ 53 | |
Impaired Loans [Member] | Minimum [Member] | Appraisal of collateral [Member] | Measurement Input, Appraised Value [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 0 | |
Impaired Loans [Member] | Minimum [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 4 | |
Impaired Loans [Member] | Maximum [Member] | Appraisal of collateral [Member] | Measurement Input, Appraised Value [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 10.59 | |
Impaired Loans [Member] | Maximum [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 6.97 | |
Impaired Loans [Member] | Weighted Average [Member] | Appraisal of collateral [Member] | Measurement Input, Appraised Value [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 9.75 | 10 |
Impaired Loans [Member] | Weighted Average [Member] | Present value of future cash flows [Member] | Measurement Input, Discount Rate [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 5.55 | |
Foreclosed Real Estate Owned [Member] | Appraisal of collateral [Member] | Measurement Input, Liquidation Espenses [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Assets, Fair Value Disclosure | $ | $ 965 | $ 1,556 |
Servicing Asset, Measurement Input | 7 | |
Foreclosed Real Estate Owned [Member] | Minimum [Member] | Appraisal of collateral [Member] | Measurement Input, Liquidation Espenses [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 0 | |
Foreclosed Real Estate Owned [Member] | Maximum [Member] | Appraisal of collateral [Member] | Measurement Input, Liquidation Espenses [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 7 | |
Foreclosed Real Estate Owned [Member] | Weighted Average [Member] | Appraisal of collateral [Member] | Measurement Input, Liquidation Espenses [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Servicing Asset, Measurement Input | 7 | 4.34 |
Fair Values of Financial Inst_7
Fair Values of Financial Instruments (Fair Value, by Balance Sheet Grouping) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Financial assets: Cash and cash equivalents, Fair Value Disclosure | $ 111,693 | $ 15,415 | |
Financial assets: Loans receivable, net, Fair Value Disclosure | 1,493,480 | 943,143 | |
Financial assets: Mortgage servicing rights, Fair Value Disclosure | 476 | 226 | |
Financial assets: Regulatory stock, Fair Value Disclosure | 3,981 | 4,844 | |
Financial assets: Bank owned life insurance, Fair Value Disclosure | 39,608 | 38,763 | |
Financial assets: Accrued interest receivable, Fair Value Disclosure | 6,232 | 3,719 | |
Financial liabilities: Deposits, Fair Value Disclosure | 1,540,661 | 961,120 | |
Financial liabilities: Short-term borrowings, Fair Value Disclosure | 63,303 | 62,256 | |
Financial liabilities: Other borrowings, Fair Value Disclosure | 43,452 | 56,618 | |
Financial liabilities: Accrued interest payable, Fair Value Disclosure | 1,601 | 2,432 | |
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure | |||
Financial assets: Cash and cash equivalents | 111,693 | 15,415 | $ 18,348 |
Financial assets: Loans receivable, net | 1,397,582 | 916,072 | |
Financial assets: Mortgage servicing rights | 337 | 187 | |
Financial assets: Regulatory stock | 3,981 | 4,844 | |
Financial assets: Bank owned life insurance | 39,608 | 38,763 | |
Financial assets: Accrued interest receivable | 6,232 | 3,719 | |
Financial liabilities: Deposits | 1,535,385 | 957,529 | |
Financial liabilities: Short-term borrowings | 63,303 | 62,256 | |
Financial liabilities: Other borrowings | 42,459 | 56,438 | |
Financial liabilities: Accrued interest payable | 1,601 | 2,432 | |
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit | |||
Fair Value, Inputs, Level 1 [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Financial assets: Cash and cash equivalents, Fair Value Disclosure | 111,693 | 15,415 | |
Financial assets: Loans receivable, net, Fair Value Disclosure | |||
Financial assets: Mortgage servicing rights, Fair Value Disclosure | |||
Financial assets: Regulatory stock, Fair Value Disclosure | 3,981 | 4,844 | |
Financial assets: Bank owned life insurance, Fair Value Disclosure | 39,608 | 38,763 | |
Financial assets: Accrued interest receivable, Fair Value Disclosure | 6,232 | 3,719 | |
Financial liabilities: Deposits, Fair Value Disclosure | 1,001,555 | 596,811 | |
Financial liabilities: Short-term borrowings, Fair Value Disclosure | 63,303 | 62,256 | |
Financial liabilities: Other borrowings, Fair Value Disclosure | |||
Financial liabilities: Accrued interest payable, Fair Value Disclosure | 1,601 | 2,432 | |
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure | |||
Fair Value, Inputs, Level 2 [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Financial assets: Cash and cash equivalents, Fair Value Disclosure | |||
Financial assets: Loans receivable, net, Fair Value Disclosure | |||
Financial assets: Mortgage servicing rights, Fair Value Disclosure | |||
Financial assets: Regulatory stock, Fair Value Disclosure | |||
Financial assets: Bank owned life insurance, Fair Value Disclosure | |||
Financial assets: Accrued interest receivable, Fair Value Disclosure | |||
Financial liabilities: Deposits, Fair Value Disclosure | |||
Financial liabilities: Short-term borrowings, Fair Value Disclosure | |||
Financial liabilities: Other borrowings, Fair Value Disclosure | |||
Financial liabilities: Accrued interest payable, Fair Value Disclosure | |||
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure | |||
Level 3 [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Financial assets: Cash and cash equivalents, Fair Value Disclosure | |||
Financial assets: Loans receivable, net, Fair Value Disclosure | 1,493,480 | 943,143 | |
Financial assets: Mortgage servicing rights, Fair Value Disclosure | 476 | 226 | |
Financial assets: Regulatory stock, Fair Value Disclosure | |||
Financial assets: Bank owned life insurance, Fair Value Disclosure | |||
Financial assets: Accrued interest receivable, Fair Value Disclosure | |||
Financial liabilities: Deposits, Fair Value Disclosure | 539,106 | 364,309 | |
Financial liabilities: Short-term borrowings, Fair Value Disclosure | |||
Financial liabilities: Other borrowings, Fair Value Disclosure | 43,452 | 56,618 | |
Financial liabilities: Accrued interest payable, Fair Value Disclosure | |||
Off-balance sheet financial instruments: Commitments to extend credit and outstanding letters of credit, Fair Value Disclosure |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Summary Of Changes In Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | $ 1,187 | |
Other comprehensive income | 3,932 | $ 6,207 |
Ending balance | 5,119 | 1,187 |
Unrealized gains and losses on available-for-sale securities [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | 354 | (5,558) |
Other comprehensive income (loss) before reclassification | 3,798 | 6,113 |
Amount reclassified from accumulated other comprehensive (income) loss | (56) | (201) |
Other comprehensive income | 3,742 | 5,912 |
Ending balance | 4,096 | 354 |
Unrealized gain (loss) on pension liability [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | 833 | 538 |
Other comprehensive income (loss) before reclassification | 190 | 295 |
Other comprehensive income | 190 | 295 |
Ending balance | 1,023 | 833 |
Accumulated Other Comprehensive Income (Loss) [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance | 1,187 | (5,020) |
Other comprehensive income (loss) before reclassification | 3,988 | 6,408 |
Amount reclassified from accumulated other comprehensive (income) loss | (56) | (201) |
Other comprehensive income | 3,932 | 6,207 |
Ending balance | $ 5,119 | $ 1,187 |
Accumulated Other Comprehensi_4
Accumulated Other Comprehensive Income (Significant Amounts Reclassified Out Of Each Component Of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Net realized gains on sales of securities | $ 71 | $ 254 |
Income tax expense | (3,286) | (2,608) |
Net income | 15,080 | 14,215 |
Amount Reclassified From Accumulated Other Comprehensive Income (Loss) [Member] | Unrealized gains and losses on available-for-sale securities [Member] | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
Net realized gains on sales of securities | 71 | 254 |
Income tax expense | (15) | (53) |
Net income | $ 56 | $ 201 |
Acquisition of UpState New Yo_3
Acquisition of UpState New York Bancorp, Inc. and USNY Bank (Narrative) (Details) - USD ($) | Jul. 07, 2020 | Dec. 31, 2020 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Business Acquisition [Line Items] | ||||||
Total Assets | $ 1,851,864,000 | $ 1,851,864,000 | $ 1,230,610,000 | |||
Deposits | 1,535,385,000 | 1,535,385,000 | 957,529,000 | |||
Stockholders’ equity | $ 44,803,000 | 194,785,000 | 194,785,000 | 137,428,000 | $ 122,285,000 | |
Cash paid per share | $ 33.33 | |||||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 1,865,738 | |||||
Loans acquired with credit deterioration | 15,410,000 | 15,410,000 | ||||
Goodwill resulting from merger | $ 17,959,000 | 29,290,000 | 29,290,000 | 11,331,000 | ||
Accumulated depreciation | 1,224,000 | 1,224,000 | $ 1,110,000 | |||
UpState New York Bancorp, Inc. [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Total Assets | $ 463,800,000 | |||||
Deposits | 412,800,000 | |||||
Stockholders’ equity | $ 44,800,000 | |||||
Conversion of shares | 0.9390 | |||||
Cash paid per share | $ 33.33 | |||||
Percent exchanged for stock | 90.00% | |||||
Percent exchanged for cash | 10.00% | |||||
Performance conditions | $ 0.67 | |||||
Payments to Acquire Businesses, Gross | $ 8,845,198 | |||||
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 1,865,738 | |||||
Loans Acquired Without Evidence Of Deterioration, Unpaid Principal Balance | $ 400,127,000 | |||||
Loans Acquired Without Evidence Of Deterioration, Fair Value | 393,580,000 | |||||
Credit impaired loans acquired subject to a non-accretable difference | 15,410,000 | |||||
Non-accretable difference for credit impaired loans acquired | $ 5,213,000 | |||||
Goodwill and intangible assets | 17,959,000 | 17,959,000 | ||||
Goodwill resulting from merger | 17,959,000 | 17,959,000 | ||||
Reduction in goodwill | 923,000 | |||||
Asset Impairment Charges | 0 | |||||
UpState New York Bancorp, Inc. [Member] | Core Deposits [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Finite-Lived Intangible Assets, Gross | 409,000 | 409,000 | ||||
Accumulated depreciation | $ 37,000 | $ 37,000 |
Acquisition of UpState New Yo_4
Acquisition of UpState New York Bancorp, Inc. and USNY Bank (Schedule of Business Acquisitions, by Acquisition) (Details) - USD ($) $ / shares in Units, $ in Thousands | Jul. 07, 2020 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Business Acquisition [Line Items] | |||||
Acquiree shares settled for stock | 1,987,206 | ||||
Exchange Ratio | 0.939% | ||||
Norwood Financial Corp shares issued | 1,865,738 | ||||
Value assigned to acquirer common share, per share | $ 24.30 | ||||
Purchase price assigned to UpState New York Bancorp, Inc. common shares exchanged for Norwood Financial Corp shares | $ 45,337 | $ 45,337 | |||
UpState New York Bancorp, Inc. shares exchanged for cash, excluding fractional shares | 220,794 | ||||
Purchase price paid to each UpState New York Bancorp, Inc. common share exchanged for cash | $ 33.33 | ||||
Purchase price assigned to UpState New York Bancorp, Inc. common shares exchanged for cash | $ 7,359 | ||||
Purchase price consideration - Cash-in-lieu of Fractional Shares | 1,479 | ||||
Cash in lieu of fractional shares | 6 | ||||
Total purchase price | 54,181 | ||||
UpState New York Bancorp, Inc. shareholders' equity | 44,803 | 194,785 | $ 137,428 | $ 122,285 | |
Tangible equity | 44,803 | ||||
Adjustments to investments acquired to fair value | (112) | ||||
Adjustments to interest rates on loans acquired to fair value | 3,982 | ||||
Adjustments to general credit on loans acquired to fair value | (10,529) | ||||
Adjustments to specific credit - non-amortizing on loans acquired to fair value | (5,213) | ||||
Adjustments to specific credit - amortizing on loans acquired to fair value | (1,724) | ||||
Adjustments to core deposit intangibles acquired to fair value | 409 | ||||
Adjustments to deferred loan fees acquired to fair value | (812) | ||||
Adjustments to premises and equipment acquired to fair value | (1,211) | ||||
Adjustments to allowance for loan and lease losses acquired to fair value | 5,982 | ||||
Adjustments to deferred tax assets acquired to fair value | 3,449 | ||||
Adjustments to other assets acquired to fair value | (48) | ||||
Adjustments to time deposits acquired to fair value | (2,754) | ||||
Net Assets Acquired: Cash | 24,037 | ||||
Net Assets Acquired: Securities available for sale | 13,836 | ||||
Net Assets Acquired: Loans | 405,221 | ||||
Net Assets Acquired: Premises & equipment, net | 4,318 | ||||
Net assets acquired: Regulatory stock | 2,487 | ||||
Net Assets Acquired: Accrued interest receivable | 1,426 | ||||
Net Assets Acquired: Core deposit intangible | 564 | ||||
Net Assets Acquired: Other assets | 5,117 | ||||
Net Assets Acquired: Time deposits | (414,113) | ||||
Net Assets Acquired: Accrued interest payable | (175) | ||||
Net Assets Acquired: Other liabilities | (6,496) | ||||
Net Assets Acquired | 36,222 | ||||
Goodwill resulting from merger | $ 17,959 | 29,290 | $ 11,331 | ||
UpState New York Bancorp, Inc. [Member] | |||||
Business Acquisition [Line Items] | |||||
Norwood Financial Corp shares issued | 1,865,738 | ||||
Purchase price paid to each UpState New York Bancorp, Inc. common share exchanged for cash | $ 33.33 | ||||
UpState New York Bancorp, Inc. shareholders' equity | $ 44,800 | ||||
UpState New York Bancorp, Inc. goodwill and intangibles | (17,959) | ||||
Goodwill resulting from merger | $ 17,959 |
Acquisition of UpState New Yo_5
Acquisition of UpState New York Bancorp, Inc. and USNY Bank (Future Amortization Expense) (Details) $ in Thousands | Dec. 31, 2020USD ($) |
Business Acquisition [Line Items] | |
2021 | $ 123 |
2022 | 101 |
2023 | 85 |
2024 | 69 |
2025 | 54 |
After five years | 98 |
Amortization Expense for the Core Deposit Intangible, Total | 530 |
UpState New York Bancorp, Inc. [Member] | |
Business Acquisition [Line Items] | |
2021 | 37 |
2022 | 71 |
2023 | 63 |
2024 | 56 |
2025 | 48 |
After five years | 134 |
Amortization Expense for the Core Deposit Intangible, Total | $ 409 |
Acquisition of UpState New Yo_6
Acquisition of UpState New York Bancorp, Inc. and USNY Bank (Proforma) (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Business Acquisition [Line Items] | ||
Net interest income | $ 50,476 | $ 38,606 |
Non-interest Income | 7,780 | 6,778 |
Net Income | $ 15,080 | $ 14,215 |
Earnings Per Share, Basic | $ 2.09 | $ 2.27 |
Earnings Per Share, Diluted | $ 2.09 | $ 2.25 |
UpState New York Bancorp, Inc. [Member] | ||
Business Acquisition [Line Items] | ||
Net interest income | $ 7,291 | |
Non-interest Income | 313 | |
UpState New York Bancorp, Inc. [Member] | Pro Forma [Member] | ||
Business Acquisition [Line Items] | ||
Net interest income | 52,897 | $ 50,487 |
Non-interest Income | 8,726 | 7,959 |
Net Income | $ 20,613 | $ 18,842 |
Earnings Per Share, Basic | $ 2.52 | $ 2.31 |
Earnings Per Share, Diluted | $ 2.52 | $ 2.30 |
Risks and Uncertainties (Narrat
Risks and Uncertainties (Narrative) (Details) $ in Millions | Dec. 31, 2020USD ($)item |
Risks and Uncertainties [Abstract] | |
Number of applications | item | 1,100 |
PPP loans | $ | $ 95 |
Risks and Uncertainties (Summar
Risks and Uncertainties (Summary of Loan Forbearance) (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2020USD ($)loan | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 1,215 |
Balance | $ | $ 274,190 |
Residential Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 118 |
Balance | $ | $ 10,883 |
Commercial Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 385 |
Balance | $ | $ 218,984 |
Agricultural Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 16 |
Balance | $ | $ 5,267 |
Construction Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 24 |
Balance | $ | $ 4,125 |
Commercial [Member] | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 186 |
Balance | $ | $ 23,801 |
Consumer Loans To Individuals [Member] | |
Risks And Uncertainties [Line Items] | |
Number of Loans | loan | 486 |
Balance | $ | $ 11,130 |
Risks and Uncertainties (Summ_2
Risks and Uncertainties (Summary Of Loans That Remain In Forbearance) (Details) $ in Thousands | Dec. 31, 2020USD ($)loan |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 314 |
Loans Remaining In Forbearance | $ | $ 55,646 |
Residential Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 14 |
Loans Remaining In Forbearance | $ | $ 2,163 |
Commercial Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 67 |
Loans Remaining In Forbearance | $ | $ 39,925 |
Agricultural Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 2 |
Loans Remaining In Forbearance | $ | $ 428 |
Construction Real Estate Loans [Member] | |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 3 |
Loans Remaining In Forbearance | $ | $ 7,240 |
Commercial [Member] | |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 47 |
Loans Remaining In Forbearance | $ | $ 3,773 |
Consumer Loans To Individuals [Member] | |
Risks And Uncertainties [Line Items] | |
Number Of Remaining Loans In Forbearance | loan | 88 |
Loans Remaining In Forbearance | $ | $ 2,117 |
Norwood Financial Corp (Paren_3
Norwood Financial Corp (Parent Company Only) Financial Information (Balance Sheets) (Details) - USD ($) $ in Thousands | Dec. 31, 2020 | Jul. 07, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Condensed Financial Statements, Captions [Line Items] | ||||
Cash on deposit in bank subsidiary | $ 19,445 | $ 15,038 | ||
Securities available for sale | 226,586 | 210,205 | ||
Other assets | 17,583 | 14,242 | ||
Total Assets | 1,851,864 | 1,230,610 | ||
Liabilities | 1,657,079 | 1,093,182 | ||
Stockholders’ equity | 194,785 | $ 44,803 | 137,428 | $ 122,285 |
Total Liabilities and Stockholders' Equity | 1,851,864 | 1,230,610 | ||
Parent Company [Member] | ||||
Condensed Financial Statements, Captions [Line Items] | ||||
Cash on deposit in bank subsidiary | 854 | 2,848 | ||
Investment in bank subsidiary | 195,035 | 135,433 | ||
Other assets | 2,337 | 1,875 | ||
Total Assets | 198,226 | 140,156 | ||
Liabilities | 3,441 | 2,728 | ||
Stockholders’ equity | 194,785 | 137,428 | ||
Total Liabilities and Stockholders' Equity | $ 198,226 | $ 140,156 |
Norwood Financial Corp (Paren_4
Norwood Financial Corp (Parent Company Only) Financial Information (Statements of Income) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Condensed Financial Statements, Captions [Line Items] | ||
Net realized gain (loss) on sales of securities | $ 71 | $ 254 |
Income before Income Taxes | 18,366 | 16,823 |
Income tax expense | 3,286 | 2,608 |
Net income | 15,080 | 14,215 |
COMPREHENSIVE INCOME | 19,012 | 20,422 |
Parent Company [Member] | ||
Condensed Financial Statements, Captions [Line Items] | ||
Dividends from bank subsidiary | 15,319 | 6,113 |
Expenses | 1,704 | 637 |
Income before Income Taxes | 13,615 | 5,476 |
Income tax expense | (180) | (232) |
Income before equity in undistributed earnings | 13,795 | 5,708 |
Equity in undistributed earnings of subsidiary | 1,285 | 8,507 |
Net income | 15,080 | 14,215 |
COMPREHENSIVE INCOME | $ 19,012 | $ 20,422 |
Norwood Financial Corp (Paren_5
Norwood Financial Corp (Parent Company Only) Financial Information (Statements of Cash Flows) (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2019 | |
Condensed Financial Statements, Captions [Line Items] | ||
Net Income | $ 15,080,000 | $ 14,215,000 |
Net realized gains on sales of securities | (71,000) | (254,000) |
Other, net | (7,920,000) | (522,000) |
Net Cash Provided by Operating Activities | 13,797,000 | 18,438,000 |
Proceeds from sale of securities | 24,497,000 | 27,247,000 |
Net Cash Used for Investing Activities | (61,357,000) | (39,780,000) |
Stock options exercised | 268,000 | 638,000 |
Sale of treasury stock for ESOP | 130,000 | 127,000 |
Acquisition of treasury stock | (108,000) | (428,000) |
Cash dividends paid | (7,263,000) | (6,041,000) |
Net Cash Provided by Financing Activities | 143,838,000 | 18,409,000 |
Net Increase (Decrease) in Cash and Cash Equivalents | 96,278,000 | (2,933,000) |
CASH AND CASH EQUIVALENTS - BEGINNING | 15,415,000 | 18,348,000 |
CASH AND CASH EQUIVALENTS - ENDING | 111,693,000 | 15,415,000 |
Parent Company [Member] | ||
Condensed Financial Statements, Captions [Line Items] | ||
Net Income | 15,080,000 | 14,215,000 |
Undistributed earnings of bank subsidiary | (1,285,000) | (8,507,000) |
Other, net | 28,000 | 335,000 |
Net Cash Provided by Operating Activities | 13,823,000 | 6,043,000 |
Investment in bank subsidiary | (8,844,000) | |
Net Cash Used for Investing Activities | (8,844,000) | |
Stock options exercised | 268,000 | 638,000 |
Sale of treasury stock for ESOP | 130,000 | 127,000 |
Acquisition of treasury stock | (108,000) | (428,000) |
Cash dividends paid | (7,263,000) | (6,041,000) |
Net Cash Provided by Financing Activities | (6,973,000) | (5,704,000) |
Net Increase (Decrease) in Cash and Cash Equivalents | (1,994,000) | 339,000 |
CASH AND CASH EQUIVALENTS - BEGINNING | 2,848,000 | 2,509,000 |
CASH AND CASH EQUIVALENTS - ENDING | $ 854,000 | $ 2,848,000 |